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INTRODUCTION 
  Siddha system is one of the ancient systems of medicine in our country. The 
word siddha come from the siddhi  which means an object to attained such as 
perfection in life or eternal bliss.It not only deals with physical body of man but also 
with the sinner  soul. 
  Siddhars are the forerunner of this system who are the divine persons attained 
siddhi and siddha system of medicine was inherited by them from lord siva. Siddha 
system of medicine doesn‘t consider treatment and prevention separately. The main 
aim of this system is prevention of disease as it is well said that 
“Prevention is better than cure.” 
   Siddha system based on five elements, 96 thathuvam and three life factors 
vatha, pitha and kapha. They are the three fundamental principles and essential factors 
in the composition of human body .In all tissue of the body they exist in different ratio.              
  The three life factor vatha, pitha, kaba, represent the five basic element or 
Bhuthas.  
 Vatha consist of vali and vin (air and ether) 
 Pitham consists of Thee (fire) 
 Kaba consists of man and neer (earth and water) 
 
They all persist in the body in subtle form. There appearance in the body is felt 
by their special characteristic features and their function in the body.  
When these three life factors get deranged due to extrinsic and intrinsic factors 
like diet and habit they bring about disease peculiar to their influence. 
                      “      
                        .” 
                                                                       - . 
                 Equating the five elements both in universal substances and the human body 
guides the physician in the choice of appropriate medicine suited to each case. 
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                The five basic elements form the connecting like between the microcosm 
man and the macrocosm or the world through vatha, pitha and kabha. Hence the 
siddhar‘s statement  
                       ―What all persists in the universe persists in man  
                      And what all persists in man persists in the universe‖ 
Any changes in the universe due to naturals or unnatural causes will create changes in 
human system. 
               If the diet regimen is followed as per siddha principle of life it will not 
produce any harm to the harmonious functions of the three life factors no disease will 
occurs. 
   ―      
     
           - . 
            Here the right food habit helps the body to keep the life factors in good 
condition. Hence diet  becomes medicine in the preventive aspects. 
 ―    ‖ 
    - . 
Since the disease occurs due to the derangement of three life factor siddhars 
have classified the disease accordingly .They classified as vatha disease 80, pitha 
disease 40, kapha disease 21.Swasakasam is one among the kapha disease.                 
 As per Yugi Swasa kasam is a disease condition contributed by the following 
sign and symptoms such as severe cough with or without expectoration, Expiration is 
like a hiss of a serpent, frequent hemming, sense of heat in both nostrils, Hoarseness of 
voice, indigestion, flatulence which may be co-related to the disease condition 
―Bronchial Asthma‖ in modern science. 
             Bronchial asthma is a very common disease in the society due to increasing 
exposure to air pollution and western life style. It is common in both sex but more 
prevalent among boys, while during adolescence and adulthood, it affects girls and 
women more. 
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              The prevalence of bronchial asthma has increased significantly since the 
1970s. About 300 million people world wide have asthma and by 2025 it has been 
estimated that a further 100 million will be affected  
                In India, it is estimated that 57,000 deaths were attributed to Bronchial 
Asthma in 2004(WHO2400) and it was seen as one of the leading cause of morbidity 
and mortality in rural India (Smith 2000). In 2009 Bronchial asthma caused 250,000 
deaths globally. 
                 In order to specify the importance and prevention of this disease, GINA 
(Global Intiative for Asthma )  sponsors World Asthma Day held each year on the 1
st
 
Tuesday of month of May to create awareness and graded asthma severity as  
intermittent,mild,moderate and severe persistent  based on the symptoms. 
   So there is a noticeable increase in health care burden for asthma in several 
area of the world to change in it epidermiology and symptoms. Since other system of 
medicine use  long term of steroid drug for  Bronchial Asthma  it is need for hour to 
explore siddha drug formulations to avoid  complication produced by steroid drug. So 
Author have intended to evaluate the efficacy of the Siddha formulation 
Thuthuvalayathy chooranam   for Swasakasam (Bronchial asthma). 
The ingredient of this drug said to possess expectorant, stimulant, carminative, 
antispasmodic action, immunomodulatary, bronchodailator, anti-oxidant, anti-
inflammatory, anti-histamine actions and cost effective treatment. The above said drug 
formulation, has not undergone any clinical trial, so far. So, it is proposed to carry an 
open clinical trial to find out its efficacy in Swasa Kasam.  
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AIM AND OBJECTIVES 
  AIM    :                                                                                                                              
            To document the siddha drug Thuthuvalayathy chooranam in the treatment 
of  Swasa Kasam(Bronchial asthma) by the standard process of evaluation of safety 
and efficacy of the drug. 
OBJECTIVES: 
1) Primary Objectives:  
  
            To evaluate the therapeutic efficacy of the siddha drug, “Thuthuvalayathy 
chooranam” (Internal) in the treatment of “Swasa Kasam”. 
2)  Secondary objective: 
 
 To evaluate the safety profile (acute, long term toxicity studies) of the trial 
drug.   
 To study the siddha cofactors towards the efficacy of medicine. 
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SIDDHA ASPECTS 
OTHER NAMES (SYNONYMS): 
As per Yuki Vaidhya Chinthamani Says,    
 Isivu Irumal. 
 Izhuppu Irumal. 
 Swasa Irumal. 
Eyal (definition): 
              Sever cough with or without expectoration, expiration is like a hiss of a 
serpent, frequent hemming and sense of heat in both nostrils, hoarseness of voice, 
indigestion and flatulence. 
Noi Varum Vazhi (Etiology): 
Yugi Vaidhya Chinthamani Says, 
“     
  ‖      
  
―     
    
    
    
    
   
    
     ‖.   
- ä¸¢ º¢ó¾¡Á½¢ 
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Diet and habits: 
 Exposed to excessive smoke 
 Excessive intake of cold water, food items 
 Increased acidity 
 Excessive intake of non-vegetarian diet 
 Lack of Exercise 
 Intake of allergy inducing food 
 Starving on hunger 
 Taking Improperly cooked food 
 Excessive Mental Stress 
 
―                  
         
    
         
     
         
    
         ‖ 
 ä¸¢ º¢ó¾¡Á½¢ 
Character and Behaviors 
Mental stress due to: 
 Stealing foods which were offered to GOD 
 Cursing life partner 
 Ingratitude 
 Persons who don‘t keep his words 
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Siddha Maruthuvam [Pothu] Says, 
 
 
 
 
 
 
 
CAUSES: 
 Exposure to cold weather 
 Over strain in hot climate 
 In-taking of cold and hot foods 
 Singing/speaking in high pitched voice 
 Irritants caused by following dust, mud, lime etc... 
 Inhalation of pleasant/irritable odor. 
Madhava Nidhanam Ennum Roga Vrichayam say‘s 
 Excessive Smoke 
 Excessive gastric secretion and regurgitation 
 Taking improperly cooked food 
 Food enters into the larynx while swallowing 
 Controlling reflexes like sneezing and Cough. 
Thanvandri Vaidhyam say‘s 
 «Ãº§Ã¡ ¸ó¾Éì§¸ Â¨ÁîºÃ¡ö ¸¡º§Ã¡¸õ  
 ¾¨Ã Á¢¨º Á¡ó¾÷ ¾õ¨Áî º¡÷ó¾¢Îõ Å¨¸§Â¡ ¾ýÉ¢  
 ÖÃÁ¢¨º º¢§Äºó ¾íÌ ÓÚÐÂ Ã¡Ö Á¡¾÷  
      ¾ÕÁÂÄ¡Öó àÁ  º¡÷Ð¸û Ó¸÷ó¾¡Öõ  
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 Stress 
 Excessive Coitus 
 Inhalation of dusts, pollens etc. 
Anubava Vaitheya Deva Ragaseyam Says, 
  ,  , , , , , 
, , ,     
 . 
 Elevation of vital humours such as Vatham and Kabam 
 Diarrhea due to indigestion. 
 Vomiting 
 Anemia due to toxicity. 
 Persistence fever 
 Air pollution of dust, husk etc… 
 Excessive Cold 
 Trauma of vital organs. 
Murkurigal (Preliminary Signs): 
 Sore throat. 
 Redness of throat. 
 Pricking sensation in the throat. 
 Low pitched voice. 
 Running nose. 
 Pain in the Chest. 
 Aspiration of hot foods. 
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§¿¡ö ±ñ (Classification): 
Yugi Vadihya Chindamani says, 
 
¾¡É¡É ¸¡ºÁÐ ÀýÉ¢¦Ãñ ¼¡Ìó  
 ¾¡ì¸¡É Áó¾¡Ã ¸¡ºò §¾¡Î 
À¡É¡É Àì¸Áó ¾¡Ã ¸¡ºõ 
 À¡í¸¡É Í¼÷ ¸¡ºõ Å¡¾ ¸¡ºõ 
§ÀÉ¡É À¢ò¾Á¡í ¸¡ºò §¾¡Î 
 §À÷¦À¡¢Â ÍÅ¡º¸¡ ºò§¾¡ ¦¼¡ì¸ 
²É¡É Ãò¾Á¡í ¸¡ºò §¾¡Î 
 ¨ÃôÀ¡É º¢§ÄòÁ¸¡ ºó¾¡ É¡§Á. 
 
           ¬¸¢ýÈ À£É¢ºò¾¢ý ÍÅ¡º ¸¡ºõ 
  «Æ¢Å¡¾ À¢ò¾ò¾¢ý ¸¡º Á¡Ìõ 
 §À¡¸¢ýÈ À¢ò¾º¢§ÄðÁ ¸¡ºó ¾¡§É 
  Ò¸ú¦À¡¢Â ¦º¡ó¾Á¡í ¸¡ºò §¾¡Î 
 §¾¸¢ýÈ ¸¡ºÁÐ ÀÉ¢¦Ãñ ¼¡Ìó 
 §¾Ç¢Å¡¸ þ¾Û¨¼Â ¦ºÂ¨Äì §¸§Ç! 
Swasa kasam is one among the twelve types of Kasam. 
The Twelve types are,       
1. Mandhara Kasam. 
2. Pakka Mandhara Kasam. 
3. Sudar Kasam. 
4. Vatha Kasam. 
5. Pitha Kasam. 
6. Swasa Kasam. 
7. Ratha Kasam. 
8. Silethuma Kasam.                      
9. Peenisa Kasam. 
10. Vathapitha Kasam. 
11. Pitha silethuma Kasam. 
12. Thontha Kasam. 
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T.V.Sambasivam Pillai Dictionary says 
There are twenty types of kasam, 
1. Swasa kasam                11. Eelai kasam 
2. Manthara kasam    12. Sudar kasam 
3. Ratha kasam     13. Pakka kasam 
4. Vadha kasam     14. Pakka manthara kasam 
5. Pitha kasam     15. Pennisa kasam 
6. Vali kasam     16. Naadha kasam 
7. Silethuma kasam    17. Virana kasam 
8. Thontha kasam    18. Karppa kasam 
9. Neela kasam     19. Adaippu kasam 
10. Bala kasam      20. Gunma kasam 
 
Agasthiayar – 2000 Says, 
There are eight types, those are, 
1. Vatha Kasam 
2. Pitha Kasam 
3. Kaba Mandhara Kasam 
4. Pakka Mandhara Kasam 
5. Mandhara Kasam 
6. Sudhika Kasam 
7. Marundheedu Kasam 
8. Kasam 
Tamilaga Siddha Vaitheya Gurugulam Says, 
There are twelve types. Those are, 
1. Vatha Kasam 
2. Pitha Kasam 
3. Kaba Kasam 
4. Vatha Kasam 
5. Pitha Kaba Kasam 
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6. Thontha Kasam 
7. Swasa Kasam 
8. Mandhara Kasam 
9. Patcha Mandhara Kasam 
10. Ratha Kasam 
11. Peenisa Kasam 
12. Sudar Kasam 
Vaidya sara sangraham classifies as 
1. Manthara eraippu 
2. Swasa kasam  
3. Pachai udambi ledutha swasakasam 
 
 Jeeva Rakshamirtham Says, 
There are five Types of Kasam, Those are, 
1. Vatha Kasam 
2. Pitha Kasam 
3. Silethma Kasam 
4. Ratha Kasam 
5. Shaya Kasam 
Raja Vaidhya Bodhini – Part I Says, 
There are twelve types. Those are 
1. Vatha Kasam 
2. Pitha Kasam 
3. Sethuma Kasam 
4. Vatha Pitha Kasam 
5. Pitha Sethuma Kasam 
6. Mandhara Kasam 
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7. Swasa Kasam 
8. Shaya Kasam 
9. Sudar Kasam 
10. Peenisa Kasam 
11. Naadha Kasam 
12. Thontha Kasam 
Kuri Gunangal (Signs and Symptoms): 
Siddha literatures described the signs and symptoms of Swasa kasam as follows, 
Yugi Vaidhya Chinthamani Says, 
“      
    
    
    
    
    
    
   .‖ 
Characteristic of swasa kasam According to Yugi Vaidhya Chinthamani sever 
cough with or without expectoration, expiration is like a hiss of a serpent, frequent 
hemming, sense of heat in both  nostrils, emaciation, hoarseness of voice, indigestion, 
flatulence. 
Raja Vaidhya bodhini – Part I says, 
 ,         
,  ,  ,  , , 
,  ,  , . 
The vatha and pitha pulsation is felt like the movement of tortoise, 
characteristics of Swasa kasam are flatulence, indigestion, mucoid sputum, cough, 
dryness of nose, low pitched voice, burning sensation along the vertebral column, 
dyspnoea. 
17 
 
Tamilaga Siddha Vaitheya Gurugulam Says, 
  ,    
 , , ,   ,  
, ,  ,   ,  
 , . 
Cough with expectoration of excess amount of sputum, breath sound like 
hissing of snake, indigestion, flatulence, dryness and heat sensation in the nose, 
emanciation, low pitched voice, dyspnoea, viscous secretion in Uvula, wheezing and 
Hysteria. 
Uyir Kakkum Siddha Maruthuvam entra Athma Ratchamirtham Says, 
  , , , , ,  . 
   ,   ,  ,  
. 
Characteristics of Swasa kasam as per Uyir kakkum siddha maruthuvam as 
follows Dryness of the skin, fever, cough, fatigue, headache, vomiting due to 
indigestion, constipation with sweating, excessive thirst, pedal edema. 
Mukkutra Verupadugal (Pathology): 
In siddha system of medicine, the manifestation of all the diseases are due to 
dearrange ment of Doshas ie. Vatham, Pitham, Kabam. The Prime factor which is 
involved in Swasakasam is Kaba, which is accompanied with vitiated doshas Vatha or 
Pitha and produce clinical symptoms of disease Swasakasam.  
This is clearly indicated by Theraiyar as, 
“     ‖    -  
1.    Excess of Kaba in the respiratory organs affects the Melnooku kal and uyir kal and 
so the vayu is not able to reach the terminal points of respiration which producing 
gasping and labored breathing. 
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 2.   Some authors say that the disease is caused by deranged Vatha. This thought is 
also acceptable because the destruction of Vayu in the respiratory tract is abnormally 
present. 
3.   Excessive intake of Pitha prompting diet induces Pitha Kutram. This type of Pitha 
produces more heat and this heat goes to head resulting in running nose, heaviness of 
head and neck, sneezing and also induces formation of water vapours in the lung and 
causing narrowing of air passage, which leads to the onset of the disease. This 
indicated as,  
                                    
The changes in the diet and deeds which elevates Vatha and Kaba produce the 
clinical symptoms of Swasa Kasam. 
In Uyir Nilaigal, Anagatham (chest) which is the residence of Udhanan 
(melnokku kal) and Pranan (Uyir kal) is deranged. 
When Pranan, the primary vayu is affected it lead to difficulty in breathing and 
involvement of Udhanan leads to cough and sneezing. 
Involvement of Kirukaran leads to running nose, cough, sneezing. Involvement 
of Devathathan leads to tiredness. Involvement of Samanan causes inability to control 
the other Vayus and causes loss of appetite. Involvement of Sadhaga pitham leads to 
sluggishness. In Kaba, the derangement of Avalambagam leads to dyspnoea, cough, 
wheezing. In the seven Udal Thathus, Saaram, Senneer are affected which leads to 
lethargy and depression. In severe cases Oon and Kozhuppu are also affected leads to 
symptoms of emaciation and body pain.  
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Piniyari Muraimai (Diagnosis) 
The way of diagnosis is very important by which a physician can deal the 
disease, by which he can rule out the cause of the disease which is the main thing to be 
treated.  
Thiruvalluvar Said,  
“     
  ‖ 
                                             -  
Piniyari muraigal (Method of Diagnosis) is based upon three main principles, 
1) Poriyal Arithal (Inspection). 
2) Pulanal Arithal (Palpation). 
3) Vinaathal (Interrogation). 
 
1. Poriyal Arithal: 
Porigal are the five organs of perception. They are Eyes, Ears, Nose, Tongue, Skin. 
Poriyal arithal is examining the Pori of the patient by the Pori of the physician. In 
Swasa kasam, it is as follows, 
        Mei (Skin)                :      Normal 
  Vai (Tongue) :      Excessive Salivation 
 Kann (Eye)  :      Diminished vision  
 Mookkuu (Nose) :      Running nose or nasalblock 
 Sevi (Ear)    :       Normal 
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2. Pulanal Arithal: 
Pulangal are the five objects of senses. 
Ooru (Tactile sensation) :   Warmth 
 Oosai (Hearing)             :    Normal 
 Ozhi (Visual)              :    Normal 
 Suvai (Taste Sense)             :    Normal 
             Naatram (smell sense)            :    Altered or absent due to Runningnose  
                                                                  and inflammation of nasal mucosa. 
3.  Vinadhal: 
The influence factors such as Name, Age, Family history, Socio-economic 
status, occupation, History of allergies related to food, seasons, deeds, etc. 
4. Kaalam (Age Distribution): 
 According to siddhar‘s the period of human life is totally 100 years. This is 
divided into three stages, as per to the domination of the three humours, 
1. Vatha  Kaalam  -  1 to 33 years 
2. Pitha Kaalam  -  34 to 66 years 
3. Kapha Kaalam  -  67 to 100 years 
Even though in each of these stages, the other humours are also involved a 
particular humour is dominating other two humours. According to this, Kapha types 
of diseases are more prone in the later stage (Kapha Kaalam)  
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5.  Ivagai Nilangal (Geographical Distribution): 
            Study of Ivagai Nilangal is very important since geographical distribution plays 
a vital role in altering Mukkutram and produce disease which is peculiar to that area. 
 
1. Kurinchi -  Mountains range and its surroundings. 
2. Mullai  -  Pastoral area of the forests and its surroundings. 
3. Marudham - The fertile river bed and its surroundings. 
4. Neidhal -  The coastal region and its surroundings. 
5. Paalai  - Arid-Deserts and its surroundings. 
Kurinchi: 
―     
   -  
     
   .‖ 
                         -  . 
In Kurunchi Nilam, people are affected by fever that results in blood 
dyscariasis, disease of spleen and liver, and prevalence of kaba disease is more in 
Kurunchi nilam.  
 Mullai: 
“      
   -  
     
  ‖ 
                                  -   . 
In Mullai Nilam, the pastoral land of the forest is the birth place of many pitha 
diseases and diseases like abdominal colic and other vatha diseass also occur. 
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Marudham: 
“     
  -  
    
  ‖  
                        -   . 
           Marudham the agricultural land is fertile with very good water which will drive 
out the diseases of all the three humors. The nourishing food with all the tastes never 
allows such diseases to occur. 
Neidhal: 
         “     
            -  
              
            ‖ 
                                  -   . 
Though Neithal Nilam has the dominant taste of Uvarppu (salt), it is the place 
of Pitha Vayu. The people who dwell here are susceptible to odema due to Kaba, 
Silapatha Rogam (Filariasis), Kudalanda Viruthi (Hernia). 
Paalai: 
          “     
              –  
               
             ‖ 
                                  -   . 
 
The Palai Nilam is the birth place of all the disease caused by the derangement 
of Vatha, Pitha and Kapham. From Ivagai Nilangalwe understood that kapha disease is 
predominant in kurinchi Thinai. 
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6.  PARUVA KAALAM (Season):  
 As the earth revolves around the sun, it gets sunlight at various positions. With 
reference to the position of the earth with the sun, year is divided into six seasons. 
They are, 
1. Karkaalam (Avani & Purattasi)         :  August 16 & October 15. 
2. Koothirkaalam (Iyappasi & Karthigai) :  October 16 & December 15. 
3. Munpanikallam (Margazhi & Thai) :  December 16 &February 15. 
4. Pinpanikallam (Masi & Panguni)          :  February 16 & April 15. 
5. Elavenilkaalam (Chithirai & Vaigasi)       :  April 16 & June 15. 
6. Mudhuvenilkaalam (Aani & Aadi)           :  June 16 & August 15. 
 
 According to siddha literature, all kapha diseases including swasakasam come 
during rainy season like Karkaalam. In Koothirkaalam also incidence of disease 
increased due to cold winds. 
 Swasakasam mainly occurs due to vitiation of Kapham. 
 Kapham thannilai sirappuram Kaalm – Karthigai to Masi.  
       “     
                     
                
                     
                 
                       
                ‖ 
                          (  – ) 
                                 -      
 Hence the disease Swaskasam can occur from the later part of Koothir Kaalam 
to early part of Pinpani Kaalam, (i.e.,) from the last two weeks of October to 
the first two weeks of February. 
 Totally the prevalence of disease is from August to February. 
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7. MUKKUTRA NILAIGAL: 
VATHAM: 
Pranan: 
         Pranan start from moolatharam and comes through the nostril and responsible for 
respiration in the ratio of 8:12. 
          In Swasakasam, this vayu is affected leading to difficulty in breathing. 
Abanan: 
          It starts from swathittanam and descents down. It‘s responsible for excretion of 
urine and faeces.  In Swasakasam, Abanan is affected resulting in Constipation. 
Viyanan: 
          It arises from the shoulder and go through all the 72,000 nerves and responsible 
for movement of the body, appreciates the sense of touch; help to take the essence of 
the food to the strategic points the body and guards the body. 
Samanan: 
         Samanan start from the umblicial cord and spread out upto the lower limbs and 
responsible for the balance of other four vadha and digestion. In Swasakasam, this 
vayu is affected since it cannot control the other vayus. 
Udhanan: 
 It starts from umbilical region (udarakkini) and its main function is generation 
of speech and distributes the saaram equally to all tissues. 
In Swasakasam, this vayu is affected resulting in low pitched voice due to 
difficulty of breathing. 
Nagan: 
      It is responsible for higher intellectual function, hearing, thinking etc. It causes 
opening and closing of eye lids. 
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Koorman: 
       It start from mind and causes winking of the eyelids,yawing and closure of 
mouth.It gives strength and helps to visualize things and causes lacriminal secretion. 
Kirugaran: 
       It lies in tongue and causes salivary and nasal secretion, sneeze reflex, cough 
reflex and increase the appetite, it makes to concentrate on one thing. 
In Swasakasam, this vayu is affected and causing running nose, sneezing, 
excessive cough and loss of appetite. 
Devathathan: 
        It either stays at the anus or at urinary orifice. Laziness, occular movement and 
human passions are attributed to this vayu. 
  In Swasakasam, this vayu is deranged causing emotional stress and insomnia. 
Dhananjeyan: 
           It functions from the nose and it is responsible for the bloating of the body after 
death and also for the foul smell.After 3
rd
 day of death it escapes through the head. 
PITHAM: 
Anal Pitham: 
It lies between the stomach and the intestine .It causes digestion and dries up 
moist ingestion substances. 
In Swasakasam, most of the patients complain loss of appetite and indigestion. 
Ranjagam: 
This fire lies in the stomach, where it helps in the absorption of food materials 
and finally it promotes the absorbed nutrients and gives red colour to the chyme and 
produces blood into the circulation. 
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Sadhagam: 
It resides in the heart and executes the day to day activities according to the 
consciousness of the person. In Swasakasam disease, restlessness, breathlessness 
present. 
Aalosagam: 
It resides in both eyes and is responsible for clear vision. 
Prasagam: 
It resides in skin and gives complexion and brightness to skin.In Swasakasam, 
some patients may have allergic skin lesions. 
KAPHAM: 
Avalambagam: 
It lies in lungs and helps in respiration. It controls the functioning of other four 
types of kapham and equillbrium as well as the heart. In Swasakalam patients, due to 
disarrangement of Avalambagam, will occur and causes   tightness of chest, cough, 
wheezing and difficulty in breathing.  
Kilethagam: 
It resides in the stomach and moistures the food materials making them soft and 
thereby helps in digestion process. In Swasakasam disease, some patients have 
indigestion. 
Pothagam: 
Resides in the tongue and helps to realize the taste of the consuming food. 
Tharpagam: 
Sustaining in the head and gives refrigerant effect to cool the eyes and other 
sense organs.In some patients of Swasakasam, Tharpagam is affected resulting in 
Burning sensation. 
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Sandhigam: 
It resides in the joint and helps in the free and easy movements of joints. 
UDAL KATTUGAL 
Saaram (Chyle): 
It strengthens the body and mind. It is deranged in Swasakasam due to loss of 
appetite causing tiredness in the body and mind. 
Senneer (Blood): 
It is responsible for knowledge, strength, boldness and complexion in a person. 
In Swasakasam it is affected resulting in general weakness of the body. 
Oon (Muscles): 
It gives the shape to the body according to the of the physical activity and  
nourishment of  bone growth 
Enbu (Bone): 
It forms the frame to the body and supports it to stand erect. It protects soft 
organs of the body and it also responsible for postures and movement of the body. 
Kozhuppu (Adipose tissue): 
It gives lubrication to the joint and other parts of the body to function smoothly.  
Moolai(Bone marrow): 
It resides the medulla of the bone and gives strength and softness to it. 
Sukkilam / Suronitham (sperm or ovum): 
    It is responsible for reproduction. 
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4.  ENN VAGAI THERVUGAL: (Eight diagnostic Tools): 
It is the unique diagnostic tool in Siddha system of Medicine. The following lines 
reveal this as follows.  
“    
   ‖ 
           -§¾¨ÃÂ÷ 
And,  
“     ‖ 
                                                                   -§¾¨ÃÂ÷ 
                
The diagnostic value of EN VAGAI THERVUGAL is specific to Siddha 
system of medicine and presumes the vitiated dhoshas in the patients. 
Enn Vagai thervugal are, 
a. Naa (Tongue). 
b. Niram (Colour of the skin). 
c. Mozhi (Speech). 
d. Vizhi (Eye). 
e. Malam (Motion). 
f. Moothiram (urine). 
g. Sparisam (Palpation). 
h. Naadi (Pulse). 
Naa:    
         It is observed for its color, presence of ulcer, coating, etc. 
Niram:   
       Color of the skin, conjunctive.In Swasakasam, Niram is affected when the patient 
suffer from allergic skin lesions and anaemia etc. 
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Mozhi:  
     In Swasa kasam mode of speech may be emotional or difficulty in speech, 
low pitched voice, wheezing sound is heard. 
Vizhi: 
In Swasa kasam, the eyes may have itching and burning sensation  
 Malam: 
Consistency  hard or semisolid or diarrhea, undigested food, fluid resembling 
the water used to clean meat, color, frothy, dysentery, bloody, pus, mucous, smell, 
frequency of defecation, constipation, reduced or increased stool content, lower 
abdominal pain during defecation are noted. 
Siruneer: 
Colour – yellow, black, white copper colored, mixed color, color of fumes, 
Smell – smell of fire, honey, sweet odours, fragrance of flowers, fruity odour of deer 
flesh, frothy or not, frequency and quantity are noted. 
 Sparisam: 
By Sparisam, the present of temperature and tenderness can be observed. 
  Naadi: 
Naadi is the very important tool for diagnosis and prognosis of the disease. 
In Noi Naadal Noi Mudhal Naadal Text,  
Naadi is defind as, 
“      
     ‖ 
Genesis of Naadi: 
“     
    
     
   ‖ 
      -   
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       Naadi is responsible for existence of life and can be felt one inch proximal 
to the wrist on radial side by means of palpitations with the tips of index, middle and 
ring fingers corresponding vatham, pitham, kapham respectively. 
 The three humors vatham, pitham and kabam exisits in the ratio 1: ½: ¼  
normally. Derangement in these ratios leads to various disease entities. 
            The three Uyir Thathukkal are formed by the combination of three Naadi and 
three Vayus. 
                          Idakalai + Abanan         =  Vatham 
Pinkalai + Pranan           =  Pitham 
Suzhumunai + Samanan = Kabam 
Naadi Nadai in Swasa kasam: 
 
     Vatha Kapha Naadi: 
           “     
                        
                  
                        
                  
                        
                  
                        . 
                                                                                                          -  . 
        Iya Naadi: 
              “     
                          
                   
                          
                   
                          
                   
                        ‖ 
                                                                                          -  . 
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Kaba Pitha Naadi: 
              “     
                          
                     
                           
                    
                           
                   
                           ‖ 
                                                                  -  .   
   Iya Ushnam:   
 “    
          
                    
                           
                     
                            
                     
                            “ 
                                                                   -  . 
 
   Iya Vayu: 
                 “     
                           
                     
                            
                     
                            
                      
                            ‖ 
                                       -  . 
 
Hence the Naadi Nadai in swasa kasam is Kapha, Vatha Kapha, Kapha Pitha, 
Iya Ushna, increased kapha and Iya Vayu.  
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Nei Kuri : 
Neikuri is a prognostic tool in Siddha system of Medicine. For this examination 
first urine is collected in the early morning in a clear wide mouthed glass dish or China 
clay container and is subjected to analysis of ―Neerkkuri and Neikkuri‖ within one and 
a half an hour. 
 Prior to the day of urine examination the patient is instructed to take a 
balanced diet and quantities of food must be proportionate to his routine intake. As per 
theraiyar Neerkkuri and Neikkuri nool: 
 “    
    
   
    
   
   “ 
                
 “     
    
   
   
   ‖                 
                                 
After collecting the urine in a wide cleaned glass bowel a drop of gingelly oil is 
dropped into it which is kept under sunlight in a calm place. The derangement of the 
three dhoshas can be diagnosed by the mode of spread of gingelly oil on the urine 
surface. 
                           ―    ‖ 
                    ―     
   ‖, 
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 If oil spreading like a snake indicates derangement of Vatham. 
 If oil spreading like a ring indicates derangement of Pitham 
 If oil spreading like a pearl indicates derangement of Kapham 
        ―    
             
          ‖ 
  .   
 When oil spreads like snake and ring, ring and snake, snake and pearl, ring and 
pearl indicates Dhondha Dhosham. (Dhondham – Combination of two) 
DIFFERENTIAL DIAGNOSIS 
NOI KANIPPUVIVATHAM   are, 
Silethuma Vatha Suronitham: 
“     
    
     
   
    
    
    
      ‖ 
                -    
 
In Silethuma Vatha Suronitham  symtomps like chillness of body, abdominal 
distention  with  tenderness in abdomen, body pain, headache, expectoration, 
dyspnoea, fainting, dreaming, decreased salivation, loss of taste, rapid pulse etc., 
In Swasakasam, there is no abdominal distention and decreased salivation.   
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Swasa Pitham: 
“    
    
    
     
    
    
    
   ‖ 
    -    
 In Swasa Pitham, there is increased breathing (tachypnoea), flatulence, pain all 
over the body, excessive salivation, loss of consciousness, pain in the chest followed 
by cough, loss of appetite etc., In Swasa kasam there is no loss of consciousness and 
pain in the chest followed by cough. 
Swasa Silethumam: 
“     
    
    
    
    
    
    
      ‖ 
    -   
 
In Swasa Silethumam, there is accumulation of phlegm in the chest, cough, nasal 
block, difficulty in breathing, fever with rigor, syncope, tightness of chest, dryness of 
mouth, running nose, excessive thirst etc., In Swasa kasam, there is no fever with 
rigor, excessive thirst etc. 
 
 
35 
 
Mandhara Kasam: 
"     
    
     
    
    
    
    
    
   -    
In Mandhara kasam there is running nose, sneezing, chest tightness, breath sound 
is like hissing of snake, excessive sweating  present all over the body, cough with 
expectoration,  hoarsness of voice , breathing difficulty  etc. 
In Swasa kasam there is no sweating present all over the body.  
Kandakiragam: 
“     
    
     
    
    
    
    
   ‖ 
                                                     -    
In kandakiragam, there is difficulty in speech, pain in the chest and occipital 
region, pain all over the body, breathlessness, oral breathing, sweating in face, pain in 
the ribs and loss of appetie. In swasakasam, there is no pain in the occipital region. 
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LINE OF TREATMENT: 
            In siddha system of medicine siddhar‘s follow different line of treatment for 
different disease. The line of treatment of Swasakasam consists of the following. 
1. Kalichal Maruthuvam         – To bring the dhoshas in equilibirium. 
2. Internal Medicine     – Mainly anti-spasmodic, expectorant to relieve the  
      spasm respiratory system and to expel the sputum.                                            
3. Diet               –To maintain tri-dhoshas and energy in equilibrium.                
      
4. Prevention methods  –To strengthen the muscles of respiration (Pranayamam) 
5.Yoga therapy   – To maintain dhasa vayukkal and to improve 
    mental and physical health. 
 
Kalichal Maruthuvam (Purgation):  
Patients are given laxative medicine Mantha Ennai at the dose of 8ml with 
warm water at the early morning, in empty stomach. 
                                     Ref: Siddha pharmacopoeia of Indian medicine. 
Administration of Internal medicine: 
   For the treatment of the disease swasa kasam, Thuthuvalayathi chooranam- 1.5gm 
with honey twice a daily was given after meals. 
Dietary advice:   
“       
     
     
     ‖ 
 -     
“     
   –  
    
  ‖  
                                                   -     
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Vegetables to be added 
  (Solanum melongena Linn) 
  (Trichosanthes cucumerina.Linn ) 
  (Dolichos lab-lab. Linn) 
  (Solanum xanthocarpum. Barm.f) 
  (Ficus glomavata. Linn) 
   (Luffa acutaugula. (Linn),Roxb) 
  (Mangifera indica. Linn) 
  (Musa paradisica. Linn) 
  (Moringa tinctoria.Lam) 
  (Solanum torvum. Swartx) 
 
Tuber to be added: 
  (Raphanus sativus. Linn) 
  (Allium sativum, Allium cepa. Linn) 
  (Zingiber officinale. Rose) 
  (Amorphophallus companulatus.Dennst ) 
 Onion contains ‗quercetin‘, an anti-inflammatory compound and considered 
as most effective remedy for asthma. 
Greens to be added 
  
  (Solanum nigrum.Linn) 
  (Eclipta alba. Linn) 
  (Aerva lanata. Linn) 
  (Bascella alba. Linn) 
 (Amaranthus gangeticus. Linn)  
  (Gisekia pharmacoides. Linn) 
  (Justicia madurensis. Chois) 
  (Oxalis corniculata. Linn) 
 Green leafy vegetable, fresh fruits and herbs are quite effective for asthma 
due to its antioxidant features. 
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Swasakasam patient can have food as follows: 
 Steamed food like idly,idiyappam,puttu. 
 Mussumusukai adai,kalyanam murungai ada. 
 Turmeric and Pepper mixed milk. 
 Ginger,suku mixed coffe. 
 Crap soup,veg.soup, Pepper rasam,mutton leg soup. 
 Thuthuvalai ,manathakali thuvayal. 
 Apple daily since flavonoids of apples reduce inflammation. 
Diet Restriction: 
―      
     
     
    ‖ 
                -   
 
 Mustard seeds 
 Bengal gram 
 Mango 
 Garlic 
 Tobacco 
 Bitter guard 
 Asafotida 
 Gingelly oil 
 Coconut 
 Jack fruit 
 Horse gram 
 Alcohol 
 Sesban 
 Avoid over indulgence in sex. 
These are general diet and habitual restrictions for all diseases. 
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Swasa kasam patients should restrict the following also. 
 Cool drinks, chocolate, cake. 
 Curd, ghee, butter, cheese. 
 Sweets, sour food. 
 Tuberous food.  
 Allergen food. 
 Fish, dry-fish, chicken, beaf. 
 Vegetables like cucumber, snake guard etc. 
Prevention: 
 To educate the patients to prevent swasakasam 
 Avoid smoking, alcoholism, tobacco. 
 Avoid exposure to chill and cold weather 
 Avoid working in dust, cement, cotton mills and in husks etc., 
 Have dinner before 7‘o clock. 
 Avoid full stomach at night  
 Intake of hot water and hot food 
 Advised to practice Pranayamam.  
 Advise to sleep in phoenix mat etc, 
―     
   –  
    
  ‖ 
-   
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PRANAYAMAM (Breathing Exercise): 
  Pranayama is control of Breath". "Prana" is Breath or vital energy in the body. 
On subtle levels prana represents the pranic energy responsible for life or life force, 
and "ayama" means control. So Pranayama is "Control of Breath". One can control the 
rhythms of pranic energy with pranayama and achieve healthy body and mind. 
   Pranayamam or breathing exercise mainly consists of Pooragam (inhalation of 
air by deep inspiration), Kumbagam (holding the breath as far as possible) and 
Resagam (exhalation of air by expiration)  
     During breathing exercise, the lungs filled with fresh air in its anatomical dead 
space also and expand well and get proper supply of oxygen by proper expansion of 
chest. So, pranayama practice is one of the prevention for Swasa kasam. 
        By this exercise, the duration of Kumbagam is increased. These result in 
proper gaseous exchange which provides increased oxygen supply to the lung tissues 
and purges the lungs of residual carbon dioxide. Since body organs gets more oxygen 
and toxins are removed from the body.   
       By the regular practice of Pranayamam, one can get rid of mental and physical 
stress. It provides increases mindfulness, Generates internal heat, appetite, strength, 
improves and provides vitality. It strengths immune system and prevent Hereditary  
disorder.  
  ―     
   
    
   
   
   
   
  ‖  
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      YOGA THERAPY 
              Yoga is a system inclusive of physical and mental training that can benefit 
people of all ages. It involves Asanas (body postures) and Pranayama (art of breath 
control), among which of its physical uses are to reduce stress-related conditions, help 
with circulatory and respiratory disorders such as Asthma, Bronchitis and improve 
over-allhealth. Asanas strengthen the muscles of respiration and diaphragm as well as 
regulate respiration. So, practicing asanas is more helpful in asthmatic patients as 
supportive therapies. The following asanas are helpful in Bronchial asthma. 
 SIRSASANAM ( the head stand pose):  
            The lungs gain the power to resist any situation and stand up to any 
work, which may relieves one from cough, tonsillitis and asthma. 
 SARVANGASANAM (shoulder stand pose)  :   
             Sarvangasana improves respiration and helps in treating bronchial 
asthma. 
 UTTHANASANAM (the squat and rise pose): 
              Utthanasana helps to empty impurity from lungs and gives the feeling 
of supercharges of energy. 
 PASCHIMOTTANASANAM (the fierce or powerful pose): 
             Paschimottanasna improves the efficiency of spinal nerves and has 
beneficial repercussions throughout the body. 
 BHUJANGASANAM (the cobra pose):     
            Bhujangasana expands the chest more than usual, thus helps to improve 
breathing and lungs capacity. 
  SALABHASANAM (the locusts pose):  
                 Salabhasana improves the functions of lungs. 
 UTTAN PADASANAM( the raised foot pose) : 
                Uttanpadasana gives full expansion to the chest wall and keep the 
bronchi3qal healthy. 
 ARDHA MATSYENDRASANAM (the half spinal twist pose):  
               It is one of the important asana for proper functioning of lungs 
thereby helps in controlling Aeeesx v 
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MODERN ASPECTS 
ANATOMY & PHYSIOLOGY OF RESPIRATORY SYSTEM 
The respiratory system brings air in close relationship with the mixed venous 
blood enabling tissue respiration by uptake of oxygen into the circulation and 
elimination of carbon dioxide. The principal organs of the respiratory system are  
 Nose,  
 Pharynx, 
 Larynx,  
 Trachea, 
 Bronchi 
 Lungs.  
            The conducting division of the respiratory system consists of those 
passages that serve for airflow, mainly from the nostrils through the bronchioles. 
            The airway from the nose through the larynx is often called the upper 
respiratory tract. 
             The regions from the trachea through the lungs compose the lower 
respiratory tract. 
               Muscles of respiration - the inter costal muscles and the diaphragm  
THE NOSE AND NASAL CAVITY 
          The nose is the external protuberance of an internal space, the nasal cavity. It is 
subdivided into a left and right canal by a thin medial cartilaginous and bony wall, the 
nasal septum. Each canal opens to the face by a nostril and into the pharynx by the 
choana. The floor of the nasal cavity is formed by the palate, which also forms the roof 
of the oral cavity. The complex shape of the nasal cavity is due to projections of bony 
ridges, the superior, middle, and inferior turbinate bones (or conchae), from the lateral 
wall. The passageways thus formed below each ridge are called the superior, middle, 
and inferior nasal meatuses. 
43 
 
           On each side, the intranasal space communicates with a series of neighbouring 
air-filled cavities within the skull (the paranasal sinuses) and also, via the nasolacrimal 
duct, with the lacrimal apparatus in the corner of the eye. The duct drains the lacrimal 
fluid into the nasal cavity. The sinuses are located in four different skull bones - they 
are the maxillary sinus, which is the largest cavity; the frontal sinus; the ethmoid 
sinuses; and the sphenoid sinus, which is located in the upper posterior wall of the 
nasal cavity.  
        The sinuses have two principal functions: because they are filled with air, they 
help keep the weight of the skull within reasonable limits, and they serve as resonance 
chambers for the human voice. 
          The nasal cavity with its adjacent spaces is lined by a respiratory mucosa. 
Typically, the mucosa of the nose contains mucus-secreting glands and venous 
plexuses; its top cell layer,  it consists principally of two cell types, ciliated and 
secreting cells. Two regions of the nasal cavity have a different lining. The vestibule, 
at the entrance of the nose, is lined by skin that bears short thick hairs called vibrissae. 
In the roof of the nose, the olfactory organ with its sensory epithelium checks the 
quality of the inspired air. About two dozen olfactory nerves convey the sensation of 
smell from the olfactory cells through the bony roof of the nasal cavity to the central 
nervous system. 
Function of nose 
         This structural design reflects the particular ancillary functions of the nose and of 
the upper airways in general with respect to respiration. They clean, moisten, and 
warm the inspired air, preparing it for intimate contact with the delicate tissues of the 
gas-exchange area. During expiration through the nose, the air is dried and cooled, a 
process that saves water and energy. 
PHARYNX: 
 Pharynx is the passage extending from the base of skull to the level of 6
th
 
cervical vertebra where it is continuous with the oesophagus. It is 13 cm length, 35 cm 
width. The pharynx can be divided into three floors. 
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 The upper floor- the nasopharynx:  
            It is primarily a passageway for air and secretions from the nose to the oral 
pharynx. It is also connected to the tympanic cavity of the middle ear through the 
auditory tubes that open on both lateral walls. The act of swallowing opens briefly the 
normally collapsed auditory tubes and allows the middle ears to be aerated and 
pressure differences to be equalized. In the posterior wall of the nasopharynx is located 
a lymphatic organ, the pharyngeal tonsil. When it is enlarged it may interfere with 
nasal respiration and alter the resonance pattern of the voice.  
The middle floor -oral pharynx or oropharynx: 
              The middle floor of the pharynx connects anteriorly to the mouth and is 
therefore called the oral pharynx or oropharynx. It is delimited from the nasopharynx 
by the soft palate, which roofs the posterior part of the oral cavity.  
The lower floor- hypopharynx 
          The lower floor of the pharynx is called the hypopharynx. Its anterior wall is 
formed by the posterior part of the tongue. Lying directly above the larynx, it 
represents the site where the pathways of air and food cross each other 
Functions: 
 Passage of air and food, warming and humidifying of air, taste, hearing 
protection. 
LARYNX: 
 The larynx is the voice box extends from the root of the tongue at the inlet of 
the larynx to the commencement of the trachea at the level of the 6
th
 cervical 
vertebra.It is 4.3 cm length.  
        The larynx is an organ of complex structure that serves a dual function: as an 
air canal to the lungs and a controller of its access, and as the organ of phonation. 
 Sound is produced by forcing air through a sagittal slit formed by the vocal cords 
and the glottis. 
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          The laryngeal skeleton consists of almost a dozen pieces of cartilage, most of 
them very small, interconnected by ligaments and membranes.  
 
              Thyroid Cartilage -The largest cartilage of the larynx. 
              The arytenoid cartilages - A pair of small pyramidal pieces of cartilage,  
        The cricoid-another large cartilaginous piece of the laryngeal skeleton,               
has a signet-ring shape. 
 
         The arytenoid cartilages articulate with the cricoid plate and hence are able to 
rotate and slide to close and open the glottis.  
The vocal ligaments are part of a tube, resembling an organ pipe, made of elastic 
tissue. 
Functions 
 Production of sound, speech occurs during expiration when the sound 
produced by the vocal cords in manipulated by the tongue, cheeks and 
lips. 
 Protection of lower respiratory tract from the swallowed food from 
mouth. It is the passage for air between pharynx and trachea. 
 Humidifying, filtering and warming continue as the air travels through 
the larynx. 
        TRACHEA 
             Below the larynx lies the trachea, a tube about 10 to 12 centimetres long and 
two centimetres wide. Its wall is stiffened by 16 to 20 characteristic horseshoe-shaped, 
incomplete cartilage rings that open toward the back and are embedded in a dense 
connective tissue. 
              The dorsal wall contains a strong layer of transverse smooth muscle fibres that 
spans the gap of the cartilage. The interior of the trachea is lined by the typical 
respiratory epithelium. The mucosal layer contains mucous glands. 
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 At its lower end, the trachea divides in an inverted Y into the two stem bronchi, 
one each for the left and right lung. The right main bronchus has a larger diameter, is 
oriented more vertically, and is shorter than the left main bronchus.  
          The practical consequence of this arrangement is that foreign bodies passing 
beyond the larynx will usually slip into the right lung. The structure of the stem 
bronchi closely matches that of the trachea. 
STRUCTURAL DESIGN OF THE AIRWAY TREE: 
               The hierarchy of the dividing airways, and partly also of the blood vessels 
penetrating the lung, largely determines the internal lung structure. 
                Functionally the intrapulmonary airway system can be subdivided into three 
zones: 
 Proximal- purely conducting zone, 
 Peripheral- purely gas-exchanging zone  
 Transitional zone- in between 
Morphologically it is relatively thick-walled, purely air-conducting tubes from those 
branches of the airway tree structurally designed to permit gas exchange. 
            The branching of airway is according to the rules of irregular dichotomy. The 
conducting airways comprise the trachea, the two stem bronchi, the bronchi, and the 
bronchioles. Their function is to further warm, moisten, and clean the inspired air and 
distribute it to the gas-exchanging zone of the lung. They are lined by the typical 
respiratory epithelium with ciliated cells and numerous interspersed mucus-secreting 
goblet cells. 
             The last purely conductive airway generations in the lung are the terminal 
bronchioles. Distally, the airway structure is greatly altered by the appearance of 
cuplike outpouchings from the walls. These form minute air chambers and represent 
the first gas-exchanging alveoli on the airway path. In the alveoli, the respiratory 
epithelium gives way to a very flat lining layer that permits the formation of a thin air–
blood barrier.  
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 After several branching of such respiratory bronchioles, the alveoli are so 
densely packed along the airway that an airway wall proper is missing; the airway 
consists of alveolar ducts. The final generations of the airway tree end blindly in the 
alveolar sacs. The branching pattern plays a role in determining air flow and particle 
deposition. 
LUNGS: 
Lungs are paired organs of respiration. They are situated one on each side of 
the mediastinum with the thoracic cavity. Each lung resembles a half cone. It has an 
apex, a base, medial surface and costal surface. 
Right lung is broader than the left lung  andrepresents 56 percent of the total 
lung volume and  divided in to three a superior, middle, and inferior lobe, separated 
from each other by a deep horizontal and an oblique fissure, , where as the left lung 
smaller in volume because of the asymmetrical position of the heart and divided in to 
two lobes by oblique fissure.The apex is rounded and rises into the roof of the neck 
about  25mm above the level of middle third of the clavicle. The base is concave and 
semilunar in shape and is closely associated with the thoracic surface of the 
diaphragm. 
  The costal surface in convex and in closely associated with the costal 
cartilages, the ribs and the intercostal muscles. The medial surface in concave and has 
roughly triangular shaped area, called hilum at the level of 5
th
, 6
th
 and 7
th 
thoracic 
vertebra. Structures that enter and leave at the hilum are 1 bronchus, 1 pulmonary 
artery, 2 pulmonary veins, 1 bronchial artery, 1 bronchial vein, lymph vessels, 
parasympathetic and sympathetic nerves. The area between the lungs is the 
mediastinum. It is occupied by heart, great vessels, trachea, right and left bronchi, 
oesophagus, lymph nodes, lymph vessels and nerves.  
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PLEURA AND PLEURAL CAVITY: 
                   The inside of the thoracic cavities and the lung surface are covered with 
serous membranes, respectively the parietal pleura and the visceral pleura, which are in 
direct continuity at the hilum. Depending on the subjacent structures, the parietal 
pleura can be subdivided into three portions: the mediastinal, costal, and diaphragmatic 
pleurae. The shape of the lungs is determined by the shape of the pleural cavities. 
Because of the presence of pleural recesses, which form a kind of reserve space, the 
pleural cavity is larger than the lung volume. 
                    During inspiration, the recesses are partly opened by the expanding lung, 
thus allowing the lung to increase in volume. The lungs are maintained in close 
apposition to the thoracic wall by a negative pressure between visceral and parietal 
pleurae. A thin film of extracellular fluid between the pleurae enables the lungs to 
move smoothly along the walls of the cavity during breathing. 
THE GAS-EXCHANGE REGION: 
                The gas-exchange region comprises three compartments: air, blood, and 
tissue. Whereas air and blood are continuously replenished, the function of the tissue 
compartment is twofold: it provides the stable supporting framework for the air and 
blood compartments, and it allows them to come into close contact with each other 
(thereby facilitating gas exchange) while keeping them strictly confined. The 
respiratory gases diffuse from air to blood, and vice versa, through the 140 square 
metres of internal surface area of the tissue compartment. The gas-exchange tissue 
proper is called the pulmonary parenchyma, while the supplying structures, conductive 
airways, lymphatics, and non-capillary blood vessels belong to the non-parenchyma. 
BLOOD SUPPLY:  
              The bronchial circulation has a nutritional function for the walls of the larger 
airways and pulmonary vessels. The bronchial arteries originate from the aorta or from 
an intercostal artery. The capillaries surround the walls of bronchi and vessels and also 
supply adjacent airspaces. Most of their blood is naturally collected by pulmonary 
veins. Small bronchial veins exist which originate from the peribronchial venous 
plexuses and drain the blood through the hilum into the azygos and hemiazygos veins 
of the posterior thoracic wall. 
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LYMPHATIC DRAINAGE 
             The lymph is drained from the lung through two distinct but interconnected 
sets of lymphatic vessels. The superficial, subpleural lymphatic network collects the 
lymph from the peripheral mantle of lung tissue and drains it partly along the veins 
toward the hilum. The deep lymphatic system originates around the conductive 
airways and arteries and converges into vessels that mostly follow the bronchi and 
arterial vessels into the mediastinum. 
NERVE SUPPLY 
              The pleurae, the airways, and the vessels are innervated by afferent and 
efferent fibres of the autonomic nervous system. Parasympathetic nerve fibres from the 
vagus nerve (10th cranial nerve) and the fibres stimulate bronchial constriction. 
sympathetic  nerve are derived from spinal segmentT2to T5. The sympathetic fibres 
mediate a vasoconstrictive action in the pulmonary vascular bed and a secretomotor 
activity in the bronchial glands.  
RESPIRATION 
Inflation and deflation of the lungs ensues that regular exchange of gases takes 
place between alveoli and external air. This is dependent upon the arrangement of 
pleura and the contraction and relaxation of muscles of respiration and the elastic 
connective tissue.  
MUSCLES OF RESPIRATION: 
The expansion of the chest during inspiration occurs partly voluntary and partly 
involuntary.  The muscles of normal quiet breathing are the inter costal muscles and 
the diaphragm. During difficult breathing they are assisted by the muscles of the neck, 
shoulder and abdomen.  
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CYCLES OF RESPIRATION: 
This occurs 12-15 times per minute and consists of three phases. 
 Inspiration 
 Expiration 
 Pause 
INSPIRATION: 
The capacity of the thoracic cavity is increased by simultaneous contraction of 
the inter costal muscles and the diaphragm. The parietal pleura move with the walls of 
thorax and the diaphragm. This reduces the pressure in the pleural cavity to the level 
considerably lower than the atmospheric pressure. The visual pleura follow the parietal 
pleura. During the process, the lungs are stretched; the pressure within the alveoli and 
the air passage reduced drawing air into the lungs in an attempt to equalize the 
atmospheric and alveolar air pressure. 
The process of inspiration is active as it requires expenditure of energy for 
muscle contraction. The negative pressure created in the thoracic cavity aids venous 
return to the heart and is known as respiratory pump 
EXPIRATION: 
Relaxation of inter costal muscles and the diaphragm results in the downward 
and inward movement of the rib cage and the elastic recoil of the lungs. As this occurs, 
the pressure of the gases inside the thorax exceeds the atmospheric pressure and 
therefore air is expelled from the respiratory tract. The lungs still contain some air and 
are prevented from complete collapse by the intact pleura. The process is passive as it 
does not require the expenditure of energy. 
After expiration there is a pause, before the next cycle begins.  
PULMONARY FUNCTION TESTS: 
       Pulmonary function tests are a broad range of tests that measure how well the 
lungs take in and exhale air and how efficiently they transfer oxygen into the blood. 
ulmonary function tests (PFTs) are noninvasive diagnostic tests that provide  
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measurable feedback about the function of the lungs. By assessing lung volumes, 
capacities, rates of flow, and gas exchange, PFTs provide information that help to 
evaluated and diagnosis certain lung disorders. They may not be able to detect early 
stages of the diseases in which function has not been appreciably reduced.  
TESTING FOR VENTILATOR CAPACITY:  
                      The simplest test of dynamic ventilatory function is the tests of forced 
expiration. A spirometer is used for this test, and the procedure is called spirometery. 
Nowadays, computerized spirometery is available which gives a print out of the data, 
as well as the predicted value. 
LUNG VOLUMES AND CAPACITY: 
In normal quiet breathing there are about 15 complete respiratory cycles per 
minute. The lungs and air passages are never empty and as the exchange of gases take 
place only across the wall of the alveolar ducts and alveolar. The remaining capacity of 
the respiratory passages is called the anatomical dead space (about 150ml).  
TIDAL VOLUME: 
 The volume of air breathed in and out of lungs in a single  normal quite  
respiration.It signifies the normal depth of breathing .Normally it is about 500ml. 
INSPIRATORY RESERVE VOLUME: 
It is an additional amout of air that can be inhaled into the lungs after the end of 
normal inspiration beyond the tidal volume.normal value is 3300ml. 
 EXPIRATORY RESERVE VOLUME: 
                         Maximal volume of air which can be expired out forcefully after the 
expiration of a tidal volume or normal  breath. It is about 1000ml . 
 RESIDUAL VOLUME: 
The volume of air remaining in the lung seven after forced expiration.It cannot be 
measured by spirometry.It is significant because it help to aerate the blood in between 
breathing and expiration.It is about 1200ml. 
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 LUNG CAPACITIES:  
                    Four lung capacities are recognized and each includes two or more lung 
volume. 
INSPIRATORY CAPACITY (IC): 
                    It is the maximum volume of air that can be inspired by forced inspiration 
after a normal expiration. IC  =  TV+IRV 
                              500+3300=3800ml 
 VITAL CAPACITY (VC): 
                It is the maximum amout of air that can be expelled by a forced expiration 
after a maximum inspiration.VC= IRV + TV + ERV  
                            3300+500+1000=4800ml. 
FUNCTIONAL RESIDUAL CAPACITY (FRC):  
                       It is the volume of air remaining in lung at the end of a normal 
expiration. The FRC is physiologically very important. If there is no FRC and the lung 
is completely emptied during each respiratory cycle, the alveolar PO2& PCO2 will 
vary widely during breathing and will interfere with diffusion of respiratory gases.  
                                              CFR  =ERV + RV 
                                                         1000+1200=2200ml 
TOTAL LUNG CAPACITY (TLC):  
                      The amount of air present in the lungs after a maximal(deep) inspiration. 
                              TLC=IRV+TV+ERV+RV 
                                        3300+500+1000+1200ml 
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ALVEOLAR VENTILATION: 
This is the volume of air that moves into and out of the alveoli per minute. It is 
the tidal volume minus the anatomical dead space, multiplied by the respiratory rate. 
Alveolar ventilation = (TV-anatomical dead space) respiratory rate 
= (500-150) ml x 15 per minute = 5.25liters / minute. 
Lungs function tests are carried out to determine respiratory function and are 
based on the parameters out lined above.  
EXTERNAL RESPIRATION: 
This is the exchange between alveoli and blood. Total area of gas exchange in 
the lungs is 70-80 square meters. CO2 diffuses from venous blood along the 
contraction gradient into the alveoli until equilibrium with alveolar air is reached. By 
the same process O2 diffuses from alveoli to the blood.  
INTERNAL RESPIRATION: 
This is the exchange of air between the tissue and blood. When there is 
difference in partial pressures, oxygen diffuses outward from the blood to extra cellular 
fluid then into the cell walls. The process involved is diffusion. 
Control of Respiration: 
Control of respiration is normally involuntary. Voluntary control is exerted 
during activities such as speaking, singing but is over ridded if homostasis of arterial 
PO2 and PCO2 is threatened i.e. if this is high arterial PCO2 or low arterial PO2. 
                                 THE RESPIRATORY CENTRE 
This is formed by group of nerve cells that control the rate and depth of 
respiration. They are situated in the brain stem and depending upon the situation they 
are classified into two groups 
 Medulla center 
 Pontine center 
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In the medulla there are inspiratory neurons and expiratory neurons. Neurons in the 
pneumotoxic and apneutic centre situated in the pons influence the inspiration and 
expiratory neurons of the medulla. 
Motor impulses leaving the respiratory centre pass in the phrenic nerves and inter 
costal nerves top the diaphragm and inter costal nerves. 
Chemoreceptor: 
These are the receptors that response to the changes in chemical constituents of 
blood . these receptors are the sensory  free nerve ending,which are highly sensitive to 
chemical change in blood.They are located centrally and peripherally. 
Central receptor- Present on the surface of medulla oblongata and bathed in 
CSF.When PCO2  raised even slightly, the Central receptors  respond  by stimulating 
respiratory centre, by increasing ventilation and reducing  PCO2. The sensitivity to 
raised PCO2  is the most important factor in maintaining hemostasis of blood gases in 
health. 
Peripheral chemoreceptors are situated in the arch of aorta and in the carotid 
bodies. 
An increase in H
+   
Concentration Stimulated the Peripheral chemoreceptors 
resulting in increased Ventilation, increased Co2   excretion and reduced P
H .
Others 
factors influencing respiration are, 
 Speech, singing 
  Emotional displays 
 Drugs e.g. – Sedatives, alcohols 
 Sleep 
Temperature influenced breathing. In fever, respiration is increased due to 
increased metabolic rate while in hypothermia it is decreased. It is depressed as in 
metabolism, temporary changes in respiration occur in swallowing, sneezing and 
coughing.  
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 BRONCHIAL ASTHMA 
Introduction: 
Bronchial Asthma ( the Greek -"panting") is a bronchial hypersensitivity disorder 
characterized by reversible airway obstruction,produced by a combination of mucosal 
edema,constriction of the bronchial musculature and excessive  secretion of viscid 
mucus,causing mucous plugs. 
Definition: 
Asthma is characterized by recurrent attacks of dyspnea, cough with expectoration of 
tenacious muciod sputum and usually wheezing. Symptoms may be mild and may 
occur only in association with respiratory infection or they may occur in various  
degrees of severity to the point of being life –threatening. 
Prevalence:  
The prevalence of asthma increased steadily over the later part of the last century 
first in developing world current estimates suggest that asthma affects 300million 
people world-wide and an additional 100million person will be diagnosed by 2025. 
           Around age 20, the ratio of asthma between men and women is the same. At age 40, 
ie in adult age asthma occurs   more  in females than males in the ratio of 3:1 . 
Etiology:  
Etiologicaly asthma is heterogeneous disease. There are two types of asthma 
and Rackemann first introduced the terms ―extrinsic‖ and ―intrinsic‖ asthma in 1947 
 Early onset asthma (atopic, allergic, extrinsic) 
 Late onset asthma(Non-atopic, Idiosyncratic, Intrinsic) 
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                                          SYMPTOMS DURING ASTHMA 
 
 
 
BRONCHIAL CHANGES DURING ASTHMA ATTACK 
 
 
 
59 
 
Atopic Asthma: 
Atopic asthma is the most common type of asthma usually begins in childhood. 
This  disease has been thought to be result from sensitization of the bronchial mucosa 
by tissue specific antibodies .The antibodies produces a specific immunoglobulin IgE 
(type 1) class and the total Serum IgE levels are usually .Exposure to the  
environmental antigens, such as dust, pollens, animal‘s dander, fungal spores and food 
result in an antigen antibody reaction. A positive family history of atopy is common, 
and asthmatic attacks are often preceded by allergic rhinitis, utricaria or eczema. A 
skin test with antigen results in an immediate wheal and flare reaction, a classic 
example of type I – IgE mediated hypersensitivity reaction. 
Non – Atopic Asthma:  
Approximatetly 50% of asthmatics are of the non atopic (intrinsic) type in 
which the bronchial reaction occurs in response to non immunological stimulai such as 
infection , irritating inhalants,cold air ,exercise and emotional upset. Associated with 
nasal polyp and chronic bronchitis are commonly present. About 10% of patients 
become hypersensitive to drugs. This type of asthma develops later in adult life with 
negative personal (or) family history of allergy, negative skin test and normal serum 
levels of IgE.  
Pathophysiology of Asthma: 
The common denominator underlying the asthmatic diathesis is a nonspecific 
hyper irritability of trachea-Bronchial tree. When airway reactivity is high, symptoms 
are severe and persistent and the magnitude diurnal fluctuation in lung function is 
greater .The patients tend to awaken at night or in the early morning with 
breathlessness. 
In both normal and asthmatic patients, air reactivity rises following vital infections of 
the respiratory tract and exposure to oxidants such as ozone and nitrogen dioxide. 
Allergen can cause airway responsiveness to rise within minutes and remain elevated 
for weeks. 
A number of causes have been postulated for the increased airway activity of 
asthma, but the basic mechanism remains unknown. The most popular hypothesis at 
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present is that of airway inflammation. Increased numbers of mast cell, epithelial cells, 
neutrophils, eosinophils and lymphocytes have been found in the broncho alvelolar 
levage fluid of patients with asthma & have number of mediators. 
 
The airway can be oedematous and infiltered with eosinophils, neutrophils and 
lymphocytes with or without the smelling of the epithelial basement membrane. There 
may be glandular hypertrophy. The most obvious finding is a generalized increase in 
cellularity associated with an elevated capillary density. 
Although, the translation of this histological observation into the disease is still 
incomplete, it widely believed that the physiological and clinical features of asthma 
derived from interaction among the residence and infiltrating inflammatory cells in the 
airway and the surface epithelium. The cells that play more important role are mast 
cells, eosinophils, macrophages neutrophils and lymphocytes. The mediators released 
are histamine, bradykininm the leukotrienes C, D, & E,platelet activating factor(PAF) 
and oedema formation.  
In addition to their ability to evoke prolonged constriction of airway smooth 
muscles and mucosal edema, the leukotrienes may also account for some of other 
patho physiologicalfeatures of asthma such as increased mucous production an 
impaired mucociliary transport. 
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Chemo tactic factors elaborated bring eosinophil, platelets and polymorphic 
nuclear leukocytes to the site of reaction. These infiltrating cells and resident 
macrophages and airway epithelial cells themselves potentially are and additional 
source of mediators to enhance immediate and the cellular phase. 
Like Mast cells in the early reaction the eosinophils play an important role in 
the infiltrative components. The granular protein in thin cell major basic protein and 
the eosinophilic cationic protein are capable of destroying the airway epithelium, 
which then sloughed into the bronchial lumen in the form of creak bodies. Besides 
resulting in a loss of barrier and secretary function, such damage elicits the production 
of chemo static cytokines leading to further inflammation. In theory it also can expose 
sensory nerve endings, thus irritating neurogenic inflammatory pathways. That in turn, 
converts a primary local event into a generalized reaction via a reflex mechanism. 
T lymphocytes also appear to be important in the inflammatory response. These 
cells are present in increased number in asthmatic airways and produce cytokines that 
activate cell-mediated immunity as well as humoral (IgE) immune system. 
Furthermore, Th1, Th2 lymphocyte subtype have functions that may influence 
the asthmatic response. The Th1   cytokines interleukin (IL-2) and interferon‘s (IFN)g 
can promote the growth and differentiation of b cells and activation of macrophages 
respectively. 
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TH2 cytokine IL-4 and IL-5 stimulate b cell growth and immunoglobulin section 
and IL-5 promote eosinophilic proliferation, differentiation and the activation. It can 
also facilitate granule release from basophiles. 
      The stimuli that interact with airway responsiveness and incite acute episodes of 
asthma can be grouped into ten major categories – allergic, pharmacological, 
environmental, occupational, infections, and exercise – related and emotional stress, 
food and drink, smoking, heart burn. 
Risk factors for Bronchial Asthma 
1. Allergens: 
Allergies with asthma is a common problem. Eighty percent of people with 
asthma have allergies to airborne substances such as tree, grass, and weed pollens, 
mold, animal dander, dust mites, and cockroach particles. 
Allergic asthma is dependent on IgE response controlled by T and B lymphocytes 
and activated by the interaction of antigen with mast cells-bound IeG molecule. 
2. Pharmacological stimuli: 
    The drugs most commonly associated with the induction of acute episodes of 
asthma are aspirin, coloring agents – tartazine, b- adregenic antagonists, sulfating 
agent. 
Aspirin – sensitive syndrome affects adults through seen in childhood. The 
problem usually begins with perennial vasomotor rhinitis that is followed by a hyper 
plastic rhino sinusitis with nasal polyps, progressing to asthma. Indomethacin, 
fenoprofen, naprocen, zonepirae sodium, ibuprofen, mefanamic acid and 
phenylbutazone are particularly important. 
B-Adrenergic antagonist regularly obstructs the airway in asthmatics. In fact, 
the local use of b- blockers in the eye for the treatment of glaucoma has been 
associated with worsening asthma. 
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3. Environment and Air pollution: 
 Environmental caused of asthma are usually related to climate conditions that 
promote the concentration of atmospheric pollutants and antigens. These conditions 
tend to develop heavily industrial or densely populated urban areas and frequently 
associated with thermal inversion or other situation that cause stagnant air masses. The 
air pollutants known to have this effect are ozone, nitrogen dioxide & sulphur dioxide. 
4.Occupational factors: 
Occupation –related asthma is significant health problem and acute and chronic 
airway obstructions have been reported to follow exposure to a large number of 
compounds used in many types of industrial process. 
Broncho constriction can result from working with or being exposed to metal 
salts, wood and vegetable dust, husk of grains, flour, castor bean, gum acacia, karay 
gum, tragacanth, pharmaceutical agents e.g. antibiotics, piperazine and cimetidine, 
industrial chemicals and plastics, biological enzymes, laundry detergents and 
pancreatic enzymes, animal & insect dusts, serum and secretions.  
There seems to be three underlying mechanisms 
1. In some cases, the offending agent results in formation of significant IgE. 
2. Substances cause direct liberations of broncho constrictor substances. 
3.  Substances cause direct or reflex stimulation of the airway of latent of frank 
asthmatics. 
6. Infections: 
Cold, flu, bronchitis, and sinus infections can cause an asthma attack. These 
respiratory infections that trigger asthma can be viral or bacterial .This airway 
sensitivity that causes the airways to more easily narrow can last as long as two months 
after an upper respiratory infection. It's thought that anywhere from 20% to 70% of 
asthmatic adults have coexisting  sinus disease. Conversely, 15% to 56% of those with 
allergic rhinitis (hay fever) or sinusitis have evidence of asthma. 
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7.Exercise:  
                 Strenuous exercise can cause a narrowing of the airways in about 80% of 
people with asthma. In people, exercise is the main trigger for their asthma symptoms. 
In exercise-induced asthma, some patient feel chest tightness, coughing, and difficulty 
breathing within the first five to eight minutes of an aerobic workout. These symptoms 
usually subside in the next 20 to 30 minutes of exercise, but up to 50% of those with 
exercise-induced asthma may have another asthma attack six to 10 hours later. It is 
important to warm up slowly and adequately prior to rigorous exercise. This may 
prevent an attack. 
        The mechanisms, by which exercise produce obstruction, may be related to a 
thermally produced hyperthermia and engorgement of the microvasculature of the 
bronchial wall and doesn‘t appear to involve smooth muscle contraction. 
8.Emotional Stress: 
 Psychological factors can interact with the asthmatic diasthesis to worsen or 
ameliorate disease process. Changes in airways caliber seem to be mediated through 
modification of nasal efferent activity, but endorphins also may play a role. 
9.Food and Drink: 
              Food allergies can cause mild to severe life-threatening reactions. Atopic 
asthmatics may occasionally notice that their symptoms are provoked by certain foods 
or drinks The most common foods associated with allergic symptoms are: 
 Eggs 
 Cow's milk 
 Peanuts 
 Soy 
 Wheat 
 Fish 
 Shrimp and other shellfish 
 Salads and fresh fruits 
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Food preservatives can also trigger asthma. Sulfite additives, such as sodium bisulfite, 
potassium bisulfite, sodium metabisulfite, potassium metabisulfite, and sodium sulfite, 
are commonly used in food processing or prepadration and may trigger asthma in those 
people who are sensitive. 
10.Smoking:  
 Smokers appear to be at greater risk of developing asthma and have a higher 
prevalence of hyper-reactivity. Children of smokers also seem to have and increased 
risk of developing wheeze. Women who smoke during pregnancy increase the risk of 
wheezing in their babies. Babies whose mothers smoked during pregnancy also have 
worse lung function than non –smoking mothers.  
11.Heartburn and Asthma: 
Severe heartburn and asthma often go hand-in-hand. Recent studies show that up to 
89% of asthma patient also suffer from severe heartburn, known as gastroesophageal 
reflux disease (GERD). GERD generally occurs at night when the sufferer is lying 
down. Normally a valve between the esophagus and stomach prevents stomach acids 
from backing up into the esophagus. In GERD, the valve does not function properly. 
The stomach acids reflux, or back up, into the esophagus; if the acid reaches into the 
throat or airways the irritation and inflammation can trigger an asthma attack. 
CLINICAL FEATURES: 
1. The symptoms of asthma consist of a triad of dyspnoea, cough and wheezing 
the last often being regarded as the sine quo none. In its most difficult form, 
asthma is and episodic disease and all the three symptoms co-exist. At the onset 
of attack patient experiences a sense of constriction in the chest often with a 
non-productive cough. 
2.  Respiration becomes predominant, expiration is prolonged patient frequently 
has tachypnoea, tachycardia and mid-systolic hypertension. The lungs rapidly 
become over-inflated and antero posterior diameter is increased. The lungs 
rapidly become over-inflated and antero posterior diameter is increased.  
3. If the attack is severe or prolonged, there may be loss of adventitious breath 
sounds and wheezing becomes very high pitched.Further the accessory 
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muscles, which become visible active and a paradoxical pulse often develops. 
These two sings have been found to be extremely valuable indicating the 
severity of the obstruction.  
4. Pulmonary function tends to be significantly more impaired. The development 
of paradoxical pulse depends on the generalization of large negative intra 
thoracic pressure. Thus, if the patient‘s breathing even though obstruction is 
quite severe. 
5. The end of the episode is frequently marked by a cough, that produce stingy 
mucus which often takes the form of casts of the distal airway crushman‘s 
spirals and when examined microscopically often shown eosinophils and 
charcot- leydan crystals. 
6.  In extreme situation, wheezing may lessen markedly and even disappear cough 
may become extremely in effective and the patient may begin a gasping type of 
respiratory pattern. These finding imply extensive mucous plugging and 
impeding suffocation. Ventilatior assistance required. Atelectasis due to 
insppissated secretion occsasionlly occurs with asthmatic attack. 
7. Less typically, a patient with asthma may complain of intermittent episode of 
nonproductive cough or excretional dyspnoea. Unlike other asthmatics, when 
the patients are examined during symptomatic period, they tend to have normal 
breathing, but may have wheeze after repeated forced expiration and or may 
have ventilator impairments when tested in the laboratory. In the absence of 
these signs a broncho-provococation test may be required to make the 
diagnosis. 
1. Acute Severe Asthma (Status Asthmticus) 
1 It is a medical emergency;  
2 Patient is hypoxic  and  cyanosed due to severe bronchospasm. 
3 Severe dysphoea, unproductive cought, patient adopts an upright position  
fixing the shoulder gridle to assist the accessory muscles of respiration 
4 It is characterized by tachycardia (Pulse rate> 120) Tachyphoea (respiratory 
rate> 30/minute) sweating, pulsus paradoxus, altered level of consciousness 
and an inspiration, expiration ratio of 1:3 or 1:4. 
5 The presence of a silent chest and bradycardia in such patients is an  
ominous sign. 
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ACUTE SEVERE ASTHMA-GRADE 
Grade1A: Able to carry out house work or job with moderate difficulty. 
Sleep occasionally disturbed. 
Grade1B:       Only able to carry out house work or job with great difficulty. 
Sleep frequently disturbed. 
Grade2A :      Continued to chair (or) bed, but also to get up with moderate   
                          difficulty. Sleep disturbed, with little or no relief from inhaler. 
Grade2B:         Confined to chair or bed and only able to get up with great difficulty 
unable to sleep. Pulse over 120/min  
Grade 3: Totally confined to chair or bed. No sleep. No relief from inhaler.Pulse 
over 120/min. 
Grade 4     :    Immobilized and completely exhausted. 
1. Nocturnal Asthma 
 Nocturnal asthma is defined as an overnight fall of more than 20% in 
the FEV, or PEFR. It may be due to  
a. Early morning fall in circulating adrenaline 
b. Overnight changes in vagal tone (increased vagal tone in early morning) 
c. Airway cooling at night 
d. Circadian changes in plasmas cortisol concentration (mid night to early 
morning fall in cortisol level 
2. Cough Variant Asthma 
  Cough may be the dominant symptoms and the lack of wheeze (or) 
breathlessness. 
3. Asthma 
  Worsening of asthma after meals or dyspnoea occurring only after 
meals is due to gastro-oesophageal reflex. 
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                                DIAGNOSIS AND INVESTIGATION  
An account of episode wheeze, breathlessness interpreted with period of 
normality is sufficient evidence to suspect asthma and further evidence comes from a 
history or marked variability, attacks in small hours of the night, provocation by strong 
exercise and allergens and paroxysmal cough, productive small amount of sticky 
sputum. 
   CONFIRMATION OF THE DIAGOSIS 
1. Lung function tests: 
 Pulmonary or lung function tests are simple and safe investigations routinely used in 
clinical practice for the diagnosis and evaluation of a variety of respiratory 
diseases.The physiological function of the lung can be accurately measure by lung 
functional testing. Many sophisticated tests are possible but even the simplest 
equipment can produce useful information. It is of particular value to perform lung 
function tests in order to give an objective assessment to lung performance. The 
commonest reason for performing a lung function test is to reach a diagnostic. In 
addition, there can be most useful for following the progress of a disease and for 
testing objectively the effects of treatment. 
2. Spirometry: 
There are many types of spiroment available and all record similar information.  
A spirometry test measures the volume of air that you are able to expel from the lungs 
after taking a full breath in.  
The normal forced vital capacity (FVC) is fully exhaled in less than 3 seconds 
more than three quarter is exhaled in the first second. In addition to measuring the vital 
capacity in liters, volume expired in first second of the first second or first expiratory 
volume at 1 second (FEV1) can be measured and the ratio of FEV1 : FEC can be 
calculated. The results are compared with predicated values based on age height and 
ethnic group. FEV1/FEC ratio is normally greater than 70%. 
69 
 
If diffuse airflow obstruction is present, the rate at which the air can be exhaled 
is diminished throughout expiration. The length of expiration is prolonged and FEV1 is 
much reduced. This is an obstraction pattern and is seen in as time, chronic bronchitis 
and emphysema. In patients with asthma this obstruction may be reversible with 
bronchodilators or even corticosteroids. 
In a restrictive pattern, there is a reduced lung volume, perhaps as a result of 
pulmonary fibrosis or that wall deformity but there is no obstruction to airflow and 
FEV1 in normal. 
3. Peak Expiratory Flow Meter. 
It is a popular instrument for assessing airflow obstruction there is a cheap, 
simpler version called the mini peak flow meter which is suitable for use at home by 
individual patients. Those machines measure the maximal rate of flow which is 
achieved during a forced expiration and most healthy people will achieve values of 
greater than 400 liters/min. Patients with lung fibrosis and restriction changes on the 
spirogram may also have normal expiratory flow rates so the meter is not suitable for 
assessment of their disability. Patients with airflow obstruction will have reduced flow 
rates, which values below 200 liters/min being very significant and those below 100 
liters/min extremely severe. 
4. Flow Volume Curves 
The plotting of flow versus volume during both maximal expiratory and 
inspiratory maneuvers is of major help in differentiating central airflow obstruction 
(leading to strider)   from diffuse airflow obstruction as seen in COPD and Asthma. 
5. Lung Volumes    
Measurement of total lung capacity and residual volume is best performed 
using a whole body plethysmograph, but can be measured by a helium dilution 
method. In general, restrictive lead to reduced values, and obstructive defects to 
increased values. 
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6. Measurement of Diffusing Capacity 
The diffusing capacity (DLCO) is a measure of lung‘s ability to transfer gas 
from alveoli to blood. The test utilized of carbon monoxide from a single breath of 0.3 
% mixture in air, this gas is chosen because it combines rapidly with hemoglobin and 
provides a true estimate of diffusion across the alveolar capillary membrane. The 
diffusing capacity is reduced in patients with disease principally affecting alveoli such 
as fibro sing alveoli is or emphysema. The transfer coefficient (KCO) is a measure of 
diffusing capacity expressed per volume of ventilated lung during the single breath test 
and is useful to confirm that low DLCO is due to alveolar disease rather than 
misdistribution of ventilation. High values of DLCO may be seen in alveolar 
hemorrhage. 
7. Arterial Blood Gases and Oximetry 
Measurement of hydrogen ion concentration PaO2 and PaCO2, derived 
bicarbonate of arterial blood are essential in assessing the degree and type of 
respiratory failure and for measuring overall acid-base status. Use of a pulse oximeter 
allows a non-invasive continuous method of assessing oxygen saturation in patients 
who require continuous method of assessing oxygen saturation in patients who 
required continuous monitoring in order to assess hypoxemia and its response to 
therapy, including supplemental oxygen. 
8. Exercise Tests     
Formal exercise testing with measurement of metabolic gas exchange and 
respiratory and cardiac response using cycle aerometry or treadmill exercise is useful 
in providing a detailed analysis of both pulmonary and cardiac function in the 
breathless patients. Exercise challenge with measurement of spirometry before and 
after can also be helpful in demonstrating exercise – include asthma. Finally, the 6 
minute walk test or ‗shuttle‘ test can provide a simple but adjective assessment of 
disability and response to treatment. 
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9. Skin Hypersensitivity Test 
A prick is made in the skin with a fine needle through a drop of an aqueous 
extract of the substance to be tested. A positive reaction is indicated by the 
development of a wheal and flare, which begins to appear within few minutes. Tests 
are usually performed with a group of common allergens knows to cause bronchial 
asthma. It is seldom possible with these tests to identify the one particular allergens as 
the causes of asthma are an individual patient and their chief vale is to distinguish 
atopic from non-atopic subjects. 
10. Physical Signs of the Chest 
 During an attack of asthma, the following signs are detectable.Respiratory rate 
is increased with the use of accessory muscles of respiration. Hyper – resonant 
percussion note over the lungs. Breath sounds are vesicular in character with prolonged 
respiration. Numerous high pitched polyphonic expiratory and inspiratory rhonchi are 
audible.During very severe attacks the airflow may be insufficient to produce rhonchi. 
This results in a ‗Silent Chest‘ which is an ominous sign. In between attacks the chest 
is clear and no abnormal physical signs may be detectable. Chronic asthmatics usually 
have some scattered rhonchi persisting always in their chest. 
11. Radiology Examination 
In an acute attack of asthma, the lungs appear hyper inflate. Between episodes 
the chest x-ray is usually normal. In long standing case, the appearance may be 
indistinguishable from hyper-inflation caused by emphysema and a lateral view may 
demonstrate a ‗pigeon chest‘ deformity. Occasionally when a large bronchus is 
obstructed by tenacious mucus, there is opacity caused by lobar of segmental collapse. 
A chest x-ray should be performed if possible in all patients with severe acute 
asthma to exclude pneumothorax a rate but potentially fatal complication of the 
pulmonary hyper – inflation produced by severe airflow obstruction in asthma. The 
chest x-ray show meditational and subcutaneous emphysema in very severe disease. 
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12. Sputum Examination 
Sputum eosinophilia is useful indication of an asthmatic type of airway 
reaction. Stained section of sputum fixed in alcohol or formalin is probably severe 
indication of asthma than a sputum eosinophil count. This is useful for the 
demonstration of aspergillums fumigates. Eosinohhils are a prominent feature of the 
inflammatory exudates within the airway lumen lies a thick tenacious mucus which 
under the microscope is seen to contain strips of desquamated epithelial cells 
(Curschman‘s spirals) eosinophils, isolated metaplastic epithelial cels (Creola bodies) 
& crystalline materials consisting largely of major basic protein derived from 
eosinophilic granules. (charcot – leydon crystals). 
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NORMAL X - RAY 
 
 
 
PEAK EXPIRATORY FLOW METER 
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DIFFERENTIAL DIAGNOSIS 
The differentiation of asthma from other disease associated with dyspnoea, 
wheezing is usually not difficult, particularly when the patient in seen during acute 
attacks. 
            The physical sign and symptoms listed above and the history of periodic 
attacks are quick characteristic. A personal history or family history of allergic disease 
such as eczema, rhinitis or urticaria is valuable contributory evidence. An extremely 
common feature of asthma is nocturnal awakening with dyspnoea and / or wheezing. 
In fact, the phenomenon is so prevalent that, its absence raises doubts ballot the 
diagnosis. 
  1. Difference between Cardiac Asthma and Bronchial Asthma 
S.No FACTORS CARDIAC ASTHMA BRONCHIAL ASTHMA 
1 Past history Hypertension, aortic or coronary 
disease  
Previous attacks of asthma or 
other allergic conditions in 
patients of other member of the 
family 
2 Age Onset usually after 50y yrs Any age 
3 Precipitatin
g factors 
May be precipitated by execration 
or acute myocardial infarction or 
hypertension  
Trigger factors may by infected 
non specific irritants, external, 
allergies, exercise of emotional 
factors  
4 Symptoms 
a.  Cough 
Cough and dyspnoea, cough 
associated with watery 
expectoration which increases in 
intensity towards end of attacks. 
Starts with dyspnoea, 
expectoration of small sticky 
sputum, paroxysm of wheezes 
when cough becomes profuse 
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 2. Difference between Bronchial Asthma and Plumonary Tuberculosis 
S.NO FACTORS PLUMONARY 
TUBERCULOSIS 
BRONCHIAL ASTHMA 
1 Age Generally aged persons Usually starts before 3 yrs of 
age 
2 History History of chronic cough History of previous attacks 
3 Duration of 
symptoms 
May last longer May last up to old age 
4 Time of onset - Early onset 
5 Mode of onset May be precipitated lay 
infection 
May be precipitated by allergy 
6 Loss of weight  Common Seldom 
7 Symptoms:   
 i.Fever Various extent Rare 
 ii.Cough Frequent, sharp, short, may 
be dry in the early stages, 
later it is persistent with 
copious, purulent, 
expectoration dyspnoea is 
later feature.  
Paroxysmal cough more than 
dyspnoea 
 
 iii.wheezing Localized wheezing due to 
bronchial narrowing by 
tuberculoses lymph nodes 
Wheezing present all over the 
Field 
 iv.Sweating Especially during night Rare, unless in asthmatics 
 v.Haemoptysis Early stage blood stained 
sputum 
Nothing relevant 
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8 Inspection Affected side of chest 
flattered with displaced, 
apex impulse to the side of 
lesion, clubbing of fingers, 
present 
No flattering of the chest apical 
impulse in position. 
9 Palpation Movement of chest in 
affected side, vocal 
fermitus diminished, 
increased in consolidation, 
Iymphadenopathy is noted 
In Long-standing cases, right 
ventricular enlargement  
10 Percussion Dull note in the apex, 
others impaired 
Normal 
11 Auscultation Breath sounds bronchial 
early wheezing, late creak 
ling rales, diminished vocal 
resonance in early and 
increased in later 
conditions 
Prolonged expiration wheezing 
rhonchi heard all over the field 
 a.Pulse Increased or low Normal or low 
 b. Blood        
    pressure 
Low Normal or low 
 c. Signs of 
underlying 
disease 
               
_ 
No evidence of cardio vascular 
disease 
 d. sputum Hard, thick, tenacious 
sputum, positive in culture  
Sticky pellets 
 e. Blood Lymphocyosis, raised ESR Eosinophils, ESR normal 
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  3. Difference between Bronchial asthma and COPD 
s.no Parameter Bronchial asthma COPD 
1. Clinical Young age of asthma 
Associated history of 
allergy(rhinitis,urticaria, 
eczema) evidence of 
corpulmonale-absent 
sign of hypercarbia unusal 
 
More older people 
History of smoking, exposure to 
pollution. 
No history of allergy 
corpulmonale-frequent 
sign of hypercarbia frequent - 
2. Airflow 
obstruction 
Variable (irreversible 
component may be there in 
late stages) 
Progressive deterioration of lung 
function. 
3. Postmortem Hyperinflation,mucus 
plugs(exudates+mucus) 
No or little emphysema 
Excessive mucous 
(mucoid/purulent) 
Small airway disease-
emphysema 
4. Sputum Eosinophilia, metachromatic 
cell,creola bodies. 
Neutrophilia. 
5. Surface 
epithelium 
Fragility undetermined Fragility loss 
6. Bronchiolar 
mucus cell 
Mucus metaplasia debated Metaplasia/hyperplasia definit 
7.  Bronchial 
smooth 
muscle 
Enlarge mass(large airway) Enlarged(small air way) 
8. Bronchial 
glands 
Enlarge mass,but no change 
in mucin histochemistry 
Enlarge mass, increased acidic 
glycoprotein. 
9. Cellular 
infiltrates 
Predominantly CD3, CD4, 
CD25.Marked 
esinophilia(activated) 
Predominantly 
CD3,CD8,CD68,HLA-1 
Mild esinophilia. 
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4. Vocal cord dysfunction: 
           Vocal cord dysfunction may exist alone or with asthma, it is caused by 
paradoxical adduction of the vocal cords during inspiration, and may disappear with 
panting, speech, or laughing. Patients with chronic symptoms suggestive of asthma, 
normal spirometry, poor response to asthma medications, and frequent evaluations 
should be evaluated for vocal cord dysfunction. Usually, the diagnosis can be made 
using direct laryngoscopy, but only during symptomatic periods or after exercise. The 
presence of flattening of the inspiratory limb of the flow-volume loop may also suggest 
vocal cord dysfunction, but this is only seen in 28% of patients at baseline.
 
 
5. Tracheal and bronchial lesions: 
                   A variety of airway tumors are reported to manifest with symptoms similar 
to those of asthma. These tumors include endobronchial carcinoid and 
mucoepidermoid tumors and other tracheal lesions can include bronchocentric 
granulomatosis, subglottic stenosis, subglottic web, tracheal hamartoma, bronchogenic 
cysts, leiomyoma, and tracheobronchopathia osteoplastica. All these types of tracheal 
lesions have been reported with symptoms similar to asthma.  
Persistent wheeze localized to one area on the chest in associated with 
paroxysms of coughing indicates the bronchial diseases, such as foreign body 
aspiration  
6. Congestive heart failure: 
Congestive heart failure causes engorged pulmonary vessels and interstitial pulmonary 
edema, which reduce lung compliance and contribute to the sensation of dyspnea and 
wheezing. Cardiac asthma is characterized by wheezing secondary to bronchospasm in 
congestive heart failure, and it is related to paroxysmal nocturnal dyspnea and 
nocturnal coughing
. 
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7. Pulmonary migraine  
                Pulmonary migraine consists of combined recurrent asthma; cough with 
thick mucoid sputum; lower back pain radiating to the shoulder; subtotal or total 
atelectasis of a segment or lobe; and, occasionally, nausea with vomiting
 
The 
symptoms are often accompanied closely in time by focal headache. Spastic narrowing 
of the bronchi is postulated—along with retained mucous secretions, smooth muscle 
hypertrophy, and thickened bronchial walls—to cause expiratory collapse of selected 
airways. Cerebral and abdominal vascular migraine episodes are believed to 
accompany pulmonary migraine.  
8. Chronic Bronchitis 
In chronic bronchitis, there are no true symptom –free periods and one can 
usually obtain a history of chronic cough and sputum production as a background upon 
which acute attack wheezing are superimposed. Frequently patients with this condition 
will present the episode of breathlessness particularly on exertion and they sometimes 
wheeze. 
Complications: 
Mortality is uncommon in asthma but a severe attack may result in respiratory 
failure and death. 
This is more in 'status asthmaticus'. Other complications include frequent 
respiratory infection, pulmonary collapse due to obstruction by viscid secretions, 
pneumothorax, and emphysema and cough fracture (fracture of ribs due to violent 
coughing), children with asthma may show retardation of growth, especially if toiled 
with corticosteroid on a long term basic. Long standing bronchial asthma, punctured 
with frequent expiratory infections may lead to emphysema and chronic corpulmonale. 
Prognosis: 
The prognosis of the individual attack is good, except in severe acute asthma, 
when there is occasionally a fatal outcome, especially if treatment is inadequate of 
delayed. Spontaneous remission is fairly common in episodic asthma, particularly in 
children, but rare in chronic asthma, which can lead to irreversible airflow obstruction. 
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Seasonal fluctuation can occur in both types of asthma. Atomic subject with episodic 
asthma are usually worse in the summer, when they are more heavily exposed to 
antigens, while chronic asthmatics are usually worse in winter months, because of the 
increased frequency of viral infections. 
Prevention: 
Avoidance of allergens: 
There are few instances, in which a single agent can be identified as the cause 
for attacks of asthma. These allergens include grass pollens, mites, animal dander, 
drugs, industrial chemicals such as isocyanates and certain articles of diet. The 
majority of patients are hypersensitive to a wide range of allergens and attempts to 
avoid all of them are impracticable. 
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PROPERTIES OF TRIAL DRUG 
The trial drug Thuthuvalayathy Chooranam consists of 13 herbo mineral 
ingredients. Most of the ingredients are having pungent taste [kaarpu suvai]. 
Least among them belongs to bitter and astringent taste [kaippu & thuvarppu 
suvai]. 
Siddha system of medicine is based on five elements  
A Maruthuva Thanipadal quotes the formation of six tastes from five 
elements. 
‖        
      
      
     ”                        
       -  
EARTH +      =   SWEET 
 +     ` =   SOUR 
EARTH +                 =   ASTRINGENT 
 + FIRE         =   SALT 
 +                      =   PUNGENT 
 +  SPACE                =             BITTER 
 
As per Maruthuva thanipaadal the action and characters of kaarpu, kaippu 
& thuvarppu suvai as mentioned below 
 The pungent taste stimulates appetite. 
 It cures the diseases of throat 
 It destroys the vitiated kapha. 
CHARACTER OF ASTRINGENT TASTE: 
     “    
         –  
           
        ‖  
                           -     
 Astringent taste controls the hyper secretion of glands in the body. 
 It changes the vitiated kapha. 
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 “      
     
    
   
    
     .‖ 
                                                          -    
 Bitter taste changes the hatred towards food. 
 It converts the vitiated kapha and pitha. 
 It reduces the hyper secretions of glands in the body. 
 Considering the actions and characters of kaarppu, kaippu and thuvarppu 
suvai, the drug is formulated in such a way that the adverse effect of excessive 
kaarppu is counteracted by kaippu and thuvarppu suvai. Also, kaippu and 
thuvarppu suvai corrects the deranged dheeshakini in the body and produces 
good appetite. Both kaippu and thuvarppu suvai has the ability to reduce 
excessive secretion of the sputum and expel out by expectorant action. Hence 
kaarppu suvai, by its inherent property antagonizes kapha by having fire as its 
component. 
Generally in kapha disease patient‘s complaints reduced appetite or 
anorexia. In Swasa kasam patients their condition gets worse if they suffer from 
dyspnoea particularly after food due to improper digestion. Siddhars had given 
us plethora of drugs, mostly combinations of herbs as compound drugs.The 
drugs Thuthuvalayathy chooranam and one among those formulations.  Most of 
the ingredientsof these drugs have the property of carminative, stomachic, 
stimulant, which suits for the kapha disease patients. 
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 INGRIDIENTS OF THE TRIAL MEDICINES 
  1. : 
Botanical Name  :           Solanum trilobatum, Linn. 
Family     :  Solanaceae  
Vernacular names 
Sans   : Alarka 
English   : Climbing Brinjal 
Tamil  : Thuthuvalai 
Mal  : Mullakaththari. 
Organoleptic: 
                Taste  :   Mild Bitter,Pungent 
    Potency :   Hot 
     Division :  Pungent 
Parts Used   : Leaves, Flower, Unriped Fruit. 
Actions      : Stimulant, Expectorant, Tonic. 
Gunam    : 
    
    
    
   . 
                                                  -    . 
Uses      :    
 It cures all the Kapha diseases.  
 It is used in the treatment of respiratory diseases like cough, asthma, chronic 
febrile infections, tuberculosis, cardiac and liver diseases.  
 The ethanolic extracts of S. trilobatum showed mast cell degranulation 
inhibition property.    
 The extract exhibit antimicrobial activity against Gram (+) and Gram (-) 
bacteria. 
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2. ®îÍÃãÄ¢: 
Botanical Name   :    Aristolochia indica.Linn 
Family    : Aristolochiaceae 
Vernacular names 
Sans    : Ishwari 
English      : Indian birthwort 
Tamil   :  Echchura muli  
 Mal                         : ishrukap-pul,karalekam.  
Organoleptic: 
 Taste     : Bitter 
 Potency  : Hot 
 Division  :  Pungent  
 Actions      :      Stimulant, Tonic,Emmenagogue. 
 Gunam    : 
                           ¦ÀÕÁÕó¾¢ý §Å÷À¢ò¾õ À£È¢¨ÃôÒ ¸¡ºõ 
         ÅÕÍÃõ ¯¼õÒÅÄ¢ Å¡¾õ-¯Õ×Å¢„õ 
         ´ýÈ¢Â Á¡¸Ê¸û µðÎõ ¯Ä¸¢Ä¢Ð 
              «ýÈ¢ÂÐ §¸¡îº¢¸¢î¨ºì ¸¡õ.                       -                            
     -  . 
Uses: It cures vatha, pitha diseases,cough, asthma,fever,body pain and all poison. 
3. º¢üÈÃò¨¾:    
Botanical Name   :  Alpinia officinarum.Linn  
Family:                      Zingiberaceae 
 Vernacular names 
 
 Sans    :Rasna 
English      :Galangal the lesser,Java galangal. 
Tamil   : Chittarattai. 
  Mal                         :Aratha.  
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Organoleptic: 
             Taste- Pungent 
             Potency- Hot 
                        Division - Pungent 
Actions    :  Expectorant,Febrifuge,Stomachic . 
 Parts Used:Root   
Gunam    : 
                               Å¡¾À¢ò ¾í¸ÃôÀ¡ý Å¡¾ï º¢§Ã¡§Ã¡¸ï 
                §º÷ó¾¸À Óò§¾¡¼ï º£§Á¡Î-§¿÷ó¾ÍÃõ  
                ÁüÈÃò¨¾ì ¸¡ðÊ ÅÕÁ¢ÕÁ Öó¾£Õõ 
                º¢üÈÃò¨¾ ÅýÁÕó¾¡ø §¾÷. 
                               - §¾¨ÃÂ÷  
Uses: The root of this plant is used to cure vatha,kapha 
diseases,eczema,cough,all type of fever it is use to equlised the three dhoases.  
 The phytochemical diary heptanoid phenylhept (HMP) in lesser Galangal 
exhibit the anti-inflammatory properties on mouse macrophage cell line and human 
peripheral blood mononuclear cells (PBMCs) in vitro. It significantly inhibited 
lipopolysaccharide (LPS)-stimulated nitric oxide (NO) production. It also inhibited the 
release of LPS-induced proinflammatory cytokines interleukin-1 beta (IL-1 beta). 
4) ¸Õïº£Ã¸õ: 
Botanical Name   : Nigella sativa .Linn 
Family :                       Ranunculaceae 
Vernacular name 
Sans    :Upakunchika 
English   :Black cumin,Small fennel 
Tamil    :karuchirakam  
 Mal    :karinchirakam  
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Organoleptic: 
          Taste -Bitter  
            Potency - Hot  
  Division -Pungent 
Parts used: Seed 
Action: Carminative, Stomachic, Parasiticide, Emollient. 
Gunam: 
    ¸Õïº£Ã¸ò¾¡ý ¸ÃôÀ¡¦É¡Î ÒñÏõ  
    ÅÕïº¢Ã¡öô À£¿ºÓ Á¡üÚõ-«Õó¾¢É¡ø 
    ¸¡öîºø ¾¨ÄÅÄ¢Ôí ¸ñÅÄ¢Ôõ §À¡ÓÄ¸¢ø 
    Å¡öîº ÁÕó¦¾É§Å ¨Å.                          -                                                                                              
      -  . 
Uses: it is indicated for, 
cough,vomiting,nasea,jaunice,eczema,wounds, 
peptic ulcer,oedema,flatulanc,internal fever.  
 Nigellone has proved to be an excellent prophylactic agent for both bronchial 
asthma and asthmatic bronchitis. 
            Jewish and Muslim prophets with Mohammed refer to Nigella, reported to have 
described the seeds as a remedy for ―every illness except death‖ 
 
5.þÖô¨ÀôÀ¢ñ½¡ìÌ: 
Botanical Name       : Madhuca lonifolia .Macbride 
                 Family   : Sapotaceae 
               Vernacular names 
             Sans   :Madhaka-vrhaiskha 
              English     : Narrow leaved mohua,south indian mahua. 
              Tamil :lluppai 
              Mal  :lruppai 
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  Organoleptic: 
                           Taste              -   Bitter, Astrigent. 
                         Potency            -   Hot 
                         Division       -   Pungent 
          Parts used: 
                           Leaf,flower,fruit,seed, ghee,oilcake,bark,root bark. 
         Action: emetic 
        Gunam : 
               ¦À¡ò¾¢ì ¸ÎÅ¦É¡Î ÒñÏí ¸ÃôÀÛõ§À¡õ 
               Å¢ò¾¨¾ôÒ §¾¡¼Á¢¨Å Å£È¡Å¡õ-¦Áò¾É§Å 
               ±ñ¦½öì ¸º¢×¸Ù §ÁÌ Á¢Öô¨ÀÅ¢¨¾ô 
  À¢ñ½¡¸Ìì ¦¸ýÈ¡È¢Âô §ÀÍ                        
            -  . 
 Uses : Hunch backWound,eczema,threedhosha,oedema 
 
6) : 
Botanical Name         :       Zingiber officinale, Rose. 
Family  :       Zingiberaceae 
Vernacular names 
Sans    : Nagaram 
English      : Dried Ginger 
Tamil   : Chukku 
Mal   : Chukku  
Organoleptic: 
Taste      -    Pungent  
Potency    -    Hot 
Division      -    Pungent 
Action:       Stimulant, Stomachic, Carminative 
Parts used:    Dried rhizome 
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Gunam: 
    
   –  
    
  . 
                   -   . 
Uses: 
It is extremely valuable in dyspepsia, flatulence, colic, vomiting, spasms 
and other painful affections of the stomach and the bowels unattended by fever; 
for cold, cough, asthma, dyspepsia and indigestion. 
 Research studies showed that ginger reduces inflammation and has antioxidant 
actions. Gingerol has the ability to reduce inflammation of the airways, according to a 
study published in the December 2010 issue of the "Journal of International 
Pharmacology."  
7) : 
Botanical Name   :    Piper nigrum, Linn 
Family               : Piperaceae 
Vernacular names 
Sans     : Maricha 
Hindi    : Kali - mirch 
English    : Black pepper 
Tamil    : Milagu 
             Mal    : Kurumulak.  
Organoleptic: 
Taste      -   Bitter, Pungent 
Potency     -   Hot 
Division      -   Pungent 
Parts used          -         Seed, Stem 
            Actions                -         Carminative, Antidote, Stimulant 
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Gunam: 
    
   –  
    
 . 
                         -  . 
Uses:   
It is used to treat asthma, chronic indigestion, colon toxins, obesity, sinus, 
congestion, fever intermittent fever, cold extremities, colic, gastric ailments and 
diarrhoea.  
8) : 
Botanical Name   :    Piper longum, Linn. 
Family               : Piperaceae 
    Vernacular names 
Sans   : Pippali 
English   : Long pepperr 
Tamil  : Thippili 
Mal  : Thippili  
Organoleptic: 
Taste        -     Astrigent 
Potency       -     Hot 
Division        -      Sweet 
     Parts used      :  Unriped fruit.  
    Actions            :    Stimulant, Carminativ 
 
Gunam: 
    
   –  
    
  . 
                                                     -    
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Phytochemicals: 
1% of volatile oil, resin, alkaloid, pipperine, piperlonguminine, calcium 
phosphorous, iron. 
Uses:  
Powder of Long pepper with honey will relieve cough, cold, asthma, 
hoarseness and hiccup.  
          Piperine relieves inflammation, pain and asthma improves and digestion.  It has 
analgesic, ant-pyretic, anti-inflammatory, anti - convulsion and CNS depressant 
activities. 
9) : 
Botanical Name:    Terminalia chebula. Retz 
Family : Combretaceae 
    Vernacular names 
Sans   :  haritaki 
Hindi  : Pile Hara 
English  : Chebulic Myrobalan 
Tamil  : Kadukkai 
Mal  : Katukkai 
 Organoleptic: 
Taste             - It has all six taste 
Potency   -    Hot 
Division     -    Sweet 
         Parts Used    -     Unripedfruitand fruit. 
Gunam : 
          
                –  
                  
               . 
                                               -   .  
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Uses : 
 Fruits are used in fever, cough, asthma, urinary disease, piles etc. 
 Fruits contain astringent substances tannic acid, Chebulinic acid, gallic acid etc. 
 It can be used as home remedy against fever, cough, asthma andurinary disease 
 
10) ¦ÀÕí¸¡Âõ: 
         Botanical Name:        Ferula asafetida. 
         Family:                     Apiaceae 
        Vernacular names 
                 Eng   :Asafoetida 
                Tam  :Perungayam 
                San   :Hingu 
                Mal  : Perungayam 
 Organoleptic: 
                     Taste: Bitter, 
                     Potency: Hot, 
                     Division: Pungent 
Parts used: Gumresin  
 
Action: Stimulant, Carminative, Antispasmodic, Expectorant . 
 
Gunam 
 
      ¾ó¾ ãÄò¦¾ØýÀ¢½¢  
      ºÕÅ¸¡Çõ Å¢Õîº¢¸í¸£¼õÁ¡ 
      º¢§ÄòÐÁòÐÚõÅÄ¢ 
      Á¡Ô¿¡Ú¿ü ¸¡Âí¸¢¨¼ø¸¢§É. 
                         -- §¾¨ÃÂ÷  
 
U  
 It is indicated for all type of poison, ascites, peptic ulcer,pain due to kapham.The 
smoke of powered asafoetida with vigna mungo is inhaled for asthma. 
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11. ¾¢ôÀ¢Ä¢§Å÷: 
 Botanical Name  : Piper longum, Linn. 
Family              : Piperaceae    
Vernacular names 
Sans   : Pipalee-moola  
Hindi  : Felfelai-maya 
English   : long pepper root 
Tamil  : thippili-ver 
Mal  : kattu-thippili  
Organoleptic: 
         Taste             -  Pungent . 
       Potency -   Hot 
  Division -   Pungent 
 Part used: Root      
Act ion: Stomachic, Carminative. 
 
Gunam 
¾¢ôÀ¢Ä¢§Å÷ ¾¡¸À¢ò¾ï§º¡¸ó ¾½¢Â¡î ÍÃÁ¢ÕÁø   
§Á¸í ÌÃü¸õÁø ¦Áöì¸ÎôÒõ-²Ìí¸¡ñ 
¾¢ôÀ¢Ä¢ã Äí¸ñ¼ò ¾¢ôÀ¢Ä¢Â ¾¡õ¿ÚìÌò 
¾¢ôÀ¢Ä¢¦Âý §È¦Â¡Õì¸¡ü ¦ºôÒ. 
                        -    
 Uses: It cures fever, cough, sore throat, body pain, loss of appetite. 
          It cantain pipperine, piper lonumine and dihydrostigmasterol which 
reduced inflammation of respiratory diseases. 
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13. : 
Chemical Name             :  Sodium chloride impura  
Vernacular names 
English   : Rock salt, Halite. 
Tamil  :  Indhuppu  
Gunam  : 
         
               –  
                
              . 
                                 Ref: Gunapadam Thathu Jeeva Vaguppu 
Chemical constituents: 
 Along with sodium, it contains many other minerals including, calcium, zinc, iron, 
magnesium, potassium, copper and several other trace minerals.  
Uses: 
 Rock salt is used for sneezing, colds, eczema, hives, thrush, menstrual 
problems, and migraine.  
 It is given to promote digestion, improve appetite, and relieve constipation.  
 sodium chloride solution is used for dehydration, to irrigate the eye, to relieve 
nasal congestion, and as a mouthwash.  
 It is indicated for dyspepsia and other abdominal disorders, cough and asthma.    
 
13.¦Åí¸¡Ãõ: 
 Chemical name : Sodii biboras;sodii boras.  
Vernacular names 
                 English : Sodium biborate,pyroborate. 
     Tamil: Vengaara 
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Organoleptic: 
           Taste: Sweet with Asterigent 
           Potency:  Hot.  
Action: Diuretic, Emmenagogue, Astringent, Antacid, Local sedative, Antiseptic 
Gunam:        
               ¦Åí¸¡Ãï §ºòÐÁò¨¾ §ÅÚÀñÏ §Á¸ÎÌ 
                ¾íÌº¢Ä ¿£÷ÓÈ¢Âò ¾¡ýÅ¡ïÌõ. 
                                                     Ref: Gunapadam Thathu Jeeva Vaguppu 
Characters: 
Borax: Na2B4O7 10H2O; Na2O-16.2%, B2O3-36.6%, H2O-47.2%,  
specific gravity:1.7 
Borax, also known as a hydrated sodium tetraborate, is one of the most important 
ofboron compound, a mineral, and a salt of boric acid. It is a soft and light crystalline 
substance. The colour is greyish white. Exposed to the air it becomes opaque or dirty 
white. 
Uses: 
 A mixture of powdered borax and honey is used externally for  soreness of 
mouth and cough. 
 Borax is given internally in doses varying from 10- 30 grains (650mgs-2gm) in 
acidity of the stomach, amenorrhoea, menorrhagia, and puerperal convulsions. 
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PREPARATION OF THE TRIAL MEDICINES 
                 THUTHUVALAYATHY CHOORANAM (Internal medicine) 
                  Ref :    Sarabendra vaithya muraigal-kasaswasa sigitchai, pg no:152-154. 
INGREDENTS:   
1. Thuthuvalai  root bark ( Solanum trilobatum. Linn )     -1/2 padi (670 grams) 
2. Echchura muli root  (Aristolochia indica.Linn)             -1 ullaku (366grams) 
3. kadukkai  ( Terminalia chebula. Retz )                          - varagan (8.4grms) 
4. Chittarattai (Alpinia officinarum.Linn)                          -varagan (8.4grms) 
5. Chukku  ( Zingiber officinale. Rose)                             - varagan (8.4grms) 
6. Karunchirakam (Nigella sativa .Linn)                            - varagan (8.4grms) 
7. Milagu (Piper nigrum. Linn )                                         - varagan (8.4grms) 
8. Thippili ( Piper longum. Linn )                                       -varagan (8.4grms) 
9. Illuppai  oil cake ( Madhuca lonifolia .Macbride )         - varagan (8.4grms) 
10. kandathippili ( Piper longum. Linn )                               -varagan (8.4grms) 
11. Perungayam (Ferula asafoetida .Linn)                            - varagan (8.4grms) 
12. Indhuppu  ( Sodium chloride impura )                            -2 varagan (8.4grms) 
         13. Vengaaram (Sodium biborate)                                        - ¼ varagan (1 gram) 
METHOD OF PURIFICATION: 
Thuthuvalai root bark (Solanum trilobatum.Linn ):   
      It is cleaned with   pure white cloth.     
Echchura muli root (Aristolochia indica) 
It is washed in water and cleaned with pure white cloth.    
Kadukkai (Terminalia chebula. Retz): 
       Soak the kadukkai in the rice water (kazhuneer) and filter the yellowish tint of the 
water then the seed is removed from the kadukkai and it is allowed to dry under sun 
light. 
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 Chittarattai (Alpinia officinarum) 
 The skin of the Chittarattai is removed, cut into pieces and dried.  
Chukku (Zingiber officinale.Rose ): 
       Double the proportion of  calcium carbonate (Lime stone) solution with dry ginger 
is   boiled for three hours, then it is washed well with water and allowed to dry. The 
outer skin   of dry ginger is peeled off. 
Karunchirakam (Nigella sativa) 
         The seed are fry it like as golden yellow colour and taken. 
Milagu (Piper nigrum. Linn ): 
         Soak it in sour butter milk for 1 saamam (three hours). 
Thippili (Piper longum.Linn ): 
       Thippili is soaked in lemon juice and taken.  
Kandathippili ( Piper longum. Linn )  
        Remove the nodes &dried. 
 Illuppai oil cake (Madhuca lonifolia .Macbride ) 
 It is soaked in water and dried. 
Perungayam (Ferula asafoetida) 
         Purified by fried in a mud vessel. 
Indhuppu (Sodium chloride impura ):  
        It is soaked in goat‘s urine for 3 nazhigai (72 mins) and dried in sun light. 
Vengaaram (Sodium biborate) 
       Purified by fried in a mud vessel until the water content of it evaporates 
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PREPARATION OF TRIAL DRUG:  
STEP1: 
       The purified Thuthuvalai root bark (Solanum trilobatum. Linn)  is 
dried in sunlight and made into fine powder with the help of Iron mortar and pestle and 
filtered with pure white cloth and ½ padi (670 grams) is taken separately. 
 STEP 2:   
       The purified Echchuramuli rootbark (Aristolochia indica) chooranam 
of  1 ullaku (366grams) is mixed with above said  powder.(step 1) 
STEP3:  
Raw drug (3-12) of each is fried, powered and mixed with above said 
mixture.(step1&step2) 
STEP 4:  
    ¼ varagan (1gram) of the purified powder of Borax is mixed with   
above said mixture. (step1,2&3) 
        The finished chooranam is taken and   preserved  in a air tight  containner.         
      Dose                                          : Verugadi alavu (1.5 gm ) Twice daily, After food. 
      Adjuvant                                    : Honey. 
      Route of drug administration    :  Oral route 
      Course                                         : 1/2 Mandalam ( 24 days ).  
      Indication                         : Swasakasam. 
     Reference                                :  Sarabendra vaithya muraigal-kasaswasa sigitchai, 
                                         pg no:152-154.  
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THUTHUVALAYATHY CHOORANAM 
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                                                         PROTOCOL 
 TITLE: 
                    Pre clinical and clinical study on ―swasakasam‖ (Bronical asthma) and the 
drug of choice is ―Thuthuvalayathy chooranam‖ (internal) 
OBJECTIVES 
1) Primary objective: 
 To evaluate the therapeutic efficacy of the siddha drug “Thuthuvalayathy 
chooranam” (Internal) in the treatment of  “ Swasa Kasam” . 
   2) Secondary objective: 
 To evalulate the safety profile (Acute, sub - Acute toxicity studies) of 
the trial drug.   
 To study the siddha cofactors towards the efficiacy of medicine. 
STUDY DESIGN & CONDUCT OF STUDY: 
 Study type:     an open clinical trial. 
Study place :    Ayothidasar Pandithar Hosipital , 
                             Dept of Maruthumam,  
                            National institute of   Siddha ,   
                            Tambaram sanatorium , Chennai-47. 
 Study period :    12 months 
  Sample size : 40 patients. 
TREATMENT 
           Medicine  Name        : THUTHUVALAIYATHY CHOORANAM.(Internal ) 
            Dose                            : Verugadi alavu ( 1.5 gm ) Twice daily, After food. 
            Adjuvant                     : Honey. 
            Route of drug administration:  Oral route 
            Course                           : 1/2 Mandalam ( 24 days ) 
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            DIET AND MEDICAL ADVICE 
 Advised to take hot water and hot foods. 
 Advised to take bath strictly in warm water. 
 Advised to avoid cool water, milk and milk products. 
 Advised to avoid factors which cause digestive disturbance. 
 Advised to avoid smoking and snuff. 
 Advised to avoid allergic factors. 
             
SUBJECT SELECTION: 
                As and when patients   reporting at the OPD of Ayothidass Pandithar 
Hospital with symptoms of inclusion criteria will be subjected to screening test & 
documented using screening proforma. 
INCLUSION CRITERIA: 
              1)   Age 18 to 60 yrs. 
              2)   Sex: Both male and female.  
              3)  Difficulty in breathing, Tightness of chest, Wheeze - Added sound   
       (Rhonchi), cough with or without expectoration. 
       4)  H/O allergy, sneezing. 
5) Patients who are willing to take radiological investigation and provide 
blood for lab investigation. 
6) Patients who are willing to estimate volume of air forcibly expired after a 
deep inspiration by using Mini-Peak flow meter and PEFR below normal 
range  from 250L/min to 150 l/min for men; from 200L/min to 100 L/min for 
women  ,for those patients are included.   
 [Normal range of PEFR: 
         Male: young adult: 400-650 L/min; Above 40 yr: 300-500L/min 
         Female: young adult: 250-450L/min; Above 40 yr: 200-400L/min] 
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 EXCLUSION CRITERIA: 
               1.   Cardiac disease. 
               2.   Renal disease. 
               3. Tuberculosis. 
               4. COPD. 
               5. Status asthmaticus. 
               6. Diabetes mellitus. 
    7. Hyper tension.  
               8. Pregnancy.  
               9. Lactation.  
             10.psychological factor. 
             11.worm infestation. 
WITHDRAWAL CRITERIA: 
 Intolerance to the drug & development of adverse reactions during 
drug trail                          
 Poor patient compliance & defaulters. 
 Patient turned unwilling to continue in the course of clinical trial. 
 Occurrence of any serious illness 
TESTS AND ASSESMENTS: 
A. Clinical assessment. 
B. Siddha assessment. 
C. Laboratory Investigations 
1. Routine investigations 
2. Specific investigations 
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A. CLINICAL ASSESMENT: 
 Dyspnoea. 
 Dry or protective Cough. 
 Wheezing. 
 Tightness of chest.                             
 Sneezing Rhinorrhoea. 
 Hoarseness of voice. 
 Sleep disturbance. 
 Expiration is like a hiss of a serpent. 
 Frequent hemming. 
 Sense of heat in both  nostrils 
 B.SIDDHA ASSESSMENT 
1.Thinai : 
 Kurinchi (hill areas) 
 Mullai ( forest ) 
 Marutham ( fertile land ) 
 Neidhal ( coastal area ) 
 Palai ( desert ) 
2. Paruva Kalam ( season )  
  Karkaalam 
  Koothir kaalm 
  Munpanikaalm 
  Pinpani kaalam 
  Ilavenil kaalam 
  Muthuvenil kaalam 
    3. Poripulankal: 
 Mei (Skin etc) 
 Vaai (Tongue etc) 
 Kan (Eye etc) 
 Mooku (Nose etc) 
 Sevi (Ear etc) 
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4.Kanmedriyamand Gnanenthiriyam: 
 Vaai (Buccal cavity) 
 Kaal (Lower limbs) 
 Kai (Upper limbs) 
 Eruvaai (Anorectal region) 
 Karuvaai (Uro-genital region) 
  5. Ezhuudalkattugal: 
 Saram 
 Senneer 
 Uoon 
 Kozhuppu 
 Enbu 
 Moolai 
 Sukkilam /suronitham 
 
 
6.Ennvagaithervu ( Eight types of Examination): 
 Naadi 
 Sparisam 
 Naa 
 Niram 
 Mozhi 
 Vizhi 
 Malam 
 Moothiram 
-Neerkuri 
 -Nei kuri 
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C.LABORATORY  INVESTGATION 
   SIDDHA PARAMETERS 
         Malam 
         Moothiram 
-Neerkuri 
 -Nei kuri 
 ROUTINE INVESTIGATION 
      BLOOD 
 Hb (gm/dl )       -                                                                                                                                                                              
 Total WBC Count( Cells/cumm)   -   
 DC-  Polymorphs(%)    - 
 Lymphocytes(%)    – 
 Eosinophils(%)     – 
 Monocytes(%) – 
 Basophils (%) – 
 Total RBC count(Million cells / cumm)-  
 ESR(mm/hr) - 
 Blood glucose( mg/dl):  ( Fasting) - ( Post – prandial)- 
 Blood urea(mg/dl)- 
 Serum Creatine(mg/dl)- 
 Serum cholesteroSl(mg/dl)- 
  HDL cholesterol(mg/dl)- 
  LDL cholesterol(mg/dl)- 
 VLDL cholesterol(mg/dl)- 
 Serum triglycerides  (mg/dl)-       
 Liver function tests 
 Serum total bilirubin (mg/dl)  -      
 Serum Direct bilirubin (mg/dl) -       
 Serum Indirect bilirubin (mg/dl) -       
 Serum Alkaline phosphotases (u/l) - 
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 SGOT (u/l) - 
 SGPT (u/l) - 
 Serum Total Protein   ( g/dl) - 
 Serum Albumine( g/dl) - 
 Serum Globulin( g/dl) - 
 Serum Calcium (mg/dl) -       
 Serum Phosphorous (mg/dl) -       
 Serum Uric Acid (mg/dl) – 
 
URINE 
o Urine sugar (F)&(PP) 
o Albumin 
o Deposits 
MOTION 
o Ova  
o Cyst 
o Occult blood 
 
 
SPUTUM 
AFB 
 OTHER INVESTIGATION 
o X Ray Chest (PA  view) 
o ECG 
SPECIFIC INVESTGATIONS 
     PEFR( Peak Expiratory Flow Rate ) [L/min] 
STUDY ENROLLMENT  
 In this open clinical trial, patients reporting at the OPD with the clinical 
symptoms of dyspnoea , cough with or without expectoration, wheeze , 
tightness of chest ,etc will  be examined clinically for enrolling in the study 
based on the inclusion and exclusion criteria.  
 The patients who are to be enrolled would be informed (Form IV-C) about the 
study, trial drug, possible outcomes and the objectives of the study in the 
language and terms understandable to them. 
 After ascertaining the patient‘s willingness, informed consent would be 
obtained in writing from them in the consent form (Form IV-A). 
106 
 
 All these patients will be given unique registration card in which patients‘ 
Registration number of the study, Address, Phone number and Doctors phone 
number etc. will be given, so as to report easily and report any complications . 
 Complete clinical history, complaints and duration, examination findings-- all 
would be recorded in the prescribed Proforma in the history and clinical 
assessment forms separately. Screening Form- I will be filled up; Form I-A,  
Form –II and Form –III will be used for recording the patients‘ history, clinical  
examination of symptoms and  signs and laboratory investigations respectively. 
 Patients would be advised to take the trial drug and appropriate dietary advice 
(Form IV-D) will be given according to the patients‘ perfect understanding. 
 
CONDUCT OF THE STUDY: 
                   Before starting the course purgation is given with the OP medicine 
Mantha Ennai - 8 ml (od) with warm water at early morning in empty stomach  
                 The trial drug THUTHUVALAYATHY CHOORANAM (Internal) is given 
continuously for 24 days. 
For OP patients, they should visit the hospital once in 7 days.  At each clinical visit 
clinical assessment is done and prognosis is noted. For IP patients the drug is provided 
daily and prognosis is noted.  Laboratory investigations are done  0
th
 day  & 24
th
 day of 
the trial. For IP patients, who is not in a situation to stay in the hospital for a long time 
is advised to attend the OPD for further follow-up .After the end of the treatment also, 
the patient is advised to visit the OPD for another 2 months for follow-up. If any trial 
patient who fails to collect the trial drug on the prescribed day but wants to continue in 
the trial from the next day or two, he/ she will be allowed, but defaulters of one week 
and more will not be allowed to continue and be withdrawn from the study with fresh 
case being inducted. 
DATA MANAGEMENT 
 After enrolling the patient in the study, a separate file for each patient will be 
opened and all forms will be filed in the file. Study No. and Patient No. will 
be entered on the top of file for easy identification. Whenever study patient 
visits OPD during the study period, the respective patient file will be taken 
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and necessary recordings will be made at the assessment form or other 
suitable form. 
 The screening forms will be filed separately. 
 The Data recordings will be monitored for completion by HOD and adverse 
event by  Sr.Research Officer (Statistics). All forms will be further 
scrutinized in presence of Investigators by Sr.Research Officer (Statistics) 
for logical errors and incompleteness of data to avoid any bias. No 
modification in the results is permitted for unbiased reports. 
 
STATISTICAL ANALYSIS: 
          All collected data will be entered into the computer and manually cross-checked 
the correctness of the data entry. The clinical symptoms and  Peak expiratory flow rate 
( L/min ) will be analysed by comparing the two point of data(before and after 
treatment) paired test and chi-square test will be employed to study the efficacy of 
treatment. Futher, the effect of age and sex will also be analysed. 
OUT COME 
Primary Outcome: 
            Primary Outcome is mainly assessed by comparing the pre and post treatment 
Peak expiratory flow rate ( L/min ) 
  Secondary Outcome: 
           Secondary outcome is assessed by comparing the following parameters ,before 
and after the treatment   
                                    1)  Other Clinical symptoms 
                            2)  Eosinophils (%) and  ESR  
                            3) Asthma grade level. 
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ADVERSE EFFECT / SERIOUS EFFECT MANAGEMENT: 
             If the trial patient develops any adverse reaction, he/she would be immediately 
withdrawn from the trial and referred to the pharmocovigilance Department of 
National Institute of Siddha.  
ETHICAL ISSUES 
1. Informed consent will be obtained from the patient explaining in the 
understandable   language to the patient. 
      2.  After the consent of the patient (through consent form) they will be enrolled in 
the study 
3.  Treatment would be provided free of cost.  
4.  No other external or internal medicines will be used. There will be no 
infringement on the rights of patient  
5. To prevent any infection, while collecting blood sample from the patient, only 
disposable syringes, disposable gloves, with proper sterilization of lab equipments 
will be used.                            
      6. The data collected from the patient will be kept confidentially. The patient will 
be Informed about the diagnosis, treatment and follow-up.  
 7. The patients who are excluded [as per the exclusion criteria]are given proper 
treatment,  with full care at National Institute of Siddha 
      8.  In conditions of treatment failure, adverse reactions, patients will be given  
alternative treatment at the National Institute of Siddha with full care throughout  the 
end. 
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 ASSESSMENT FORM: 
FORM I   SCREENING AND SELECTION PROFORMA 
FORM I   A HISTORY PROFORMA ON ENROLLMENT 
FORM ll   CLINICAL ASSESSMENT ON ENROLLMENT 
FORM ll  A  CLINICAL ASSESSMENT DURING AND AFTER TRIAL 
FORM lll    LABORATORY INVESTIGATION ON ENROLLMENT AND  
      CONCLUSION OF TRIAL 
FORM IV A    DRUG COMPLIANCE FORM  
FORM IV B  INFORMATION SHEET  
FORM IV C    CONSENT FORM 
FORM IV D   DIETARY ADVICE FORM 
FORM IV E   WITHDRAWAL FORM 
FORM IV F   ADVERSE REACTION FOR 
 
 
 
 
 
 
 
 
 
 
110 
 
OBSERVATION AND RESULTS 
Results were observed with respect to the following criteria  
1. Sex Distribution   
2. Age Distribution   
3. Kaalam Distribution  
4. Religion Distribution  
5. Thinai Distribution  
6.  Paruva Kaalam Distribution  
7. Occupation Distribution  
8. Socio-economic status  
9. Triggering factors  
10. Clinical features  
11. Duration of Illness  
 12. Family history  
13. Diet factor  
14. Habits  
15. Gnanendhiriyam (Imporigal)  
16. Kanmendhiriyam  
17. Kosam  
18. Mukkutram  a)Vadham   b)Pitham   c) Kabam  
19. Ezhu Udal Kattugal  
20. Envagai Thervugal  
21.  Neikuri 
22. Laboratory Analysis 
23. Primary Outcome 
       PeakExpiratoryFlowRate 
24. Secondary Outcome 
      a. Clinical Features  
      b.ESR and Eosinophil count 
     c. Grading of asthma.  
25. Gradation of Results 
For this study 40 cases were selected. 
  
1.  GENDER DISTRIBUTION 
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TABLE NO: 1 
 
 
 
 
 
 
 
 
 Inference: Out 40 cases, 26 cases (65%) were Female and 14 cases (35%) 
were Male. 
             It is clear that the incidence of asthma is more in Female. 
 
 
  
 
2. AGE DISTRIBUTION 
35 %
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GENDER
Percentage
GENDER No. Of Cases Percentage (%) 
Male 14 35% 
Female 26 65% 
TOTAL 40 100 
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TABLE NO: 2 
 
 
 
 
 
 
 
 
 
 
 
 
 Inference: Out 40 cases,  2cases (5%) were in the age group between 18-20, 
12 cases (30%) were in the age group between 21-30%, 13 cases (32.5%) were in the 
age group between 31-40 , 9 cases(22.5%) were in the age group between 41-5,4 cases 
(10%) were in the age group between 51-60. 
 
3. DISTRIBUTION OF CASES BY KAALAM. (LIFE SPAN) 
TABLE NO: 3 
0
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AGE DISTRIBUTION
Percentage
S.NO Age in years  No. Of Cases Percentage (%) 
1.  18-20  2 5 
2.  21-30  12 30 
3.  31-40  13 32.5 
4.  41-50  9 22.5 
5.  51-60  4 10 
 TOTAL 40 100 
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Kaalam No. Of 
Cases 
Percentage (%) 
Vatha Kaalam  1 – 33 years 20 50 
Pitha Kaalam  34 – 66 years 20 50 
Kaba Kaalam  67 – 100 years 0 0 
TOTAL 40 100 
 
 
 
 
Inference: Out of 40 cases, 20 of cases (50% ) were found to be affected in 
their Vatha kaalam (Between 1 - 33 years)  and 20 of cases (50%) were found 
to be affected in their Pitha kaalam (Between 34-66years).  
 
4. DISTRIBUTION OF CASES BY RELIGION 
                                                                      TABLE NO: 4 
Vatha Kaalam
50%
Pitha Kaalam
50%
Kaba Kaalam
0%
KAALAM
114 
 
 
 
 
 
 
 
 
 
 
 
Inference: Out of 40 cases, 37 cases (92.5%) were Hindu, 3 cases (7.5%) were 
Christians. 
 
 
 
5. DISTRIBUTION OF CASES BY THINAI (LAND) 
TABLE NO: 5 
Thinai (Land) No. Of Cases Percentage(%) 
S.No  Religion No. Of Cases Percentage (%) 
1. Hindus 37 92.5 
2. Christians 3 7.5 
3. Muslims 0 0 
 TOTAL 40 100 
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Kurinji (Hill areas) 14 35 
Mullai (Forest) 9 22.5 
Marutham (Fertile land) 5 12.5 
Neithal (Costal area) 12 30 
Paalai (Desert) 0 0 
TOTAL 40 100 
       
 
Inference :  Among the 40 cases , 14 cases (35%) belonged to the kurinji (i.e. 
Mountains & its surroundings), 9 cases ( 22.5%) belonged to the Muillai (i.e. Forest & 
its surroundings) , 
5 cases (12.5%) belonged to the Marutham (i.e. plain & its surroundings) and 
12 cases (30%) belonged to the Neithal(costal area& its surroundings). 
 
.    6. DISTRIBUTION OF CASES BY PARUVA KAALAM 
                                         TABLE NO.6 
Kurinji (Hill 
areas)
Mullai 
(Forest)
Marutham 
(Fertile 
land)
Neithal 
(Costal area)
Paalai 
(Desert)
14
9
5
12
0
35%
22.5%
12.5%
30%
0
Thinai
No of Cases Percentage(%)
S. No  Paruva Kaalam  No. Of Cases Percentage (%) 
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Observation : Among the 40 cases, in 25 cases (62.5%) the incidence of the disease 
seems to be higher kaar kalam(Aug 16 – Oct 15) , in 13 cases(32.5%) the incidence 
occurred in Mudhuvenil (Jun 16 –Aug15) and , in 2 cases(5%) the incidence occurred 
in koothir kaalam(Oct 16-Dec15) 
 
 
7. OCCUPATIONAL DISTRIBUTION 
TABLE NO.7 
 
25 2
0 0 0
13
62.5% 5% 32.5%
Kaar Koothir Munpani Pinpani Ilavenil Mudhuvenil
PARUVAKALAM
No. Of Cases Percentage (%)
1.  Kaar (Aug 16 – Oct 15)                      25 62.5 
2.  Koothir    ( Oct 16 – Dec 15) 2 5 
3.  Munpani  (Dec 16 – Feb 15) 0 0 
4.  Pinpani    (Feb 16 – Apr 15) 0 0 
5.  Ilavenil    (Apr 16 – Jun 15) 0 0 
6.  Mudhuvenil (Jun 16 –Aug15) 13 32.5 
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S. No  Occupation  No. Of Cases Percentage(%) 
1 House Wives 14 35 
2 Student 4 10 
3 Software Engineer 5 12.5 
4 Mill Worker 2 5 
5 Textile Worker 1 2.5 
6 Sales Representative 1 2.5 
7 Tailor 2 5 
8 Poultery worker 1 2.5 
9 Driver 1 2.5 
10 Cook 2 5 
11  Mechanic 1 2.5 
12 Missionary 1 2.5 
13 Gardener 1 2.5 
14 Farmer 1 2.5 
15 Leather Factory Worker 1 2.5 
16 Dhobi 1 2.5 
17 Housemaid 1 2.5 
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Observation  : Out of 40 cases,14cases( 35%)  were House wives,4 cases( 10% ) 
Students,  
5 cases(12.5%) were Software Engineers, 2 cases(5%)  were cook, Tailor,Mill 
worker and remainding cases 2.5% of the  cases were Gardener, Texile worker,Sales 
representative, Poultery worker, Diver,Leather Factory worker 
,Mechanic,missionary,Farmer,Dhobi and Housemaid. 
                        8. SOCIO ECONOMIC STATUS DISTRIBUTION  
                                                       TABLE NO.8 
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OCCUPATION%
S. No  Socio - Economic  
Status  
No. Of  Cases Percentage(%) 
1.  Upper 0 0 
2.  Middle class  23 57.5 
3.  Lower 17 42.5 
 Total 40 100 
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             Observation : The incidence of the disease was found to be higher in 
23(57.5%) cases belonging to  middle class  and in 17(42%) cases belonging to 
economically lower class  
             9.   DISTRIBUTION OF TRIGGERING FACTORS 
 
TABLE NO.9 
 
57.5 %
42.5 %
Social Economic Status
Upper
Middle
Lower
S. No  Triggering Factors No. Of Cases Percentage(%) 
1 Dust 40 100 
2 Smoke exposure 40 100 
3 Cold exposure 32 80 
4 Food Additive 15 37.5 
5 Emotion  17 42.5 
6 Occupation  15 37.5 
7 Chemicals 12 30 
8 Fumes of Paint & Petrol 7 17.5 
9 Exercise  6 15 
10 Detergents 12 30 
11 Menstruation 2 5 
12 Husks, Grass & Pollens  6 15 
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13 OTHER 5 12.5 
40 40 32 15 17 15 12 7 6 12 2 6 5
100% 100% 80% 37.5% 42.5% 37.5% 30% 17.5% 15% 30% 5% 15% 12.5%
Triggering Factors
No. Of Cases Percentage(%)
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Inference :           
   Among 40 cases ,the following triggering factor were observed. 
  Dust and smoke is a main triggering factor in all 40 cases(100%),cold exposure in 32 
cases(80%),food additive in15 cases(37.5%),emotion in17 cases(42.5%),occupation 
in15cases(37.5%),chemicals in 12 cases(30%),fumes of paints and petrol in7 
cases(17.5%),exercise in6 cases(15%),detergent in12 cases(30%), menstruation in 
2cases(5%),husks, grains and pollens in 6 cases(15%) and other surrounding 
environment factor in 5 cases(12.5%). 
                                                
 
 
 
 
 
10.    CLINICAL FEATURES ( B T ) 
TABLE NO: 10 
                                
S. No  
Clinical Features  No 
Of 
Cases 
Percentage(%) 
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1 Wheeze 40 100 
2 Cough with or without expectoration 40 100 
3 Breathlessness 36 90 
4 Tightness of chest  40 100 
5 Sneezing 32 80 
6 Hoarseness 12 30 
7 Sleep disturbance    38 95 
 
 
        Inference: Among 40 cases, in all the 40 cases (100%) had wheezing, 
cough,tightness of chest,36cases (90%) had breathlessness, 38 cases(95%) 
had Sleep disturbance, 32 cases (80%) had sneezing and 12 cases (30%) 
had hoarseness. 
11. DISTRIBUTION OF CASES BY DURATION OF ILLNESS 
TABLE: 11 
                                       
S. No  
Duration No Of Cases Percentage(%) 
1 Below 3 month 3 7.5 
40 40 36 40 32
12
38
100% 100% 90% 100% 80%
30%
95%
Clinical Features
No Of Cases Percentage(%)
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2 3 month -6 month 5 12.5 
3 6 month -1year 8 20 
4 1-2 year 6 15 
5 2-3 year 5 12.5 
6 3-6 year 13 32.5 
              
 
 
 
Inference: 
Out of 40 cases, 13 cases (32.5%)  were affected by the illness from 3-6 
year,6cases  
( 12.5%) were affected by the illness from 1-2year, 5 case ( 12.5%) were 
affected by the illness from 2-3year, 8cases ( 20%) were affected by the illness from 6 
months-1year, 5 cases ( 12.5%) were affected by the illness from 3-6 months and      
3case ( 7.5%) were affected by the illness from below 3 months. 
 
12. FAMILY HISTORY 
TABLE NO.12 
Below 3 
month
3 month -
6 month
6 month -
1year
1-2 year 2-3 year 3-6 year
3 5 8 6 5 13
7.5% 12.5% 20% 15% 12.5% 32.5%
Duration
No Of Cases Percentage(%)
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Inference: 
Among 40 cases, 23 cases (57.5%) reported Negative family history of similar 
illness and  17cases (42.5%) reported Positive family history of similar illness. 
 
 
13. DIET 
TABLE NO: 13  
S.No Diet  No Of cases Percentage (%) 
1 Vegetarian 8 20 
2 Non- 
Vegetarian 
32 80 
42.5%
57.5%
Family History
Positive Negative 
S.No Family  
History  
No Of cases Percentage (%) 
1.  Positive  17 42.5 
2.  Negative  23 57.5 
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Inference: 
Among 40 cases, 32 cases (80%) had taken Non-Vegetarian; remaining   8 
cases (20%) were vegetarian. 
 
14. Habits 
TABLE NO: 14 
 
 
                               
 
 
 
20%
80%
DIET
Vegetarian
Non-Vegetarian
S. No  Habits  No Of cases Percentage (%) 
1. Smoker           6         15 
2.  Alcoholic          4           10 
3.  Betel nut chewer           2           5 
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Inference : 
Out of 40 cases, 6cases (15%) were smokers, 4 cases (10%) were Alcoholic and 
2cases (5%) were Betel nut chewer. 
 
15. IMPORIGAL 
TABLE NO : 15 
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S.No Imporigal No of Cases Percentage% 
1. Mei 8 20 
2. Vai 0 0 
3. Kann 5 12.5 
4. Mooku 23 57.5 
5. Sevi 0 0 
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Inference:  Among 40 cases, Mookku was affected in 23 cases 
(57.5%) due to running  nose and nasal block. Mei was affected in 8 cases 
(20%) due to pain in upper lower limbs and Kan was affected in 5 cases 
(12.5%) due to diminished vision. 
 
 
16.  KANMENDHIRIYAM 
TABLE NO: 16 
S.No Kanmendhiriyam No of Cases Percentage% 
1. Kai 4 10 
2. Kaal 6 15 
3. Vai 0 0 
4. Eruvai 3 7.5 
5. Karuvai 0 0 
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Inference:  Among 40 cases, Kai was affected in4cases (10%) , Kaal 
was affected in 6 cases(15% )which resulted in pain in upper and lower limbs. 
Eruvai was affected in3 cases( 7.5%) which resulted in constipation. 
 
 
 
                                         17.KOSANGAL 
                                      TABLE NO: 17 
 
                                              
 
 
                                              
  
 
 
 
S.NO KOSANGAL No of Cases Percentage% 
1 Annamayakosam 16 40 
2 Praanamayakosam 40 100 
3 Manomayakosam 0 0 
4 Vingyanamayakosam 10 25 
5 Anandhamayakosam 0 0 
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Inference: Among 40 cases, Pranamayakosam was affected in all 
40cases(100%) which resulted in  breathlessness,cough,wheeze and tightness 
of chest. Annamayakosam was affected in 16 cases (40%) which resulted in 
indigestion, and Vingyanamayakosam was affected in 10 cases(25%). 
         In Swasa kasam Pranamayakosam was mainly affected  
    18.MUKKUTRAM    a. VATHAM    b. PITHAM    c. KABAM 
18 a.  VATHAM  - TABLE NO: 18a 
S.No Types of Vatham No of Cases Percentage% 
1. Pranan 40 100 
2. Abanan 5 12.5 
3. Viyanan 10 25 
4. Udhanan 40 100 
5. Samanan 40 100 
6. Nagan 0 0 
7. Koorman 5 12.5 
8. Kirukaran 40 100 
9. Devathathan 38 95 
10. Dhananjeyan 0 0 
40%
100%
0 25% 0
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Inference:  Out of 40 cases observed , Pranan  was affected in 40 
cases(100%) which resulted in breathlessness, cough, wheeze , Abanan was 
affected in 5 cases(12.5%) which resulted in constipation, burning micturation, 
Udhanan was affected in 40 cases(100%)  low which resulted in pitched voice, 
Viyanan was affected in 10 patients (25%) which resulted in pain in lower 
limbs, Koorman was affected in5 cases (12.5%) which resulted in excessive   
lacrimation and diminished vision,  Kirukaran was affected in 40  cases which 
resulted in excessive cough reflex, excessive sneezing reflex and Dhevathathan 
was affected in 38 cases (95%) which resulted in tiredness.         
18 b. PITHAM 
TABLE NO: 18b 
   S.No Types of Pitham No of Cases Percentage% 
1. Analpitham 16 40 
2. Ranjakapitham 8 20 
3. Sathagapitham 40 100 
4. Aalosagapitham 5 12.5 
5. Prasagapitham 8 20 
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 Inference: Sadhaga pitham was affected in all 40 cases ( 100%), Anal 
pitham was affected in  16 cases ( 40%)  which resulted in indigestion ,poor 
appetite,  Prasagapitham was affected in 8 cases (20%) which resulted in  
lesions in any part of the body and pallor, Aalosaga pitham was affected in 5 
cases (12.5%) which resulted in dimnished vision and Ranjakapitham was  
affected  in 8cases (20%) which resulted in  pallor .   
18 c. KABAM 
                 TABLE NO : 18c 
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S.No Types of Kabam No of Cases Percentage% 
1. Avalambagam 40 100 
2. Kilethagam 16 40 
3. Pothagam 0 0 
4. Tharpagam 3 7.5 
5. Sandhigam 10 25 
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Inference: Avalambagam was affected in all the 40 cases(100%) which 
resulted in  the  presence  of  tightness  of  chest,  cough, wheezing and 
breathlessness. Sandhigam was affected in 10 cases( 25%) which resulted in 
joints pain and  Kilethagam was affected in 16 cases (40%) which resulted in 
loss of appetite and Tharpagam was affected in 3 cases (7.5%) which resulted 
in burning sensation of eyes.  
 
 
19.EZHU UDAL KATTUKAL 
TABLE NO : 19 
S.No Ezhu Udal Kattukal No of 
Cases 
Percentage% 
1 Saaram 40 100 
2 Senneer 12 30 
3 Oon 8 20 
4 Enbu 10 25 
5 Kozhuppu 38 95 
6 Moolai 0 0 
7 Sukkilam/Suronitham 0 0 
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Inference: Saram was affected in all cases 40 (100%), Senneer was 
affected in 12 cases ( 30%) which resulted in pallor  ,Oon was affected in 8 
cases (20% ) which resulted in joints pain,Kozhuppu was affected in 
38cases(95%) which resulted in body pain,Ennbu was affected in10 
cases(25%) which resulted in joint pain. 
20.  ENN VAGAI THERVUGAL 
TABLE NO : 20 
S.No Enn Vagai 
Thervugal 
No of Cases Percentage% 
1 Naa 23 57.5 
2 Niram 8 20 
3 Mozhi 40 100 
4 Vizhi 12 30 
5 Malam 3 7.5 
6 Moothiram 2 5 
7 Sparism 4 10 
8 Naadi   
 VathaPitham 24 60 
40 12 8 10 38
0 0
100% 30% 20% 25% 95%
Ezhu Udal Kattukal
No of Cases Percentage%
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  PithaVatham 12 30 
 KabaPitham 4 10 
                                                                              
                       
 
 
 Inference:  
 Mozhi was affected in all 40 cases (100%) which resulted in  low 
pitched voice and difficulty in speech,  
 Naa was affected in 23cases (57.5%) which resulted in coated tongue, 
pallor tongue, tongue ulcer,   
 Vizhi was affected in 12 cases  (30%) which resulted in diminished 
vision, pallor, itching,   
 Niram was affected in 8 cases ( 20%) which resulted in skin lesions,  
 Malam was affected in 3 cases (7.5%) which resulted in constipation,   
 Sparisam was affected in  4 cases  ( 10%) of the patients which 
resulted in sweating  
 Moothiram was affected in 2 cases (5%) which resulted in burning 
micturition. 
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    In Swasa kasam Mozhi was affected in all the patients.  Naa, Niram, Malam, 
Sparism, Vizhi, were affected in most of the patients. In Naadi Vathapitha naadi 
showed higher frequency than the others. 
                                                   
 
 
 
 
 
 
 
 
                                                             21.  NEIKURI 
                                                               TABLE NO – 21                                              
 
 
                                                  
                           
 
 
S.No Neikuri No of Cases Percentage% 
1 Vatha Neer 25 62.5 
2 Pitha Neer 7 17.5 
3 Kaba Neer 8 20 
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 Inference: Among 40 patients, 25 cases (62.5%) of the patients had Vadha 
neer(Snake Pattern), 7 cases(17.5% )of the patients had Pitha neer(Ring Pattern) and 
8 cases(20%) of the patients had kapha neer (Pearl Pattern).  
In majority of cases Vatha neer was present. 
 
 
 
 INVESTIGATIONS 
PEAK EXPIRATORY FLOW RATE 
62.5%
17.5%
20%
Neikuri
Vatha Neer Pitha Neer Kaba Neer
S.No O.P/I.P No. Age/Sex PEFR(lit/min) B.Treatment PEFR(lit/min)A.Treatment 
1. C80516 40/F 130 180 
2. C80591 20/F 120 250 
3. C79343 21/F 150 190 
4. C80968 25/F 130 280 
5. C83148 29/F 100 260 
6. 4983 29/M 180 360 
7. C83357 29/F 180 320 
8. C83859 21/F 150 210 
9. C84354 23/F 160 280 
10. C84952 46/M 210 380 
11. C85576 34/F 170 280 
12. C85444 40/F 160 290 
13. C85401 28/F 150 200 
14. C86528 38/M 230 410 
15. C87290 42/F 110 180 
16. C87412 40/M 210 360 
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EOSINOPHILS COUNT BEFORE AND AFTER TREATMENT 
17. C87563 52/F 140 270 
18. C89103 55/M 180 260 
19. C92628 32/M 160 310 
20. 4077 33/F 130 340 
21. C89542 42/F 180 290 
22. C90031 25/M 250 420 
23. C90298 30/M 210 370 
24. C93882 44/F 110 240 
25. C88940 33/F 160 250 
26. C92056 26/M 190 350 
27. C91895 18/F 180 290 
28. C91493 28/M 210 340 
29. 4043 35/F 180 360 
30. C94291 21/M 170 340 
31. C87827  32/F 190 290 
32. B73595 43/M 210 240 
33. 4254 47/F 160 310 
34. 4147 46/F 190 360 
35. 5120 54/M 230 430 
36. D001578 32/F 130 280 
37. 4206 55/F 180 230 
38. 4202 31/F 160 280 
39. 5184 37/M 220 250 
40. 4205 40/F 150 320 
S.No O.P/I.P No. Age/Sex Eosinophil%B T Eosinophil%A T 
1. C80516 40/F 5 3 
2. C80591 20/F 6 2 
3. C79343 21/F 7 4 
4. C80968 25/F 7 2 
5. C83148 29/F 5 2 
6. 4983 29/M 10 6 
7. C83357 29/F 5 2 
8. C83859 21/F 14 6 
9. C84354 23/F 4 2 
10. C84952 46/M 6 5 
11. C85576 34/F 10 4 
12. C85444 40/F 8 3 
13. C85401 28/F 4 3 
14. C86528 38/M 6 2 
15. C87290 42/F 5 1 
16. C87412 40/M 8 3 
17. C87563 52/F 4 1 
18. C89103 55/M 7 2 
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ESR RATE BEFORE AND AFTER TREATMENT 
19. C92628 32/M 9 4 
20. 4077 33/F 4 1 
21. C89542 42/F 5 2 
22. C90031 25/M 7 3 
23. C90298 30/M 6 3 
24. C93882 44/F 1 1 
25. C88940 33/F 3 1 
26. C92056 26/M 5 3 
27. C91895 18/F 7 5 
28. C91493 28/M 5 2 
29. 4043 35/F 3 1 
30. C94291 21/M 6 4 
31. C87827  32/F 4 2 
32. B73595 43/M 5 3 
33. 4254 47/F 4 2 
34. 4147 46/F 10 3 
35. 5120 54/M 6 1 
36. D001578 32/F 5 2 
37. 4206 55/F 7 3 
38. 4202 31/F 9 6 
39. 5184 37/M 3 1 
40. 4205 40/F 5 3 
S.No O.P/I.P No. Age/Sex ESR(mm/hr) BT ESR(mm/hr) AT 
½ hrs 1hrs ½ hrs 1 hrs 
1. C80516 40/F 2 8 2 4 
2. C80591 20/F 4 10 2 6 
3. C79343 21/F 4 12 4 8 
4. C80968 25/F 4 10 2 4 
5. C83148 29/F 6 16 4 12 
6. 4983 29/M 4 10 2 6 
7. C83357 29/F 10 24 6 14 
8. C83859 21/F 4 8 2 6 
9. C84354 23/F 8 6 4 2 
10. C84952 46/M 6 10 2 6 
11. C85576 34/F 8 18 2 8 
12. C85444 40/F 6 8 4 6 
13. C85401 28/F 4 12 2 8 
14. C86528 38/M 2 4 2 4 
15. C87290 42/F 2 6 2 4 
16. C87412 40/M 4 8 2 6 
17. C87563 52/F 8 26 6 18 
18. C89103 55/M 6 8 2 6 
19. C92628 32/M 4 8 2 4 
20. 4077 33/F 8 18 4 8 
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Grading of Asthma: 
21. C89542 42/F 6 14 4 6 
22. C90031 25/M 6 10 2 4 
23. C90298 30/M 2 6 2 4 
24. C93882 44/F 4 12 2 8 
25. C88940 33/F 4 10 2 4 
26. C92056 26/M 6 8 2 4 
27. C91895 18/F 4 8 2 4 
28. C91493 28/M 10 24 8 14 
29. 4043 35/F 8 10 4 6 
30. C94291 21/M 2 6 2 4 
31. C87827  32/F 4 12 2 8 
32. B73595 43/M 6 8 4 6 
33. 4254 47/F 4 10 2 4 
34. 4147 46/F 2 12 2 8 
35. 5120 54/M 8 30 4 24 
36. D001578 32/F 12 26 8 16 
37. 4206 55/F 8 12 4 6 
38. 4202 31/F 12 30 8 22 
39. 5184 37/M 2 8 2 6 
40. 4205 40/F 8 16 6 10 
S.No O.P/I.P No. Age/Sex Grading of asthma BT Grading of asthma AT 
1. C80516 40/F 2 0 
2. C80591 20/F 3 0 
3. C79343 21/F 2 2 
4. C80968 25/F 3 0 
5. C83148 29/F 1 0 
6. 4983 29/M 4 0 
7. C83357 29/F 3 1 
8. C83859 21/F 1 0 
9. C84354 23/F 2 0 
10. C84952 46/M 3 0 
11. C85576 34/F 2 0 
12. C85444 40/F 3 1 
13. C85401 28/F 2 0 
14. C86528 38/M 2 0 
15. C87290 42/F 3 0 
16. C87412 40/M 2 0 
17. C87563 52/F 2 0 
18. C89103 55/M 3 1 
19. C92628 32/M 3 1 
20. 4077 33/F 4 0 
21. C89542 42/F 3 1 
22. C90031 25/M 1 0 
23. C90298 30/M 2 0 
24. C93882 44/F 3 1 
25. C88940 33/F 2 0 
26. C92056 26/M 4 1 
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Grading of Asthma     : 0 - None; 1 - Intermittent, 2-Mild; 3 - Moderate; 4 - Severe                                                            
 None: No day and Night symptoms. 
 Intermittent :Daytime symptoms<once a week, Night symptoms-rare 
 Mild-Daytime symptoms>once a week, Night symptoms-occasional 
 Moderate- Daytime symptoms daily, Night symptoms-weekly 
 Severe –Daytime symptoms daily ,Night symptoms-frequent 
PEAK EXPIRATORY FLOW RATE IMPROVEMENT RATTINGS AFTER TREATMENT 100 and above 100 in 
(lit/min) 
 
S.No O.P/I.P No. Age/Sex PEFR(lit/min) B.Treatment PEFR(lit/min)A.Treatment Improvement(AT) 
1 C80591 20/F 120 250 130 
2 C80968 25/F 130 280 150 
3 C83148 29/F 100 260 160 
4 4983 29/M 180 360 180 
5 C83357 29/F 180 320 140 
6 C84354 23/F 160 280 120 
7 C84952 46/M 210 380 170 
8 C85576 34/F 170 280 110 
9 C85444 40/F 160 290 130 
10 C86528 38/M 230 410 180 
11 C87412 40/M 210 360 150 
12 C87563 52/F 140 270 130 
13 C92628 32/M 160 310 150 
14 4077 33/F 130 340 210 
15 C89542 42/F 180 290 110 
16 C90031 25/M 250 420 170 
17 C90298 30/M 210 370 160 
18 C93882 44/F 110 240 130 
19 C92056 26/M 190 350 160 
27. C91895 18/F 4 0 
28. C91493 28/M 3 1 
29. 4043 35/F 4 0 
30. C94291 21/M 3 1 
31. C87827  32/F 4 0 
32. B73595 43/M 2 1 
33. 4254 47/F 3 0 
34. 4147 46/F 3 0 
35. 5120 54/M 2 0 
36. D001578 32/F 3 0 
37. 4206 55/F 2 0 
38. 4202 31/F 2 0 
39. 5184 37/M 4 2 
40. 4205 40/F 2 0 
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20 C91895 18/F 180 290 110 
21 C91493 28/M 210 340 130 
22 4043 35/F 180 360 180 
23 C94291 21/M 170 340 170 
24 4254 47/F 160 310 150 
25 4147 46/F 190 360 170 
26 5120 54/M 230 430 200 
27 D001578 32/F 130 280 150 
28 4202 31/F 160 280 120 
29 4205 40/F 150 320 170 
 
PRIMARY OUT COME: 
CLINICAL OUT COME BY PEFR ( OBJECTIVE PARAMETERS ) 
S.No Result No. of cases Percentage 
(%) 
1 Good   29 72.5 
2 Moderate     9 22.5 
3 Mild  2 5 
4 Poor 0 0 
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Out of 40 cases as per PEFR ,29 cases ( 72.5%)  showed clinically 
good improvement,9 cases( 22.5% ) were moderately improved and    2 
cases( 5% ) 
were mildly improved. 
Good         – PEFR value increased 100 and above 100  
Moderate  – PEFR value increased 50 - below100. 
Mild          – PEFR value increased 10 – below 50. 
Poor          – No change in PEFR value.          
                      24.  SECONDARY OUT COME 
TABLE NO – 24 CLINICAL FEATURES (AT) 
 
S. No Clinical Features (AT) No of cases Percentage (%) 
1 Wheezing 100 100 
2 Dry or productive cough 30 75 
3 Breathlessness 100 100 
4 Tightness of chest 100 100 
5 Sneezing 34 85 
6 Hoarseness 100 100 
7 Sleep disturbance 38 95 
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        As per subjective parameters (Clinical symptoms) 
Among 40 cases, all 40 cases(100%) of were relieved from 
breathlessness, tightness of chest and hoarseness,34cases(85%) were relieved 
from sneezing,30 cases( 75% )were relieved from cough and38cases( 95%) 
were  relieved from Sleep disturbance. 
 
25. GRADATION OF RESULTS 
TABLE - 25 
S.No Result After treatment 
No Of Cases Percentage (%) 
1. Good  35 87.5 
2. Moderate 4 10 
3. Mild 1 2.5 
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Inference : 
Out of 40 cases, Good improvement were observed in 35(87.5%) of 
cases, Moderate improvement  were  observed  in 4 cases(10%) and  onlyone 
case had Mild improvement  1 cases(2.5%). 
 
STATISTICAL ANALYSIS 
Paired ‗t‘ test was used to test the significance of treatment using before and 
after treatment data on PEFR ,Clinical symptoms,  Eosinophil and ESR.,Grading of 
asthma. 
The level of significance probability 0.05 was used to test the treatment 
difference and the values are statistically significant. 
Paired „t‟ test for Peak Expiratory Flow Rate  
Group Mean Std t value  P Value 
Before 170.25 35.84 -16.30 
 
P<0.0001 
After 296.25 64.3 
PEFR before treatment is 170.25 and after treatment is 296.25 which is 
statistically significant (p<0.0001). 
87.5%
10% 2.5%
RESULT
Good
Moderate
Mild
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Paired „t‟ test for Esionophila  
Group Mean Std t value  P Value 
Before 6.00 2.428 12.262 
 
P<0.0001 
After 2.73 1.432 
 
Esionophila before treatment is 6.00 and after treatment is 2.73 which is 
statistically significant (p<0.0001). 
Paired „t‟ test for ESR ½ Hr  
Group Mean Std t value  P Value 
Before 5.42 2.747 -8.977 
 
P<0.0001 
After 3.16 1.838 
 
ESR 1/2 hrs before treatment is 5.42 and after treatment is 3.16 which is 
statistically significant (p<0.0001). 
 
Paired „t‟ test for ESR 1 Hr  
Group Mean Std t value  P Value 
Before 12.00 6.359 10.804 
 
P<0.0001 
After 7.21 4.351 
 
ESR 1 hrs before treatment is 12.00 and after treatment is 7.21 which is 
statistically significant (p<0.0001). 
Paired „t‟ test for Grading of Asthma 
Group Mean Std t value  P Value 
Before 2.65 0.864 15.959 
 
P<0.0001 
After 0.35 0.580 
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Grading of Asthma before treatment is 2.65 and after treatment is 0.35 which is 
statistically significant (p<0.0001). 
Paired „t‟ test clinical symptoms before and after treatment 
Variable Mean Std. dev t value p value 
Before 
After 
3.55 
0.55 
1.054 
0.959 
15.5 <0.0001 
 
Clinical symptoms before treatment is 3.55 and after treatment is 0.55 which is 
statistically significant (p<0.0001). 
 
 
 
DISCUSSION 
Swasa kasam is a disease  characterised as sever cough with or without 
expectoration, Expiration is like a hiss of a serpent, frequent hemming, sense of heat in 
both nostrils, Hoarseness of voice, indigestion, flatulencen be correlated with 
Bronchial asthma in Modern science. 
 The aim of the study is to the siddha to evaluate drug Thuthuvalayathy 
chooranam of the Siddha Herbo mineral formulation in the treatment of 
Swasakasam. The safety of the trial drug usage and standardization of 
the trial drug through biochemical analysis were also ensured during the 
study. 
 The drug was prepared in the Gunapadam lab of National Institute of 
Siddha after the authentication of the raw drugs by the concerned 
department. The trial drug was prepared by the standard operating 
procedure as mentioned in the protocol. 
 The preclinical toxicity studies (Acute and sub acute toxicity) for the 
above said trial drug was conducted at National Institute of Siddha after 
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getting the proper acceptance and permission from the Institutional 
Animal Ethical Committee (IAEC). The trial drug was proved to be safe 
for human beings from the observations made from the study. 
 The biochemical qualitative and quantitative analysis were done at the 
biochemistry lab of NIS and IIT Chennai respectively. It revealed the 
presence of effective minerals and the existence of the drug molecules 
at micro level. 
 The clinical study was conducted with a well defined protocol and a 
proper proforma after the approval of the Institutional Ethical 
Committee (IEC). After screening 60 cases reporting at the OPD of 
department of Maruthuvam, 40 cases were selected for induction to the 
trial. Before enrollment into the trial the informed consent was obtained 
from the patients. 
 The patients were treated for a period of 24 days with Thuthuvalayathy 
(Internal medicine) at the dose of 1.5gms, twice a day with the adjuvant 
of  honey.  
 Clinical assessment was done during each visit in OPD patients (7 days 
once) and daily for IPD patients and the data were noted in the 
prescribed proforma. 
 Laboratory investigations are done on the 0day, & 24th day of the trial 
for both OP & IP patients. For IP patients, who was not in a situation to 
stay in the hospital for a long time was advised to attend the OPD for 
the continuation of the treatment. All the patients were put under 
observation for 2 months follow up period without the trial drug 
treatment. 
 
The observations discussed below: 
 Sex Distribution 
Out of 40 patients, the incidence of Swasa kasam was found to be 
higher in Females (26 cases, 65%). 
 Age Distribution 
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A total of 40 patients of varying age group were included in this study, 
the maximum age distribution of Swasa kasam was in 31-40 age groups 
13cases(32.5%) due to  their life style. 
 Kaalam Distribution 
Out of 40 cases, 20 cases (50% ) were found to be affected in their 
Vatha kaalam (Between 1 - 33 years)  and 20 cases (50%) were found to be 
affected in their Pitha kaalam (Between 34 - 66 years). 
 Religion Distribution 
Among 40 cases, 37 cases (92.5%) were Hindu, 3 cases (7.5%) were 
Christians . 
 Thinai Distribution 
Among 40 cases, 14 cases (35%) belonged to the Kurinji (i.e Mountains 
and its surroundings) ,12 cases (30%) belonged to the neithal(i.e.sea & its 
surroundings),5 cases (12.5%) belonged to the Marutham (i.e. plain & its 
surroundings) and 9 cases (22.5%) belonged to the Mullai ( i.e. Forst and its 
surrounding) 
 Paruva Kaalam Distribution 
Among 40 cases, 25 cases (62.5%) were reported in Kaar kaalam i.e. 
Avani & Purattasi (August 15 – October 15 ), 2cases (5%) were admitted 
reported in kothir kaalami.e.iypasi&karthigai(October16 - December15)and the 
remaining 13 cases (32.5%) were reported  in Muthuvenil kaalam i.e. Aani & 
Aadi (June 16 & August 15). As per siddha literature Kaarkalam and 
Muthuvenil kaalam are the period of diseases. More over in Kaarkalam, Pitham 
is impaired and Kaba diseases occur due to contamination of water.  
 
 Occupational Distribution 
Most of the affected cases were housewives 14 cases, (35% ), Students  
4cases, (10%), Software Engineers5cases,(12.5%) , Mill workers,tailor,cook 
2cases(5%)andTextileworkers,Salesrepresentative,Poulteryworker,Divers,Mec
hanic,Missionary,Gardener,Farmer,Leather factory worker,Dhobi,housemaid 1 
cases,(2.5%)  are affected due to smoke and  dust exposure that will aggravates 
this disease .Moreover Sedentary life style adds more to this problem. 
 Distribution of  cases as per Socio-Economic status  
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Out of 40 cases the higher level of disease distribution was observed in 
middle socio economical groups  23 cases,(57.5 %) due to sedentary life style.  
 Distribution of cases as per Triggering factors : 
Among 40 cases, all the 40 cases were allergic to dust (100%), smoke 
exposure (100%),32 cases were allergic to cold exposure (80%) and food 
additive,occupation  history found in 15 cases(37.5%) and emotional condition 
is responsible for 17 cases(42.5). As per the literature Dusty, Smoke exposure, 
Cold exposure and Excessive food items,lifestyle  are considered to be  the 
main predisposing factor of  Swasa kasam. After treatment allergic to 
dust,cold,food are reduced   to 50% cases in all cases. 
 Distribution of cases as per Clinical Features 
Before treatment among 40 cases, all the 40 cases(100%) had wheezing, 
dry or production cough ,tightness of chest , 36 cases (90%) had dysponea , 38 
cases(95%) had Sleep disturbance, 32 cases(80%) had sneezing and 12cases 
(30%) had hoarseness of voice.After treatment all 40 cases (100%) were 
relieved from wheeze,tightness of chest,hoarseness of voice,breathlessness ,30 
cases(75%) were relieved from cough  , 38 cases(95%) were relieved from 
sleep  disturbance,  34 cases(85%) were relieved from sneezing .  
 Distribution of cases by Duration of illness 
Out of 40 cases, most of the cases13 (32.5%) were affected in the 
duration of 3-6 year, 8(20%) of the cases were affected by the illness from 
6month-1year,5(12.5%)cases were affected by the illness from3-6 month as 
well as 2-3year,6(15%) cases were affected by the illness from1-2 year.After 
treatment  good prognosis seen  in all cases. 
 
 Distribution of cases by Family History  
Among 40 cases 23 cases (57.5%) reported negative family history and 
17 cases (42.5%) reported positive family history of  Swasa kasam. It is 
showed that most of the patients had negative family history and positive 
family history is more seen in female 12(30%)case out of17 cases. 
 
 Distribution of cases by Diet 
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Among 40 cases, 32 cases (80%) were Non-Vegetarian; remaining   8 
cases (20%) were vegetarians. As per the literature, the dietary factors that 
cause the disease are taking non-vegetarian diet and taking improperly cooked 
food.   
 Distribution of cases by Habit 
Among 40 cases the prevalence of the disease is more among 
smokers6cases (15%).  
 Derangements noted In Imporigal  
Among 40 cases, Mookku was affected in 23 cases (57.5% ) due to 
running  nose and nasal block. Mei was affected in 8 cases (20%) due to pain in 
upper lower limbs and Kan was affected in 5 cases(12.5%) due to diminished 
vision. After treatment no nasal block and running nose  in all cases. 
 Derangements noted In Kanmendhiriyam 
Among 40 cases, Kai was affected in 4cases(10%) of the patients, Kaal 
was affected in6 cases( 15%) of the patients due to pain in upper and lower 
limbs. Eruvai was affected in 7.5% of the patients due to constipation. 
 
 
 
 
 Derangements noted In Kosam 
Out of 40 cases, Pranamaya kosam was affected in all the patients due 
to breathlessness, cough, wheeze and tightness of chest. Annamayakosam was 
affected in 16cases(40%) of the patients due to indigestion.After treatment 
pranamaya kosam and annamayakosam  were  normal in all cases. 
 
 Derangements noted In Vatham 
Out of 40 cases observed , Pranan  was affected in 40 cases(100%) due 
to breathlessness, cough, wheeze , Abanan was affected in 3 cases(7.5%) due to 
constipation, burning micturation, Udhanan was affected in 40 cases(100%) 
due to low pitched voice, Viyanan was affected in 10 patients (25%) due to 
pain in lower limbs, Koorman was affected in5 cases (12.5%) due to excessive   
lacrimation and diminished vision,  Kirukaran was affected in 40  cases due to 
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excessive cough reflex, excessive sneezing reflex and Dhevathathan was 
affected in 38 cases (95%) due to tiredness. 
 
 Derangements noted In Pitham  
Sadhaga pitham was affected in all 40 cases ( 100%), Anal pitham was 
affected in  16 cases ( 40%) due to indigestion ,poor appetite,  Prasagapitham 
was affected in 8 cases (20%) due to lesions in any part of the body and pallor, 
Aalosaga pitham was affected in 5 cases (12.5%) due to dimnished vision and 
Ranjakapitham was  affected  in 8cases (20%) due to pallor .  
 Derangements noted In Kabam 
Avalambagam was affected in all the 40 cases(100%) due  to  the  
presence  of  tightness  of  chest,  cough, wheezing and breathlessness. 
Sandhigam was affected in 10 cases( 25%) due to joints pain and  Kilethagam 
was affected in 16 cases (40%) due to loss of appetite and Tharpagam was 
affected in 3 cases (7.5%) due to burning sensation of eyes.After treatment 
Avalambagam ,kiletham were  normal in all cases. 
 
 
 
 Derangements  Noted In Ezhu udal kattugal 
Saram was affected in all cases (100%), Senneer was affected in 12 
cases ( 30%) due to pallor  ,Oon was affected in 8 cases (20% ) due to joints 
pain,Kozhuppu was affected in 38cases(95%)due to body pain,Ennbu was 
affected in10 cases(25%)due to joint pain. 
 
 Derangements noted  In Ennvagai thervugal 
Mozhi was affected in all 40 cases (100%)  due to low pitched voice and 
difficulty in speech, Naa was affected in 23cases (57.5%) due to coated tongue, 
pallor tongue, tongue ulcer,  Vizhi was affected in 12 cases  (30%) due to 
diminished vision, pallor, itching,  Niram was affected in 8 cases ( 20%) due to 
skin lesions, Malam was affected in 3 cases (7.5%)  due to constipation,  
Sparisam was affected in  4 cases      ( 10%) of the patients due to sweating and 
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Moothiram was affected in 2 cases (5%) due to burning micturition. After 
treatment  mozhi was normal in all cases,vizhi was normal in 4 cases. 
 Distribution of cases by Naadi 
In Naadi, vadha pitha naadi was observed in 24 cases (30%) ,pitha 
vatha naadi was observed in 12cases(30%)and  kaba pitha naadi was observed 
in 4 cases(10%). 
 Distribution of cases by Neikuri 
Among 40 patients, Vadha neer was observed in 25 cases(62.5%), 
17.5% of the Pitha neer was observed  in 7 cases(17.5%) and kapha neer was 
observed in8 cases(20%).   
 
Laboratory Investigations : 
Routine investigations of blood and urine were done before and after 
treatment in every case.  
Blood investigations of patients showed Eosinophils count was 
increased, its ranged from 5- 10% cells before treatment and after treatment its 
ranged from 3 – 6 %.  ESR (Erythrocyte Sedimentation Rate) was raised in 
before treatment and the after treatment was moderately reduced.   
Blood Urea, Creatinine, SGOT, SGPT and serum Alkaline Phosphatase 
were found to be in normal range before and after treatment.  
Motion test (Ova, Cyst) revealed that 100% of the patients had nil 
results before treatment as well as after treatment.  
Sputum examination (AFB) was found to be negative for all the 100% 
of both the patients. 
 
 Radiological Examination: 
Before treatment, chest X-ray PA view showed no abnormal findings 
observed in 100% of the 40 cases. 
 Special Investigation: 
Among the 26 Female (65%) patients the peak flow meter reading 
ranged from 100 lit/min to 180 lit/min before treatment and after treatment it 
ranged from 190lit/min to 360 lit/min. 
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Among the 14 Male (35%) patients the peak flow meter reading ranged 
from 160 lit/min to 250 lit/min before treatment and after treatment it ranged 
from 250lit/min to 430 lit/min. 
 Primary Outcome 
As per objective parameters ( PEFR ) 
 Out of 40 cases, 29 (72.5% )  cases has clinically good improvement, 9 (22.5%)  
cases has clinically moderate improvement and only  one  1(5%)  case has 
clinically mild improvement. 
 
 Secondary Outcome  
 
As per subjective parameters (Clinical symptoms) 
Among 40 cases,all 40 cases(100%) of were relieved from 
breathlessness, tightness of chest and hoarseness,34cases(85%) were relieved 
from sneezing,30 cases( 75% )were relieved from cough and38cases( 95%) 
were  relieved from Sleep disturbance. 
 
 
 
 
 Gradation Of Results 
 Out of 40 cases, Clinical results were found to be Good in35( 87.5%) of 
cases, moderate results were found in 4(10% )of cases and mild results were 
found in 1(2.5%) of cases. 
  Biochemical study: 
 Qualitative analysis of  Thuthuvalayathy chooranam reveals that the trial 
medicine contains Sulphate, Phosphate, Magnesium, Alkaloid, Iron, Calcium, 
Ammonium, Silicate, Carbonate, Sodium, Chloride, Tannic acid, Reducing 
sugar, Copper, Lead   and floride. 
 Acute oral toxicity study 
Thuthuvalayathi chooranam at the dose of 0.027gm/animal did not exhibit any 
mortality in mice. In Necropsy, the organs of the animal such as Liver, Heart, 
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Lungs, Pancreas, Spleen, Stomach, Intestine, Kidney, Urinary bladder, Uterus 
were appeared normal. 
 Sub acute toxicity study 
Thuthuvalayathi chooranam at the dose of 0.27gm/animal(10x)  did not 
exhibit any mortality in mice. Biochemical parameters and 
histopathology report were also normal. There were no signs of toxicity. 
 PEFR, Esinophil,ESR for ½ hr and 1 hrs before treatment and after treatment is 
statistically significant (p<0.0001). 
 
 
 
 
 
 
 
 
                                      SUMMARY 
 The aim of the study was to evaluate the therapeutic efficacy of the drug 
Thuthuvalayathy  chooranam(internal medicine) in Swasa kasam. 
 Before initiating the clinical trial, approval was got from the Institutional 
Animal Ethical Committee (1248/ac/09/CPCSEA/4/04/2011 – 20/12/2011) and 
Institutional Ethical Committee (NIS/IEC/2011/3/04 – 24/12/2011) for 
conducting the pre clinical studies and clinical studies respectively by 
submitting the well defined protocol and proforma. 
 The raw drugs were authenticated by the concerned department and the trial 
drug was prepared by the investigator in the Gunapadam lab of National 
Institute of Siddha as per the Standard Operating Procedure mentioned in the 
protocol. 
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 The medicine was then subjected to pre clinical toxicity studies (Acute and sub 
acute toxicity studies) as per the protocol and the safety of the drug was 
ensured. 
 From the Acute oral toxicity study, the trial drug was found to be safe even at 
higher dose level of 0.027gm/kg/bw.  
 From the sub acute toxicity study the trial drug at the dose of 0.27gm/kg/bw 
(10X) did not exhibit any mortality in rats. 
 The qualitative and quantitative bio chemical studies were done at the bio 
chemistry lab of National Institute of Siddha and IIT Chennai respectively. 
 For the clinical study, 40 cases were selected based on the inclusion and 
exclusion criteria. Out of this, 30 cases were treated in OPD and 10 cases were 
treated in IPD of Ayothidoss pandithar hospital of NIS, Chennai. 
 A day before starting the trial drug treatment, purgation was given to correct 
the elevated mukkutram. 
 The clinical trial was conducted in 40 patients of  Swasa kasam  with the trial 
drug thuthuvalayathy  chooranam(internal medicine) at the dose of 1.5gm twice 
a day with  adjuvant of  honey .During the study period, there were no adverse 
reactions. 
 The trial drugs were found to play the major role to correct the deranged three 
humours, thereby correcting Pranan, Abanan, Udhanan, Kirugaran, 
Devathathan Vayus, Pitham such as Anal Pitham and the vitiated kabam is 
restored to the normal. 
 Blood and urine Investigations were carried out before and after treatment and 
data were recorded in the proforma. 
 Radiological investigations (Chest X-ray PA view) and ECG were also done 
before treatment. 
 Clinical assessments Progress were done once in 7 days for OPD patients and 
daily for IPD patients. 
 
 As per objective parameters (PEFR) Out of 40 cases, 72.5% of cases had 
clinically good improvement, 22.5% of cases had clinically moderate 
improvement and 5% of cases had clinically mild improvement. 
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 Out of 40 cases, Clinical results were found to be Good in 87.5% of cases, 
Moderate results were found in 10% of cases and Mild results were found in 
2.5% of cases 
 
 Statistical analysis : 
 PEFR , Esinophil,ESR for ½ hr and 1 hrs before treatment and after 
treatment is statistically significant (p<0.0001). 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
 Toxicity study reveals that the trial drugs is safe even in higher dosage of 
thuthuvalathy chooranam – 0.27 gm/animal in albino rats as per WHO guideline 
1993.  
 The results of the clinical trial indicate that the trial drugs are clinically effective. 
No adverse effects were reported during the course of treatment.  
 The method of preparation is easy and the cost is comparatively economical. 
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 Clinical results were found to be Good in 87.5% of cases, moderate results were 
found in 10% of cases and mild results were found in 2.5% of cases. 
Because of the encouraging results clinically, the study may be undertaken with same 
medicine in a large number of cases and it may throw new lights for the treatment of 
Swasa kasam. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TOXICOLOGICAL EVALUVATION OF THUTHUVALAYATHY 
CHOORANAM  
ACUTE TOXICITY STUDY OF THUTHUVALAYATHY 
CHOORANAM  
                                                     [WHO guidelines,1993] 
Principle:  
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Acute toxicity was carried out in Swiss albino mice with a single exposure of 
10 times of the recommended therapeutic dose of test compound the study duration 
will be 14 days. 
Animal species  :   Swiss albino mice 
Age / Weight / Size  :   6 weeks.  Mice-20-25 gms. 
Gender   :   Both male and female 
Number of Animals   :   Mice: 16 
Acclimatization Period :   7 Days 
Clinical dose   :   Thuthuvalayathy chooranam – 1.5mg/day 
                                       
S.No Group No of mice 
1 Vehicle control  6  (3 male, 3 female) 
2 10XTherapeutic dose 
(0.027gm) 
 
10  (5 male, 5 female) 
 
 
 
 
Test Animals  
Test animal laboratory of the King institute, Chennai and stocked at National 
institute of siddha, Chennai. All the animals were kept under standard environmental 
condition (27+ or – 2 degree c).The animals had free access to water and standard 
pellet diet(Sai meera foods pvt.ltd, Bangalore).The principles of laboratory animal care 
were followed and the  Institutional ethical committee approved the use of animals and 
the study design. (1248/ac/09/CPCSEA/december/2011) 
Route of administration:  
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Oral route was selected, because it is the normal route of clinical administration. 
Test substance and vehicle 
The Thuthuvalayathychooranam is light green  in colour. The test substances 
are insoluble in water, in order to obtain and ensure the uniformity in drugs 
distribution, the drugs is dissolved by aqueous Tween 80 solution (10%).  
Administration of doses 
Thuthuvalayathychooranam was suspended in aqueous Tween 80 solution 
(10%), with uniform mixing and it was administered to the group‘s in a single oral 
dose. The control groups were received equal volume of the vehicle. The animals were 
weighed before giving the drug. The dose level was calculated according to body 
weight, and surface area. Since the clinical dose for Thuthuvalayathy chooranam  
was1.5gm/kg(0.27gm) They were converted to animal dose  and then administered. 
The principle of laboratory animal care was followed. 
Observations 
Observations were made and recorded systematically and continuously 
observed as per the guideline after substance administration. Animals were observed 
individually (visual observations included skin changes, alertness, grooming, 
aggressiveness, sensitivity to sound, touch and pain, restlessness, tremors, convulsion, 
righting reflex, gripping reflex, pinna reflex, corneal reflex, writhing reflex, papillary 
reflex, urination, salivation, lacrimation for first 4 hrs, then periodically during the first 
24 hrs. Animals were observed for body weight and mortality for 14 days. If animals 
dying during the period of study, the animals were sacrificed. At the end of the 14
th
 
day all animals were sacrificed and necroscopy was done. 
Body Weight 
Individual weight of animals were determined before the test substance was 
administered and daily for 14 days. Weight changes were calculated and recorded. At 
the end of the test surving animals were weighed and sacrificed. 
Results: 
Thuthuvalayathychooranam at the dose 0.27gm/k animal .No behavior changes 
were noted for the first 4 hours and for the next 24 hours and throughout the study 
period of 14 days. No weight reduction was noted before and after the acute study 
duration. Reflexes were found to be normal before and after the study. All other 
observations were found to be normal before and after the study. In Necropsy, the 
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organs of the animal such as, Liver, Heart, Lungs, Pancreas, Spleen, Stomach, 
Intestine, Kidney, Urinary bladder, Uterus all appeared normal. 
 SUB ACUTE TOXICITY STUDY OF THUTHUVALAYATHY CHOORANAM 
Animals             : Male and Female Wister albino rats 
Age                    : 6-8 weeks 
Weight   : 150-200 gms 
Gender   :  Both male and female 
Number of animals   : Rat: 40 
Acclimatization period : 7 Days 
Clinical dose   : 1.5gms\day 
Clinical duration  : 28 days 
Animal source:      
 Test animals were obtained from the animal laboratory of the King institute, 
Chennai, and stocked at national institute of siddha, chennai. All the animals were kept 
under standard environmental condition (27+ or – 2 degree c) .The animals had free 
access to water and standard pellet diet (Sai durga foods pvt.ltd, Bangalore). The 
principles of laboratory animal care were followed and the Institutional ethical 
committee approved the use of animals and the study design. 
(1248/ac/09/CPCSEA/December/2011) 
 
    S.No 
                 
             Group 
      
     No of Rats 
       1 Vehicle control (  honey ) 10 (5male,5 female) 
       2 1XTherapeutic dose (0.027gm) 10 (5male,5 female) 
       3 5XTherapeutic dose (0.135gm) 10 (5male,5 female) 
       4 10XTherapeutic dose(0.27gm) 10(5male, 5 female) 
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Identification of animal:  
 By cage number, animal number and individual marking on fur. 
Housing and Environment: 
 The animals were housed in polypropylene cages provided with bedding of 
husk. Dark and light cycle each of 12 hours. 
Administration period: 
 The period of administration of the test substance to animals are depending on 
the expected period of clinical use. Since the clinical duration of the test drug is 28 
days and as per WHO guidelines the administration period is reported to be 1 month. 
 Dose selection: 
 The results of acute toxicity studies in Swiss albino mice indicated that 
thuthuvalayathy chooranam was non toxic and no behavioral changes, mortality was 
observed. On the basis of these results, the doses were selected for the study as per 
WHO guidelines.  
Preparation and administration of dose:        
 Thuthuvalayathy chooranam was suspended in aqueous twin 80 solution 
(10%). It was administered to animals at dose levels of 1X therapeutic dose (0.027gm 
/animal), 5X Therapeutic dose (0.135gm/animal) and 10X Therapeutic dose 
(0.27gm/animal).The control animals were administered vehicle only. Administration 
was by oral (gavage) once a day for 30 days. 
METHODOLODY: 
Randomization, numbering and grouping of animal: 
 The animals were randomly divided into three groups for dosing up to 30 days. 
Each group consist of 10 animals (5 per sex in each group) were allowed 
acclimatization period of 7 days to laboratory conditions prior to the initiation of 
treatment. Each animal fur was marked with picric acid. The females were nulliparous 
and non pregnant. 
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OBSERVATION: 
 Experimental animals were kept under observation throughout the course of 
study for the following 
Body weight:  
 Weight of each rat was recorded on day 1 and at weekly intervals throughout 
the course of study and at termination to calculate relative organ weights. From the 
data mean body weights and percent body gain were calculated. 
Food and water consumption: 
 The quantity of food consumed by groups consisting of an animal for different 
doses was recorded at weekly intervals. Food consumed per animal was calculated for 
control and the treated dose groups 
Clinical sings 
 All animals were observed daily for clinical sings. The time of onset intensity 
and duration of this symptom if any were recorded. 
Mortality: 
 All animals were observed twice daily for mortality during entire course of 
study. 
 
 
TERMINAL STUDIES: 
 LABORATORY INVESTIGATIONS: 
  Following laboratory investigations were carried out. On day 31 
animals fasted overnight. Blood samples were collected by cardiac puncture using 
sodium heparin (200IU\ml) for blood chemistry and potassium EDTA (1.5 mg/ml) for 
hematology anticoagulant. Blood sample were centrifuged at 3000 r. p .m for 10 
minutes. 
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 BIOCHEMICAL INVESTIGATIONS: 
         The effect of Thuthuvalayathy chooranam on certain biochemical parameters 
were examined and compared with those of the control group. The blood samples 
collected with heparinized bottles were centrifuged at 5000 rpm for 10 minutes to 
obtain clear serum for the following investigation. Glucose was estimated using 
commercial Glucose estimation kit (Span Diagnostics) by the method of Barham et al., 
(1972) and Tenscher. et al., (1971),Haemoglobin PCV, RBC, Erythrocyte  count was 
estimated by Hemocytometer method of Ghai (1995). Total Leukocyte Count was 
estimated by Hemocytometer method of John (1972).Total, (Bilirubin test kid-malloy 
and evelyn 1937) direct and indirect bilirubins were determined. Alkaline phosphatase, 
Alanine amino tranferase (ALT) and Aspartate amino transferase (AST) were 
measured by using ALT and AST test kit (kind & king) .Total protein TP 
concentration was determined. Albumin was determined based on its reaction with 
bromocresol green (binding method). Urea was determined according to urease – 
berthelot method and plasma creatinine was estimated using jaffe reaction. Results of 
biochemical investigations conducted on day 31 revealed significant changes in the 
values of different parameters studied when compared with those of respective 
controls. 
Statistical analysis done for the above said biochemical investigations did not 
reveal any significant difference in values between the control groups and test groups 
stating that the provided test drug is non toxic. 
 
 
NECROPSY:  
          All the animals were sacrificed on day 31 under ether anesthesia. Necropsy of 
all animals was carried out and the weights of the organs including liver, kidneys, 
brain, heart, lungs and sex organs were recorded. 
HISTOPATHOLOGY: 
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 Tissue samples of organs from control and treated animals were preserved in 
10% formalin for preparation of sections using microtome. The organs included brain, 
heart, lungs, stomach, liver, kidneys, spleen, intestine, pancreas and sex organs of the 
animals were preserved and they were subjected to histopathological examination. 
  The organ pieces (3-5 micron) were fixed in 10% formalin for 24 hours 
and washed in running water for 24 hours .Samples were dehydrated in tissue 
processor and then cleaned in benzene to remove absolute alcohol. Embedding was 
done by passing the cleared sample through three cups containing molten paraffin at 50 
degree c and then a cubical block of paraffin made by the L moulds it was followed by 
microtome and the slides were stained with haematoxylin–eosin stain. Stained sections 
of each organ were examined under light microscope at high (40X) power 
magnification. All the histo pathological slides were prepared at Vels University, 
pallavaram, Chennai. 
Results:   
Control animals 
Liver:  Shows central veins with rows of radiating heapatocytes, Portal triads and cells appear 
normal. 
Kidney : Shows glomeruli tubules, interstitial cells of normal histology 
Heart: Shows normal appearing myocardial fibres with patent coronaries. 
Lung : Shows bronchioles, alveoli normal in appearance. 
Stomach : Shows gastric mucosal glands  lined by columnar cells. 
Impression : Normal study 
Test group animals 
Liver : shows central veins with radiating cords of hepatocytes, portal trials and kupfer 
cells appear normal. 
Kidney : shows normal appearing tubules and glomeruli. 
Heart : shows normal appearing myocardial fibres wit patent coronaries. 
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Lungs: Shows bronchioles, alveoli normal in appearance. 
Stomach : Shows gastric mucosa with glands lined by tall columnar cells and the 
muscular layer appear normal.  
Impression : Normal study 
Results:    
 No weight loss, abnormal animal behaviours, metabolic functions [urination, 
lacrymation, defaecation etc.,] and mortality were noted. 
 In necropsy of the animal organs showed normal appearance and weight. 
 All Haematological and biochemical parameters were within normal limits. 
 The stastical report of the Haematological and Biochemical datas didnot show any 
significant difference, between the control and test groups.  
 In Histopathological studies, No abnormal findings were observed in the organs 
such as Heart, Liver, Lungs, Kidney and Stomach in X, 5X and 10X compared 
with control group. 
                                      
 
 
 
 
BIO -CHEMICAL ANALYSIS
 
OF THUTHUVALAYATHY CHOORANAM –  
ANALYSED AT NATIONAL INSTITUTE OF SIDDHA 
Preparation of Extract: 
5gm Of Thuthuvalayathy Chooranam is weighed accurately and placed in a 250ml 
clean beaker and added with 50ml of distilled water. Then it is boiled well for about 10 
minutes. Then it is cooled and filtered in a 100ml volumetric flask and made up to 100ml with 
distilled water. 
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S.No EXPERIMENT OBSERVATION INFERENCE 
1.         Appearance of sample Brown in colour  
2. Solubility: 
a. A little(500mg) of the sample is 
shaken well with distilled water. 
b. A little(500mg) of the sample is 
shaken well with con. HCl/Con. H2So4 
 
Sparingly soluble 
 
 
Presence of Silicate 
3. Action of Heat: 
   A small amount(500mg) of the sample 
is taken in a dry test tube and heated 
gently at first and then strong. 
 
No Yellow  fumes   
developed. 
 
Absence of Carbonate 
 
4. Flame Test: 
  A small amount(500mg) of the sample is 
made into a paste with con. HCl in a 
watch glass and introduced into non-
luminous part of the Bunsen flame. 
  Bluish green flame 
appeared. 
presence of Copper 
5. Ash Test:s A filter paper is soaked into a 
mixture of sample and dil. cobalt nitrate 
solution and introduced into the Bunsen 
flame and ignited 
 Yellow colour flame Presence of sodium 
 
S.No EXPERIMENT OBSERVATION INFERENCE 
 I.Test For Acid Radicals   
1. Test For Sulphate :  
2ml of the above prepared extract is 
taken in a test tube to this added 2ml of 
4% dil ammonium oxalate solution. 
 
Cloudy     appearance 
present 
 
Presence of Sulphate 
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2. Test For Chloride: 
2ml of the above prepared extracts is 
added with 2ml of dil-HCl is added until 
the effervescence ceases off. 
 
 Cloudy appearance 
present 
 
presence of Chloride 
3. Test For Phosphate: 
2ml of the extract is treated with 2ml of 
ammonium molybdate solution and 2ml 
of con.HNO3 
 
yellow colour 
appearance 
 
Phosphate    present 
4. Test For Carbonate:  
2ml of the extract is treated with 2mldil. 
magnesium sulphate solution 
 
No cloudy appearance 
 
Absence of  Carbonate 
5. Test For Fluoride & Oxalate: 
2ml of extract is added with 2ml of dil. Acetic acid 
and 2ml dil.calcium chloride solution 
and heated. 
Cloudy appearance 
present. 
      
 Presence   of     fluoride 
and   oxalate 
6. Test For Nitrate: 
1gm of the substance is heated with 
copper turning and concentrated H2So4 
and viewed the test tube vertically down 
 
No  Brown   gas   is 
evolved 
    
Absence   of   Nitrate 
7. Test For Sulphide:  
1gm of the substance is treated with 2ml 
of con. HCL 
No Rotten Egg 
Smellinggas  evolved 
Absence of   Sulphide 
8. Test For Nitrite: 
  3drops of the extract is placed on a filter 
paper, on that-2 drops of dil.acetic acid 
and 2 drops of dil. Benzidine solution is 
placed. 
No   Characteristic    
changes 
Absence  of  Nitrite 
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5. Test For Zinc:  
      To 2ml of the extract dil.sodium 
hydroxide solution is added in 5 drops to 
excess and dil.ammonium chloride is 
added.  
 
White  precipitate   is   not 
formed 
  presence of  Zinc 
6. Test For Calcium:  
      2ml of the extract is added with 2ml 
 Cloudy appearance and 
white precipitate is 
obtained 
 
  Presence of  Calcium 
9. Test For Borate: 
  2 Pinches(50mg) of the substance is 
made into paste by using dil.sulphuric 
acid and alcohol (95%) and introduced 
into the blue flame. 
Bluish  green  colour  
flame  not  appeared 
Absence   of   Borate 
 II. Test For Basic Radicals   
1. Test For Lead: 
        2ml of the extract is added with 2ml 
of dil.potassium iodine solution. 
 Yellow  Precipitate  is 
obtained. 
presence  of   Lead 
2. Test For Copper: 
 One pinch(50mg) of substance is 
made into paste with con. HClin a watch 
glass and introduced into the non-
luminuous part of the flame. 
No   colour    precipitate 
formed. 
 
Presence    of   Copper 
 
3. Test For Aluminium: 
  To the 2ml of extract dil.sodium 
hydroxide is added in 5 drops to excess. 
No Yellow  colour  
appeared 
  Absence   of Aluminium 
4. Test For Iron: 
a. To the 2ml of extract add 2ml of 
thiocyanate ammonium solution 
b. To the 2ml of extract 2ml  
thiocyanate ammonium solution and 2ml  
of con HNO3 is added 
 
Mild red colour appear 
 
 
 
Presence of Iron 
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of 4% dil.ammonium oxalate solution  
7. Test For Magnesium:  
To 2ml of extract dil.sodium hydroxide 
solution is added in drops to excess. 
White precipitate is  
obtained 
Presence    of Magnesium 
8. Test For Ammonium:  To 2ml of extract 
1 ml of Nessler's reagent and excess of 
dil.sodium hydroxide solution are added. 
 
 Brown colour appeared 
 
Presence     of Ammonium 
9. Test For Potassium:  
   A pinch(25mg) of substance is treated 
of with 2ml of dil.sodium nitrite solution 
and then treated with 2ml of dil.cobalt 
nitrate in 30% dil.glacial acetic acid. 
 
No Yellowish precipitate is 
obtained. 
 
Presence of  Potassium 
10. Test For Sodium: 
    2pinches(50mg) of the substance is 
made into paste by using HCl and 
introduced into the blue flame of Bunsen 
burner. 
  
Yellow   colour    flame 
appeared 
   
Presence  of   Sodium 
11. Test For Mercury: 2ml of the extract is 
treated with 2ml of dil.sodium hydroxide 
solution.  
 
No yellow precipitate is 
obtained 
    
Absence of  Mercury 
12. Test For Arsenic: 2ml of the extract is 
treated with 2ml of dil.sodium hydroxide 
solution. 
 
No brownish red 
precipitate is obtained 
 
absence  of   Arsenic 
 III. Miscellaneous   
1.  Test For Starch:  
  2ml of extract is treated with weak 
dil.iodine solution  
 
 No blue   colour 
developed 
 
 Absence of   Starch 
2.  Test For Reducing Sugar:  
    5ml of Benedict's qualitative solution is 
 
Brick   red  colour 
 
 Presence of  Reducing sugar 
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taken in a test tube and allowed to boil for 
2 minutes and added 8 to 10 drops of the 
extract and again boil it for 2 minutes. 
The colour changes are noted. 
developed 
3.  Test For The Alkaloids: 
a) 2ml of the extract is treated with  2ml 
of dil.potassium lodide solution. 
b)  2ml of the extract is treated with  2ml 
of dil.picric acid. 
c)  2ml of the extract is treated with 2ml 
of dil.phosphotungstic acid. 
 
 
  
Yellow   colour developed 
 
 
 
  Presence of   Alkaloid 
4.  Test For Tannic Acid:  
  2ml of extract is treated with 2ml of 
dil.ferric chloride solution  
 
Block precipitate   is 
obtained 
 
 Presence of  Tannic acid 
5.  Test For Unsaturated Compound:  To 
the 2ml of extract 2ml of dil.Potassium 
permanganate solution is added.  
 
Potassium permanganate is  
decolourised 
 
Presence   of     unsaturated 
compound  
6.  Test For Amino Acid: 
    2 drops of the extract is placed on a 
filter paper and dried well. 20ml of  
Biurette reagent is added. 
 
Violet   colour developed 
 
Absence  of  Amino acids 
7. Test For Type Of Compound: 
    2ml of the extract is treated with 2 ml 
of dil.ferric chloride solution.  
 No Brown    colour 
developed 
Absence of  Oay  quinole, 
Pinephrine  and  Pyro catechol 
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Preliminary Qualitative phyto chemical tests procedure and interpretation of 
results for Thuthuvalayathychooranam 
 
 
 
 
 
 
 
 
S.NO PROCEDURE INFERENCE 
1. Sulphate Presence of Sulphate 
2. Calcium Presence of Calcium 
3. Chloride Presence of Chloride 
4. Carbonate Absence of Carbonate 
5. Starch Absence of Starch 
6. Iron  Presence of Iron  
7. Phosphate Presence of Phosphate 
8. Tannic acid Presence of Tannic acid 
9. Aluminium Absence of Aluminium 
10. Magnesium Presence of Magnesium 
11. Ammonium Presence of Ammonium 
12. Mercury Absence of  Mercury 
13. Alkaloids Presence of Alkaloids 
14. Reducing Sugar Presence of reducing sugar 
15. Silicate Presence of Silicate 
16. Copper presence of Copper 
17. Sodium Presence of Sodium 
18. Lead Presence of Lead 
19. Fluoride And Oxalate Presence of Fluoride and 
Oxalate 
     20. Oay quinole, pinephrine and 
pyrocatechol 
Absence of Oay quinole, 
pinephrine and pyrocatechol 
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QUANTITATIVE ANALYSIS 
Thuthuvalayathy Chooranam  ------------------------------------------------------------------------------------------- 
                                                                               Ca 317.93                   362.142 mg/L 
 
                                                                    Al 308                         BDL  
 
 
 B 249.773 475.236 mg/L   
 
  
                                                                           As193.696    BDL  
 
 
 
 Cd 226.502  BDL 
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 Cu 324.754   11.846  mg/L 
 
 
 Fe 238.204 21.428 mg/L 
 
 
  Hg253.652  BDL 
 
 
 K 766.491 239.177 mg/L 
 
 
  Mg 257.610 5.645 mg/L 
 
 
 Na 588.995 487.327 mg/L 
 
 
  P 214.914  55.442 mg/L 
 
 
  Pb 230.204 BDL 
 
 
  S 181.975  74.951 mg/L 
 
 
 Si 251.611 6.170 mg/L 
 
 
 
 
                                     
PHYSICOCHEMICAL PROPERTIES 
 
Table-1. 
Colour  characters of Thuthuvalayathy Chooranam. 
 
S No 
 
Solvent used 
 
Under ordinary light 
 
Under ultra violet light 
 
1 PPM Light Green Light Green 
PPM-Powdered plant material 
Table-2. 
Physicochemical properties of Thuthuvalayathy Chooranam.. 
  Values 
obtained 
Heavy/ toxic metals 
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S No. Parameters  (%w/w) 
1 Total ash value  7.42 Lead BDL 
2 Acid insoluble ash  0.66 Cadmium BDL 
3 Water soluble ash  7.95 Mercury BDL 
4 Moisture content  10.43 Arsenic BDL 
5 Foreign organic matter  8.2   
6 Crude fibre content  26   
7 Alcohol soluble extractive  7.12   
8 Water soluble extractive  10.53   
 
 
 
 
 
Table-3. 
Colour, nature and percent yields of extracts of Thuthuvalayathy Chooranam. 
 
S.no. 
 
Extract 
Solvents 
 
Colour 
 
TLC/GC 
(PEAKS)  
 
Nature 
 
 
% Yield(w/w) 
 
SEM-Micro graph 
partical size range in 
micron 
 
pH 
1 Water Light 
Green 
7 Solid       48 1 - 10 micron 7.4 – 7.6 
 
Table-4. 
Preliminary phytochemical analysis of different extracts of Thuthuvalayathy 
Chooranam. 
 
S.no 
 
Phytoconstituents 
 
Aqueous 
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1 Alkaloids + 
2 Flavonoids + 
3 Saponins + 
4 Glycosides + 
5 Carbohydrates + 
6 Amino acids   + 
7 Triterpenoids + 
 
 + = Present, − = Absent 
 
 
 
 
 
HR SEM-METHODOLOGY: 
An SEM is essentially a high magnification microscope, which uses a focussed 
scanned electron beam to produce images of the sample, both top-down and, with the 
necessary sample preparation, cross-sections. The primary electron beam interacts with 
the sample in a number of key ways:- 
 Primary electrons generate low energy secondary electrons, which tend to 
emphasize the topographic nature of the specimen.  
 Primary electrons can be backscattered which produces images with a high 
degree of atomic number (Z) contrast.  
 Ionized atoms can relax by electron shell-to-shell transitions, which lead to 
either X-ray emission or Auger electron ejection. The X-rays emitted are 
characteristic of the elements in the top few μm of the sample.  
SAMPLE PREPARATION: 
Sample preparation can be minimal or elaborate for SEM analysis, depending 
on the nature of the samples and the data required. Minimal preparation includes 
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acquisition of a sample that will fit into the SEM chamber and some accommodation to 
prevent charge build-up on electrically insulating samples. Most electrically insulating 
samples are coated with a thin layer of conducting material, commonly carbon, gold, 
or some other metal or alloy. The choice of material for conductive coatings depends 
on the data to be acquired: carbon is most desirable if elemental analysis is a priority, 
while metal coatings are most effective for high resolution electron imaging 
applications. Alternatively, an electrically insulating sample can be examined without 
a conductive coating in an instrument capable of "low vacuum" operation.  
 The SEM is carried out by using FEI-Quanta FEG 200-High Resolution 
Instrument. 
 
Resolution : 1.2 nm gold particle separation on a carbon substrate 
Magnification: From a min of 12x to greater than 1, 00,000 X 
Application : To evaluate grain size, particle size distributions, material 
homogeneity  and  inter metallic distributions 
   . 
Experimental Procedure: Done at SAIF, IIT Madras, Chennai-36 
SEM – Micro graph partical size 
THURHUVALAYATHY CHOORANAM 
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NATIONL INSTITUTE OF SIDDHA, 
AYOTHIDASS PANDITHAR HOSPITAL, 
 CHENNAI-47 
  FORM I- SCREENING PROFORMA 
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  PRECLINICAL AND CLINICAL  STUDY ON   SWASA KASAM      ( BRONCHIAL 
ASTHMA ) AND DRUG OF CHOICE IS “THUTHUVALAYATHY CHOORANAM ” ( 
INTERNAL ) . 
REG  NO: 32101201   / 2012-13 
 
1. O.P No ----------------       2.  S. No----- 
3 .Name ---------------------- 4. Age ---------      5 . Gender : Female / Male 
6 .Occupation ----------------------      
7 .Address  --------------------------- 
                   ---------------------------  
                   ---------------------------  
 8.INCLUSION CRITERIA                                                                Yes     No           
 Age : 18- 60 Yrs 
 Sex – Both Male and Female 
 
 The symptoms of, cough, wheezing, Difficulty in breathing etc 
 PEFR below normal range (from 150 L/min to 250 L/min for  
men; from 100 L/min to 200 L/min for women).                     
 H/O allergy  
 Patient willing to sign the informed consent stating that   he/she will  
conscientiously stick to the treatment during 24 days  but can opt out  
of the trial of his/her own conscious discretion. 
  Patients who are willing to subject themselves to take X Ray of Chest  
(PA view) ECG, PEFR, as well as to Undergo routine lab investigation. 
 
 
 
 
9. EXCLUSION CRITERIA                Yes                     No 
            1.   Cardiac disease. 
            2.   Renal disease. 
            3. Tuberculosis. 
             4. COPD. 
             5. Status asthmaticus. 
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             6. Diabetes mellitus. 
            7. Hyper tension.  
            8. Pregnancy.  
            9. Lactation.  
            10.psychological factor. 
            11.worm infestation. 
10. PEFR( Peak Expiratory Flow Rate ) [L/min] –       
11.ADMITTED TO TRAIL :           YES                    NO 
 If Yes Serial NO:  ------------------- 
 
Date: 
Station: 
 
Signature of the Investigator:  
                                         
                                                                                      Signature of the Lecturer:  
 
                           
 
                                                                                      Signature of the 
 
 
 
 
 
 
NATIONAL INSTITUTE OF SIDDHA,                                                                      
AYOTHIDASS PANDITHAR HOSPITAL,                                                             
CHENNAI-47 
                                                                                                                                                          
FORM l A   -HISTORY PROFORMA ON ENROLLMENT 
PRECLINICAL AND CLINICAL  STUDY ON   SWASA KASAM      ( BRONCHIAL 
ASTHMA ) AND DRUG OF CHOICE IS “THUTHUVALAYATHY CHOORANAM ” ( 
INTERNAL ) . 
    REG  NO: 32101201   / 2012-13 
1. O.P/ I.P No ----------------       2.  S. No----- 
3 .Name ----------------------      4. Age ---------    5 . Gender : Female / Male 
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6 .Occupation ----------------------      
7 .Address  --------------------------- 
                   ---------------------------  
                   ---------------------------  
8.Educational  Status:   A) Illiterate                            B)Literate          
 
9.Height:         cms                10.Weight:         kg 
 
11. Complaints and Duration:   
               …………………………………………………………………………….. 
               …………………………………………………………………………….. 
               ……………………………………………………………………………..  
 
12. Habit of                                  Yes      No 
    A) Smoking                                                   ………………………………………                    
                                                        
    B) Alcoholism                                               ………………………………………             
   
    C) Tobacco chewing                                     .……………………………………..     
                                                                          
    D) Betel nut chewing                                    ………………………………………      
                                
13.Dietary style: 
       vegetarian                           Non  vegetarian 
 
  14.DrugHistory: 
 
 
 
15. Wheezing trigger factors: 
 
Dust Yes/No Food additive Yes/No 
Smoke exposure  Yes/No Fumes of paints and 
petrol. 
Yes/No 
Cold exposure Yes/No Detergents Yes/No 
Exercise Yes/No Chemicals Yes/No 
Emotion Yes/No Husks, grass, pollans. Yes/No 
Occupation Yes/No Menstruation Yes/No 
Others  
 
15 MARITAL STATUS    1.Married   2.Unmarried  
 
                                      No of children:  
                                                                                                                                     
16. FAMILY HISTORY 
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      Whether this problem runs in family?         1. Yes                2.No   
  
       If yes, mention the relationship of affected person(s) ------------------------- 
                                                                                      ------------------------- 
                                             
17. MENSTRUAL HISTORY:  
               Regular                         Irregular                         Menopause       
 
18. BOWEL HABITS & MICTURITION:  Normal 1. Yes               
2.No 
 
            History of habitual constipation                          1.Yes                            2.No                                                       
 
            History of frequent diarrhoea                              1.Yes                            2.No                                                         
 
            History of frequent dysuria                                 1.Yes                            2.No                
 
 
  Date:        
  Station: 
 
  Signature of the Investigator:    Signature of the 
Lecturer: 
                             
                 
                  
                  Signature of the HOD 
 
 
 
                                             NATIONAL INSTITUTE OF SIDDHA 
CHENNAI -47 
DEPARTMENT OF MARUTHUVAM 
             PRECLINICAL AND CLINICAL  STUDY ON   SWASA KASAM      ( 
BRONCHIAL ASTHMA ) AND DRUG OF CHOICE IS “THUTHUVALAYATHY 
CHOORANAM ” ( INTERNAL ) . 
                                                   REG  NO: 32101201   / 2012-13 
       FORM II CLINICAL ASSESSMENT ON ENROLLMENT AND ON VISITS 
 
 
1. O.P/ I.P No ----------------       2.  S. No----- 
3 .Name ----------------------       4. Age ---------     5 . Gender : Female / Male 
6 .Occupation ----------------------      
7 .Address  --------------------------- 
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                   ---------------------------  
                   ---------------------------  
8. Date of assessments:   
 
SIDDHA SYSTEM OF EXAMINATION 
 
 
1 ENVAGAI THERVU: [EIGHT-FOLD EXAMINATION]  
 
 
   I. NAADI: [PULSE PERCEPTION]  
 
 
 
 
   II. NAA [TONGUE] 
 
III.NIRAM: [COMPLEXION]   
 0
th
 
Day 
8
th
 
Day 
15
th
Day 22
nd
 
Day 
25
th
 Day  0
th
 
Day 
8
th
Day 15
th
 
Day 
22
nd
 
Day 
25
th
 
Day 
Vali      Iyya vali      
Azhal      Vali Iyyam      
Iyyam      Azhal 
Iyyam 
     
Vali 
Azhal 
     Iyya Azhal      
Azhal 
vali 
           
 0
th
 Day 8 
th
Day 15
th 
 Day 22
nd
 Day 25th Day 
Colour Normal/pigmented
/cyanosed/Yellow/ 
Red/Pale 
Normal/pigmented
/ cyanosed/Yellow/ 
Red/Pale 
Normal/pigmented/ 
cyanosed/Yellow/ 
Red/Pale 
Normal/pigmented
/cyanosed/Yellow/ 
Red/Pale 
Normal/pigmented/
cyanosed/Yellow/ 
Red/Pale 
Taste Sweet / Bitter/ 
Sour/Pungent/ 
None 
Sweet/ Bitter/ 
Sour/ 
Pungent/ None 
Sweet/ Bitter/ Sour/ 
Pungent/ None 
Sweet/Bitter/Sour/ 
Pungent/None 
Sweet/Bitter/Sour/ 
Pungent/None 
Coating Present/Absent Present/Absent Present/Absent Present/Absent Present/Absent 
Fissure Present/Absent Present/Absent Present/Absent Present/Absent Present/Absent 
Saliva Normal/Increased/ 
Decreased 
Normal/Increased/
Decreased 
Normal/Increased/D
ecreased 
Normal/Increased/
Decreased 
Normal/Increased/
Decreased 
Dryness Present/Absent Present/Absent Present/Absent Present/Absent Present/Absent 
Glossitis Present/Absent Present/Absent Present/Absent Present/Absent Present/Absent 
Baldness Presesnt/Absent Present/Absent Present/Absent Present/Absent Present/Absent 
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0
th
 Day 8
th
 Day 15
th 
Day 22
nd
 Day 25th Day 
Wheatish/fair/Dark/ 
Yellow tinted/Pale 
Wheatish/fair/Dark/ 
Yellowtinted/Pale 
 
Wheatish/fair/Dark/ 
Yellowtinted/Pale 
   
Wheatish/fair/Dark/ 
Yellowtinted/ Pale 
  
Wheatish/fair/Dark/  
Yellow tinted/ Pale 
 
 
  IV.MOZHI: [VOICE]  
 
    V.VIZHI: [EYES] (Lower palpabrel conjunctiva)   
 
   
  
 
 
VI. MALAM; [BOWEL HABITS / STOOLS] 
 
 
 0
th
 Day 8
th
 Day 15 
th
 Day 22
nd
 Day 25
th
 Day 
Colour Dark/Yellow/ 
Red/Pale 
Dark/Yellow/ 
Red/Pale 
 
 
Dark/ 
Yellow/Red/Pale 
 
Dark/ 
Yellow/Red/Pale 
 
 
Dark/ Yellow/Red/Pale 
 
 
Consistency Solid/Semisolid/ 
Watery 
 
Solid/Semisolid/ 
Watery 
 
Solid/Semisolid/ 
Watery 
Solid/Semisolid/ 
Watery 
Solid/Semisolid/ 
Watery 
Stool  bulk                          Normal/Reduced 
 
Normal/Reduced Normal/Reduced Normal/Reduced Normal/Reduced 
Constipation   Present/Absent 
 
Present/Absent 
 
Present/Absent 
 
Present/Absent 
 
Present/Absent 
 
Diaarhoea Present/Absent Present/Absent Present/Absent Present/Absent Present/Absent 
Mucous Present/Absent Present/Absent Present/Absent Present/Absent Present/Absent 
Blood Present/Absent Present/Absent Present/Absent Present/Absent Present/Absent 
VII. URINE EXAMINATION(muthiram ) 
 
0
th
 Day 8
th
 Day 15
th
 Day 22
nd
 Day 25th Day 
Medium/High/Low/ 
Pitched 
Medium/ High/  
Low/ Pitched 
Medium/ High/  
Low/ Pitched 
Medium/ High/  
Low/ Pitched 
Medium/ High/  
Low/ Pitched 
0
th
 Day 8
th
 Day 15
th
 Day 22
nd
 Day 25th Day 
Normal/Yellow/ 
Red/ Pale 
Normal/Yellow 
Red / Pale 
Normal/Yellow 
Red / Pale 
Normal/Yellow 
Red / Pale 
Normal/Yellow 
Red / Pale 
Neerkuri 0
th
 Day 8
th
 Day 15
th
 Day 22
nd
 Day 25
th
 Day 
Niram 
[Colour]   
White/Yellowish
/ 
Straw coloured/ 
Crystal clear 
White/Yellowish/ 
Straw  coloured/ 
Crystal clear 
White/Yellowish/
Strawcoloured/ 
Crystal clear 
White/Yellowish/ 
Straw coloured/ 
Crystal clear 
White/Yellowish/ 
Straw coloured/ 
Crystal clear 
Manam Present/ Absent  Present/ Absent Present/ Absent Present/ Absent Present/ Absent 
184 
 
 
VIII . NEIKURI 
 
  1  . SPARISAM: [PALPATORY  PERCEPTION] 
 
2.THEGI: [ TYPE OF BODY CONSTITUTION]    
Vatham predominant Pitham predominant Kabam predominant Thondha udal 
3.NILAM: [ LAND WHERE PATIENT LIVED MOST] 
 
  Kurinji                         Mullai                  Marutham              Neithal                  Palai 
 
(Hilly terrain)            (Forest range)             (Plains)             (Coastal belt)        (Arid regions)  
 
 
 
 
 4. KAALAM 
 
Kaarkalam-                                Koothirkalam                                   Munpanikalam                         Pin 
 
Panikalam                                             Ilavenil-                                      Muthuvenil 
 
 
5. GUNAM 
Sathuvam                        Rasatham                       Thamasam 
 
  6. IMPORIGAL (SENSORY ORGANS)    
                 
[Odour] 
Nurai 
[Froth] 
Nil/Reduced/ 
Increased 
Nil/Reduced/ 
Increased 
Nil/Reduced/ 
Increased 
Nil/Reduced/ 
Increased 
Nil/Reduced/ 
Increased 
Edai 
[Sp.gravity]                                
Normal/Increase
d/Reduced  
Normal/Increased/ 
Reduced 
Normal/Increased/ 
Reduced 
Normal/Increased/ 
Reduced 
Normal/Increased/ 
Reduced 
Enjal 
[Deposits] 
Present/ Absent Present/ Absent Present/ Absent Present/ Absent Present/ Absent 
Volume   Normal/Increase
d/Reduced 
Normal/Increased/ 
Reduced 
Normal/Increased/ 
Reduced 
Normal/Increased/ 
Reduced 
Normal/Increased/ 
Reduced 
 0
th
 day 8
th
 day 15
th
 day 22
nd
 day 25
th
 day 
Serpentine 
fashion 
 at____ minutes                                        at____ minutes  at____ minutes at____ minutes at____ minutes 
Annular/Ringed 
fashion 
   at____ minutes  at____ minutes  at____ minutes  at____ minutes at____ minutes 
Pearlbeaded 
fashion    
   at____ minutes  at____ minutes   at____ minutes  at____ minutes at____ minutes 
Mixed fashion    at____ minutes   at____ minutes   at____ minutes  at____ minutes at____ minutes 
Other fashion   at____ minutes   at____ minutes    at____ minutes  at____ minutes at____ minutes 
0
th
 Day 8
th
 Day 15
th
 Day 22
nd
 Day 25th Day 
Warmth/cold/ Sweat Warmth/cold/ Sweat Warmth/cold/ Sweat Warmth/cold/ Sweat Warmth/ cold/Sweat 
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 0
th 
day 8
th 
day 15
th
day 22
nd
day 25
th
 day 
Normal  Affected  Normal  Affected  Normal  Affected  Normal  Affected  Normal  Affected 
Mei 
(Skin) 
          
Vai 
(Buccal 
Cavity) 
          
Kann 
(Eye) 
          
Mooku 
(Nose) 
          
Sevi 
(Ear) 
          
 
 
  7. KANMENDRIYAM ( MOTOR ORGANS)         
   
 0
th 
day 8
th 
day 15
th
day 22
nd
day 25
th
 day 
Normal  Affected  Normal  Affected  Normal  Affected  Normal  Affected  Normal Affected 
Kai 
(upper 
limb) 
          
Kaal 
(lower 
limbs ) 
          
Vai   
(buccal 
cavity) 
          
Eruvai 
(excretor
y organs) 
          
Karuvai  
(reprodu
ctive 
organs) 
          
 
8. KOSANGAL(Sheath)         
                              
 0
th 
day 8
th 
day 15
th
day 22
nd
day 25
th
 day 
Normal  Affected  Normal  Affected  Normal  Affected  Normal  Affected  Normal  Affected  
Annamaya 
kosam 
          
Pranamaya 
kosam  
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Manomaya 
kosam  
          
Vignanamaya 
kosm  
          
Ananthamaya
kosm  
          
 
                                                                                                                                                                                                 
 
 
 
 
 
 
 
 
 9. SEVEN DHATHUS: (7 SOMATIC COMPONENTS)         
 
                                 
   10.MUKKUTRAM:[AFFECTION OF THREE HUMORS] 
 
    A)VATHAM:          
 
 0
th
 day
 
8
th
 day 15
th 
day 22
nd 
day 25
th
 day 
Normal Affected Normal Affected Normal Affected Normal Affected Normal Affected 
Praanan           
Abaanan
  
          
Samaanan           
Udhaanan           
 0
th
 day 
 
8
th
 day 
 
15
th
 day 22 
nd
day 
 
25th day 
 
Normal        Affected Normal Affected Normal Affected Normal Affected Normal Affected 
Saaram 
[chyme] 
          
Senneer 
[Blood]  
          
Oon 
[Muscle] 
          
Kozhuppu 
[Fat] 
          
Enbu 
[Bones] 
          
Moolai 
[Bonemarrow] 
          
Sukkilam/ 
Suronitham 
[Genital 
discharges] 
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Viyaanan           
Naagan           
Koorman           
Kirukaran           
Devathathan           
Dhananjeyan           
 
 
    B) PITHAM:             
   
 0
th
 day 
 
8
th
 day 
 
15
th
 day 22
nd
 day 
 
25th day 
 
Normal        Affected Normal Affected Normal Affected Normal Affected Normal Affected 
Analapitham           
 Prasakam  
 
         
Ranjakam  
 
         
Aalosakam  
 
         
Saathakam  
 
         
 
 
 
     C) KABAM:            
             
  
0 
th
 day 
 
8
th
 day 
 
15
th
 day 
 
22
nd
 day 
 
25th day 
Normal        Affected Normal Affected Normal Affected Normal Affected Normal Affected 
Avalambagam           
Kilethagam           
Pothagam           
Tharpagam
       
          
Santhigam
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11.GENERAL EXAMINATION 
 
 0
th
 day 8
th
 day 15
th
 day 22
nd
 day 25
th
 day 
Height (cms)      
Weight (kg)      
Temperature(°F)         
Pulse rate (permin)      
Heart rate (per min)      
Respiratory rate(per 
min) 
     
Blood 
pressure(mm/Hg) 
     
Pallor      
Jaundice      
Cyanosis      
Lymphadenopathy      
Pedal edema      
Clubbing      
Jugular vein pulsation      
       
12.SYSTEMIC EXAMINATION  :Respiratory system 
 
I.Inspection: 
 
 0
th
 day 8
th
 day 15
th
 day 22
nd
 day 25
th
 day 
Trachea      
Drooping of 
shoulder 
     
Form of chest      
Apical impulse       
Intercostal 
Muscle 
Wasting 
 
     
Intercostal 
bulging 
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Respiratory 
movement 
     
Measurements:               
AP               -                 
Transverse  - 
     
 
II . Palpation : 
 
 0
th
 day 8
th
 day 15
th
 day 22
nd
 day 25
th
 day 
Tracheal position 
( trial‘s sign )  
 
     
Apical impulse 
 
     
Respiratory 
Movements 
     
Tactile vocal 
fremitus 
     
 
  III. Percussion ; 
 
 0
th
 day 8
th
 day 15
th
 day 22
nd
 day 25
th
 day 
 Normal /Dullness/ 
hyper-resonance 
     
IV. Auscultation : 
             
 0
th
 day 8
th
 day 15
th
 day 22
nd
 day 25
th
 day 
Character of  
Breath Sound 
     
Foreign 
Sounds 
     
Vocal 
Resonance 
     
  V. Sputum: 
 
 0
th
 day 8
th
 day 15
th
 day 22
nd
 day 25
th
 
Colour White/Green/ 
Yellow/red 
White/Green/ 
Yellow/red 
White/Green/Yello
w/ 
Red 
White/Green/Yellow/
red 
White/Green/Yellow/
red 
Amount  Less/More Less/more Less/More Less/More Less/More 
Consistency Mucoid/Purulent 
/Frothy 
Mucoid/Purulent 
/Forthy 
Mucoid/Purulent/ 
Forthy 
Mucoid/Purulent/ 
Forthy 
Mucoid/Purulent 
/Forthy 
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Odour Yes/No Yes/No Yes/No Yes/No Yes/No 
      
    
Other Systemic Examination: 
 
        
 0
th
 day 8
th
 day 15
th
 day 22
nd
 day 25
th
 day 
Cardio vascular 
system 
     
Alimentary 
system 
     
Central 
Nervous system 
     
Locomotor 
system 
     
Genito-Urinary 
system 
     
Endocrine 
system 
     
 
    12.Clinical Symptoms: 
 
 0
th
 day 8
th
 day 15
th
 day 22
nd
 day 25
th
 day 
Difficulty in breathing      
Tightness of chest      
Wheeze - Added sound  
(rhonchi) 
     
Dry(or)productive 
cough 
     
Sneezing 
 
     
Hoarseness of voice 
 
     
Sleep disturbance      
Associated symptoms      
 
 
     Date : 
      
     Station: 
 
     Signature of the Investigator: 
 
     Signature of the Lecturer:                                                   Signature of the HOD 
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                                            NATIONAL INSTITUTE OF SIDDHA 
             CHENNAI -47 
DEPARTMENT OF MARUTHUVAM 
  PRECLINICAL AND CLINICAL  STUDY ON   SWASA KASAM      ( BRONCHIAL 
ASTHMA ) AND DRUG OF CHOICE IS “THUTHUVALAYATHY CHOORANAM ” ( 
INTERNAL ) . 
                                   FORM III -   LABORATORY PARAMETERS-CHART 
 
1. Serial No: ________     2.Lab No : 
3. Name: ________________          4.Age:   _______ years        
 5.Gender: Male/Female         
 
 
 
 
 
     
 
 
   BLOOD INVESTIGATION 
 
BEFORE TMT 
Date: 
 
 
AFTER TMT 
Date 
 
NORMAL 
VALUES 
 
HB( gms%)     Men- 12.0-17.0 
  Women – 11.0-16 
 
T.RBC(milli/cu.mm) 
    Men-4.4-5.7 
  Women-3.8-5.0 
 
ESR (mm) 
½ hr.     Men-1-13 
  Women-1-20 1 hr.   
T.WBC (cu.mm) 
 
     M:4000-11000 
   W:4000-11000 
DIFFERENTIAL 
COUNT (%) 
Polymorphs       40-75% 
Lymphocutes       20-40% 
Monocytes       2-10% 
Esonophils        1-6% 
Basophils        0-1% 
Bloodglucose 
(mg/dl) 
 
 
Fasting       70-110 
  PP       80-140 
 Random   
 80-120 
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BLOOD INVESTIGATION 
 
BEFORE TMT 
Date: 
 
 
AFTER TMT 
Date 
 
NORMAL VALUES 
Lipid 
profile 
(mg/dl) 
Serum cholesterol   150-120 
HDL   30-60 
LDL   Upto 130 
VLDL   40 
TGL   Upto 160 
RFT 
(mg/dl) 
Blood urea   16-50 
Serum creatinine   0.6-1.2 
Serum Uric acid 
  Men:3-9, 
W0men:2.5-7.5 
LFT 
(mg/dl) 
Total bilirubin   0.3-1 
Direct bilirubin   0.1-0.3 
Indirect bilirubin   0.2-0.8 
Serum totalprotein   6-8 
Serum Albumin   3.5-5.5 
Serum globulin   2-3.5 
Fibrinogen(g/dl)   0.2-0.4 
Serum calcium 
  9-11 
Serum 
phosphorous 
  2-5 
SGOT (IU/L) 
  6-18 
SGPT (IU/L)   3-26 
Alkaline 
phosphatase (IU/L) 
  290(IU/L) 
Peak Expiratory Flow Rate (lit 
/ min) 
  M : adult 400-650: 
above 40yr 300-500 
F :adult 250-450: 
above 40yr 200-400 
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                        AFB: 
 
                       Radiological investigation- Chest X-ray PA View: 
 
                       ECG :  
 
                      Date :      
                       
                      Station: 
                                                                                                                                                                                                                                                                                                                                                                                 
Signature of the Investigator: 
                                                                                                        Signature of the 
Lecturer:  
 
 
                                                                        Signature of the 
HOD   
                                                     
 
Urine investigation 
Before TMT 
Date: 
After TMT  
Date: 
Neer Kuri   
Niram   
Manam   
Nurai   
Edai   
Enjai   
Neikuri   
Albumin   
Fasting sugar   
PP sugar   
Random Sugar   
Deposits   
Bile salt   
Bile pigments   
Urobilinogen   
MOTION TEST Before TMT 
Date:  
After TMT 
Date: 
Ova   
Cyst   
Occult blood   
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AYOTHIDASS PANDITHAR HOSPITAL 
DEPARTMENT OF MARUTHUVAM 
 
   PRECLINICAL AND CLINICAL  STUDY ON   SWASA KASAM   ( BRONCHIAL ASTHMA ) 
AND DRUG OF CHOICE IS “THUTHUVALAYATHY CHOORANAM ” ( INTERNAL ) . 
FORM IV A - CONSENT FORM 
Certificate by Investigator 
 
     I certify that I have disclosed all details about the study in the terms readily 
understood by the patient. 
 
Date:      Signature: 
                                                                Name:      
              
Consent by Patient 
    I have been informed to my satisfaction, by the attending physician, the 
purpose of the clinical trial, and the nature of drug treatment and follow-up including 
the laboratory investigations to be performed to monitor and safeguard my body 
functions. 
    I am aware of my right to opt out of the trial at any time during the course of 
the trial without having to give the reasons for doing so. 
      I, exercising my free power of choice, hereby give my consent to be included 
.As a subject in the clinical trial of Thuthuvalayathychooranam  for the management 
of Swasakasam (Bronchial Asthma)  
 
Date:                        Patient   Signature: 
                                                           Patient     Name:  
 
Date:            Signature of Witness:  
                                                                              Name:  
                                                                  Relationship:                                        
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NATIONAL INSTITUTE OF SIDDHA, CHENNAI – 47 
AYOTHIDASAR PANDITHAR HOSPITAL 
DEPARTMENT OF   MARUTHUVAM 
PRE CLINICAL AND CLINICAL STUDY ON “SWASAKASAM”(BRONICAL ASTHMA) AND THE 
DRUG OF CHOICE IS “THUTHUVALAYATHY CHOORANAM” (INTERNAL) 
FORM IV – INFORMATION SHEET 
Name of the Principal Investigator:  Dr.G.BANU 
 Name of the Institution                    : National Institute of Siddha 
                                                                  Tambaram Sanatorium  
                                                                   Chennai-47. 
 I am, Dr.G.Banu studying M.D(S) in National Institute of Siddha, Chennai.  Bronchial asthma 
is the common chronic inflammatory disease of the airway characterized by variable and 
recurring symptoms of wheezing ,coughing,  chest tightness and shortness of breath . This 
condition is being treated is NIS with many siddha formulations. As a part of M.D(S) research 
programme and developing new efficacious medicine,we propose to study the 
Thuthuvalayathy chooranam formulation for treating the condition. This formulation has 
been mentioned in siddha literature and empirical evidence with contemporary tools is required 
for documentation. You can receive medicines free of cost. The duration of treatment period is 
24days. You have to visit NIS every week and collect drugs for 7 days. The diagnosis tests will 
be carried out free of cost.  We will assess the effect of treatment after completion of 24days of 
treatment using clinical and lab parameters. 
 In this regard, we need to ask you few questions. We will maintain confidentiality of your 
comments and data obtained from you. There will be no risk of disclosing your identity and no 
physical, psychological or professional risk is involved by taking part in this study. 
 Taking part in this study is voluntary. No compensation will be paid to you for taking part in 
this study. You can choose not to answer any specific question. There is no specific benefit for 
you if you take part in the study, but you will be under our clinical monitoring and specific 
attention will be given for your health. Taking part in the study may be of benefit to the 
community, as it may help us to develop medicine for swasakasam. In case of any adverse 
symptoms during the treatment   which is expected for few patients during the treatment, shall 
be reported to PIs and care will be taken in NIS for relief. You can withdraw from the study at 
the midst of treatment period, if you are not interested to continue and you will receive our 
usual treatment without condition. 
 The information we will collect in this study, will remain between you and the principal 
investigator. We will ask you a few questions through questionnaire. We will not write your 
name on different forms which sent to different investigating/analysis sections and we will use 
a code instead given by the principal investigator. Only the principal investigator will know the 
key to this code which will be kept in safe custody. If you agree to be a participant in this study, 
you will be screened as per the study protocol.  
 If you wish to find out more about this study before taking part, you can ask me all the 
questions you want or contact Dr.G.Banu, M.D(S) scholar cum principal investigator of this 
study, attached to the National Institute of Siddha, Chennai (Mobile phone no:9962494255). 
You can also contact the Chairman/Member-secretary of Ethics committee, National Institute 
of Siddha, Chennai – 600047, Tel no: 91-44-22411611, for rights and participation in the study. 
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NATIONAL INSTITUTE OF SIDDHA 
CHENNAI -47 
DEPARTMENT OF MARUTHUVAM 
 
             PRECLINICAL AND CLINICAL  STUDY ON   SWASA KASAM      ( BRONCHIAL ASTHMA ) 
AND DRUG OF CHOICE IS “THUTHUVALAYATHY CHOORANAM ” ( INTERNAL ) . 
REG NO: 32101201 /2011-13 
FORM IV C – DRUG COMPLIANCE FORM 
 
                S. NO:                
               OPD/IPD NO  :                     
               NAME :    
 
 
Name Of The Drugs : THUTHUVALAYATHY CHOORANAM (Internal)   
 
          Drug – THUTHUVALAYATHY CHOORANAM ;     
 
 0th day 8th day 15th day 25th day 
Drug  Issued      
 
 
 
 
 8th day 15th day 25th day 
Drug  returned     
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Date :  
               
Station: 
 
Signature of the Investigator: 
 
Signature of the Lecturer:                                               Signature of the HOD 
S.NO 
DATE 
DRUG TAKEN TIME 
MORNING/TIM
E 
AFTERNOON/TIM
E 
EVENING/TIME 
Day 1        
Day 2        
Day 3        
Day 4        
Day 5        
Day 6        
Day 7        
Day 8        
Day 9        
Day 10        
Day 11        
Day 12        
Day 13        
Day 14        
Day 15        
Day 16 
       
Day 17        
Day 18 
       
Day 19        
Day 20        
Day 21        
Day 22        
Day 23        
Day 24        
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AYOTHIDASS PANDITHAR HOSPITAL 
DEPARTMENT OF MARUTHUVAM 
PRECLINICAL AND CLINICAL  STUDY ON   SWASA KASAM     ( BRONCHIAL ASTHMA ) 
AND DRUG OF CHOICE IS “THUTHUVALAYATHY CHOORANAM ” ( INTERNAL ) . 
FORM IV D              
DIET FORM 
 
 
 
 
 
 
 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
 
 
 
 
 
 
 
 
8.  
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PRECLINICAL AND CLINICAL  STUDY ON   SWASA KASAM      ( BRONCHIAL ASTHMA ) 
AND DRUG   OF CHOICE IS “THUTHUVALAYATHY CHOORANAM ” ( INTERNAL ) . 
FORM IV D              
1.Do‟s 
1. Steamed food like idly,idiyappam,puttu. 
2. Mussumusukai adai,kalyanam murungai ada. 
3. Turmeric and Peper mixed milk 
4.  Ginger,Dry ginger mixed cof fe  
5. Crap soup,veg.soup, Peper rasam,mutton leg soup. 
6. Thuthuvalai thuvayal.  
2. Don‟t 
1. Avoid cooldrinks,chocolate,cake. 
2. Oily substance 
3. Curd,gee,butter,cheese, 
4.  Dry fish,chicken,beaf, 
5.  Sweets,sour food, 
6.  Tuberous food, 
7.  Tined  food, 
8.  Allergen food 
9.  Vegetables like cucumber,snake guard etc.. 
10.  Citrus fruits 
3.General advise 
1. Avoid smoking,tobacco , alcohol, 
2. Avoid Cold weather 
3.  Avoid,pollutated area,dust., 
4.  Avoid Stress, 
5. Do pranayamam, 
6. Have your night food before 7‘o clock, 
7. Don‘t have full stomach at night . 
8. Intake of hot water and hot food. 
 
NATIONAL INSTITUTE OF SIDDHA 
CHENNAI -47 
DEPARTMENT OF MARUTHUVAM 
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PRECLINICAL AND CLINICAL  STUDY ON   SWASA KASAM  ( BRONCHIAL ASTHMA ) 
AND DRUG OF CHOICE IS “THUTHUVALAYATHY CHOORANAM ” ( INTERNAL ) . 
 
REG N O: 32101201/2012-2013 
FORM IV -E (WITHDRAWAL FORM) 
                                                           
Serial No:                                     OPD/ IPD NO:                            
Name :                                         Age:                         GENDER: M/F 
                          
Date of trial commencement: 
 
Date of withdrawal from the trial: 
Reason(s) for withdrawal; 
1. Long absence at reporting:                                Yes/No 
2. Irregular treatment:                                            Yes/No 
3. Shift of locality:                                                 Yes/No 
4. Complication/Adverse reactions if any:             Yes/No 
5. Poor patient compliance:                                    Yes/No 
Date :                                                                             
Station: 
Signature of the Investigator: 
 
Signature of the Lecturer:                                        
Signature of the HOD 
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NATIONAL INSTITUTE OF SIDDHA 
CHENNAI -47 
DEPARTMENT OF MARUTHUVAM 
REG NO:32101201/2012-13 
FORM –IV F 
ADVERSE REACTION FORM 
 
PRECLINICAL AND CLINICAL  STUDY ON   SWASA KASAM  ( BRONCHIAL ASTHMA ) 
AND DRUG OF CHOICE IS “THUTHUVALAYATHY CHOORANAM ” ( INTERNAL ) . 
 
Reg No:32101201/2012-13 
Serial No:                                                                             OP/IP No: 
Name:                                       Age:                                Gender:  M/F    
Date of trial commencement: 
Date of the adverse reaction occur; 
Time: Description of Adverse reaction: 
 
 
Date:                                                                              
Station:  
 
 
Signature of the Investigator: 
 
 
 
 
Signature of the Lecturer:                                        Signature of the HOD  
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TRBC
P L E 1/2 Hr 1 Hr F PP Total
HD
L
LDL VLDL TGL
1 C80516 40/F 11.4 7800 75 20 3 2 4 4 109 124 27 0.7 168 35 99 34 142 Normal Normal 180
2 C80591 20/F 11.9 8200 60 37 2 2 6 6 80 102 21 0.6 176 26 121 29 123 Normal Normal 250
3 C79343 21/F 11.2 8000 62 33 4 4 8 16 80 98 15 0.6 192 33 132 27 139 Normal Normal 190
4 C80968 25/F 12.5 7900 63 35 2 2 4 12 84 98 18 0.6 176 36 112 28 103 Normal Normal 280
5 C83148 29/F 11.6 7800 67 31 2 4 12 12 78 96 18 0.6 133 44 71 17 46 Normal Normal 260
6 C83357 29/F 10.9 7400 59 36 2 6 14 4 86 111 20 0.6 191 48 103 40 107 Normal Normal 320
7 C83859 21/F 12.2 8600 62 34 6 2 6 8 100 123 18 0.6 196 42 125 29 149 Normal Normal 210
8 C84354 23/F 11.3 8000 66 31 2 4 2 24 66 90 26 0.7 176 41 116 19 93 Normal Normal 280
9 C85576 34/F 10.8 9000 66 33 4 2 8 10 80 120 22 0.7 180 42 112 26 94 Normal Normal 280
10 C85444 40/F 11.2 7000 64 32 3 4 6 16 75 96 15 0.6 174 41 114 19 64 Normal Normal 290
11 C85401 28/F 10.2 8100 65 33 3 2 8 10 82 103 17 0.6 221 36 149 36 184 Normal Normal 200
12 C87290 42/F 10.4 7200 56 43 1 2 4 8 67 89 15 0.6 159 47 96 16 81 Normal Normal 180
13 C87563 52/F 12.5 7600 60 38 1 6 18 4 80 102 24 0.7 155 42 90 22 114 Normal Normal 270
14 4077 33/F 10.8 8000 62 37 1 4 8 28 103 121 19 0.6 207 39 139 29 147 Normal Normal 340
15 C89542 42/F 10.1 9300 63 35 2 4 6 16 100 124 15 0.6 235 33 168 40 168 Normal Normal 290
16 C93882 44/F 11.7 8700 63 35 1 2 8 4 63 87 20 0.7 154 37 83 34 154 Normal Normal 240
17 C88940 33/F 11.1 7200 52 47 1 2 4 12 85 111 18 0.6 180 50 100 30 150 Normal Normal 250
18 C91895 18/F 10.9 8000 62 37 5 2 4 8 80 98 22 0.7 134 32 87 15 71 Normal Normal 290
19 4043 35/F 10.9 8700 65 33 1 4 6 12 70 92 21 0.6 200 33 148 19 95 Normal Normal 360
20 C87827 32/F 10.6 7800 70 27 2 2 8 12 76 102 17 0.6 162 28 110 24 98 Normal Normal 290
OP/ IP After Treatment
Urea Creatine AFB X-RAY PERF
Cholesterol
Slno Ip/OP
DC ESR Sugar
Age/ 
Sex
Hb TC
TRBC
P L E 1/2 Hr 1 Hr F PP Total
HD
L
LDL VLDL TGL
Urea Creatine AFB X-RAY PERF
Cholesterol
Slno Ip/OP
DC ESR Sugar
Age/ 
Sex
Hb TC
21 4254 47/F 12.9 8800 63 35 2 2 4 4 82 113 20 0.6 148 40 86 22 121 Normal Normal 310
22 4147 46/F 11.8 7100 58 39 3 2 8 12 56 77 15 0.6 179 31 129 19 91 Normal Normal 360
23 D001578 32/F 10.5 5600 63 34 2 8 16 10 80 94 18 67 140 22 90 28 116 Normal Normal 280
24 4206 55/F 11.5 8200 63 35 3 4 6 8 81 99 16 0.6 124 25 87 22 101 Normal Normal 230
25 4202 31/F 11.4 7300 65 33 6 8 22 12 56 88 16 0.6 184 33 127 24 123 Normal Normal 280
26 4205 40/F 11.2 8000 66 30 3 6 10 8 87 99 17 0.6 164 30 114 20 83 Normal Normal 320
27 4983 29/M 13.4 8000 69 29 6 2 6 4 80 94 19 0.6 183 38 130 15 62 Normal Normal 360
28 C84952 46/M 13.3 7800 72 27 5 2 6 4 70 95 17 0.6 127 32 75 20 49 Normal Normal 380
29 C86528 38/M 14.2 7000 64 34 2 2 4 4 85 100 25 0.6 188 44 118 26 103 Normal Normal 410
30 C87412 40/M 14.4 8900 64 31 3 2 6 4 77 92 23 0.7 177 40 114 23 126 Normal Normal 360
31 C89103 55/M 13.3 8100 67 31 2 2 6 8 70 91 22 0.6 162 32 105 25 114 Normal Normal 260
32 C92628 32/M 12.6 8200 62 36 4 2 4 20 71 87 16 0.6 174 20 131 23 115 Normal Normal 310
33 C90031 25/M 12.9 7200 59 36 3 2 4 4 84 110 17 0.6 156 50 89 17 62 Normal Normal 420
34 C90298 30/M 15.1 8200 64 34 3 2 4 4 74 94 21 0.7 186 38 128 21 106 Normal Normal 370
35 C92056 26/M 12.1 7400 61 35 3 2 4 4 82 121 19 0.6 152 31 85 36 142 Normal Normal 350
36 C91493 28/M 11.8 7900 55 40 2 8 14 4 78 98 20 0.6 170 27 120 23 144 Normal Normal 340
37 C94291 21/M 12 8800 66 32 4 2 4 4 75 99 15 0.6 160 31 107 22 102 Normal Normal 340
38 B73595 43/M 11.8 8200 65 29 3 4 6 8 71 90 15 0.6 209 44 131 34 157 Normal Normal 240
39 5120 54/M 14.5 8800 65 32 1 4 24 4 90 121 15 0.6 184 41 126 17 60 Normal Normal 430
40 5184 37/M 13.4 7900 69 29 1 2 6 4 86 101 19 0.6 183 38 130 15 62 Normal Normal 250
TOTAL DIR INDIR ALKPHOS ALB GLOB ALB SUGAR DEP BS BP URO OVA CYST
1 C80516 40/F 0.4 0.4 0.4 22 25 139 7.6 4.9 2.7 9 3.5 2.6 NIL NIL 2-4PUS NIL NIL N NIL NIL
2 4983 29/M 0.6 0.3 0.3 19 16 159 8 4.5 3.5 10.3 3 3.8 NIL NIL 1-2 PUS NIL NIL N NIL NIL
3 C80591 20/F 0.6 0.4 0.2 26 17 162 7.2 3.7 3.5 10.5 3.2 3.6 NIL NIL 1-2PUS NIL NIL N NIL NIL
4 C79343 21/F 0.6 0.3 0.3 26 20 211 7.2 4.1 3.1 10.5 3.6 4 NIL NIL 3-5 PUS NIL NIL N NIL NIL
5 C80968 25/F 0.5 0.3 0.2 19 18 169 7.7 4 3.7 9.7 3.6 4.8 NIL NIL 1-2 PUS NIL NIL N NIL NIL
6 C84952 46/M 0.6 0.3 0.3 24 18 138 7.6 3.9 3.7 9.7 3.8 3.2 NIL NIL 2-4 PUS NIL NIL N NIL NIL
7 C83148 29/F 0.6 0.3 0.3 16 18 190 7.9 4.7 3.2 9.3 3 4.1 NIL NIL 2.4 PUS NIL NIL N NIL NIL
8 C83357 29/F 0.5 0.3 0.2 19 17 163 7.4 4.5 3.5 9.8 3.7 4.7 NIL NIL 1-2 PUS NIL NIL N NIL NIL
9 C83859 21/F 0.4 0.2 0.2 17 22 234 7.2 3.7 3.5 10.2 4.2 3.9 NIL NIL 4-8 PUS NIL NIL N NIL NIL
10 C84354 23/F 0.6 0.3 0.3 21 17 126 7 4 3 9.9 3.2 3.1 NIL NIL 1-2 PUS NIL NIL N NIL NIL
11 C86528 38/M 0.6 0.3 0.3 11 20 153 7.8 3.9 3.9 9.3 3.3 3 NIL NIL 1-2 PUS NIL NIL N NIL NIL
12 C85576 34/F 0.5 0.3 0.2 32 28 239 7.9 4.1 3.8 10.3 3.6 4 NIL NIL 2-4 PUS NIL NIL N NIL NIL
13 C85444 40/F 0.6 0.4 0.2 18 20 232 7 4 3 10 4.5 3 NIL NIL 1-2 PUS NIL NIL N NIL NIL
14 C85401 28/F 0.4 0.2 0.2 17 22 193 7 4.2 2.9 9.9 3.8 3.1 NIL NIL 2-4 PUS NIL NIL N NIL NIL
15 C87290 42/F 0.6 0.3 0.3 18 19 227 7.1 3.6 3.5 10.2 4.2 3.6 NIL NIL 2-4PUS NIL NIL N NIL NIL
16 C87563 52/F 0.5 0.3 0.2 16 22 141 8 4.6 3.4 9.6 3.5 3.7 NIL NIL 2-4 PUS NIL NIL N NIL NIL
17 C87412 40/M 0.6 0.4 0.2 26 20 186 7.8 4.4 3.4 9.8 3.5 3.2 NIL NIL 1-3 PUS NIL NIL N NIL NIL
18 C89103 55/M 0.7 0.4 0.3 22 26 152 7.5 4.5 3 9.9 3.7 3.3 NIL NIL 4-5 PUS NIL NIL N NIL NIL
19 4077 33/F 0.6 0.3 0.3 16 20 184 7.6 4.5 3.1 10.3 4.5 4 NIL NIL 1-2 PUS NIL NIL N NIL NIL
20 C89542 42/F 0.6 0.4 0.2 16 19 182 7.3 3.9 3.4 10.1 4.1 2.6 NIL NIL 1-2PUS NIL NIL N NIL NIL
21 C93882 44/F 0.7 0.4 0.3 28 27 264 6.6 4.4 2 10.5 4.2 2.7 NIL NIL 1-2 PUS NIL NIL N NIL NIL
22 C88940 33/F 0.7 0.4 0.3 23 14 194 7.5 4.3 3.2 9.5 3.9 2.7 NIL NIL 2-4PUS NIL NIL N NIL NIL
23 C91895 18/F 0.6 0.4 0.2 23 19 134 7 3.8 3.2 10.3 4.2 2.9 NIL NIL 2-3 PUS NIL NIL N NIL NIL
24 C92628 32/M 0.6 0.3 0.3 22 18 169 7.2 4.2 3 10.3 4.2 3.8 NIL NIL 1-2 PUS NIL NIL N NIL NIL
25 4043 35/F 0.5 0.3 0.2 20 19 111 7.8 4.8 3 9.7 3.2 3.2 NIL NIL 2-4 PUS NIL NIL N NIL NIL
26 C87827 32/F 0.7 0.4 0.3 18 21 102 7.2 3.8 3 9.8 3.7 3.2 NIL NIL 2-4 PUS NIL NIL N NIL NIL
27 C90031 25/M 0.7 0.4 0.3 31 25 169 7 3.9 3.1 10.3 4 4.1 NIL NIL 2.3 PUS NIL NIL N NIL NIL
28 C90298 30/M 0.6 0.3 0.3 16 17 142 7.2 4.2 3.3 9.2 3.2 3.3 NIL NIL 2-4 PUS NIL NIL N NIL NIL
29 C92056 26/M 0.7 0.4 0.3 24 21 112 7.8 4.3 3.5 9.6 3.5 3.6 NIL NIL 1-3 PUS NIL NIL N NIL NIL
30 C91493 28/M 0.5 0.3 0.2 23 20 136 7 4.2 2.8 11 3.1 3.9 NIL NIL 2-4 PUS NIL NIL N NIL NIL
31 C94291 21/M 0.7 0.4 0.3 19 22 185 7.4 4.2 3.2 9.8 4.1 3.3 NIL NIL 2-4 PUS NIL NIL N NIL NIL
32 B73595 43/M 0.5 0.3 0.2 29 23 273 8 4.6 3.4 9.7 3.4 3.3 NIL NIL 1-2 PUS NIL NIL N NIL NIL
33 4254 47/F 0.5 0.3 0.2 21 18 139 7.8 4.3 3.5 9.4 4.1 3.7 NIL NIL 1-2 PUS NIL NIL N NIL NIL
34 5120 54/M 0.7 0.4 0.3 29 31 127 7 4.3 2.7 10.3 4.3 4.1 NIL NIL 1-2 PUS NIL NIL N NIL NIL
35 4147 46/F 0.5 0.3 0.2 20 12 158 7.1 3.7 3.4 9.6 3.6 3.2 NIL NIL 2-3PUS NIL NIL N NIL NIL
36 D001578 32/F 0.7 0.4 0.3 23 13 147 7.2 4.4 3 9.7 3.3 4 NIL NIL 0-1 PUS NIL NIL N NIL NIL
37 4206 55/F 0.6 0.3 0.3 29 26 168 7.4 3.8 3.6 9.5 4 3.1 NIL NIL 3-4 PUS NIL NIL N NIL NIL
38 4202 31/F 0.6 0.3 0.3 23 14 136 7.3 4.3 3 9.9 3 4.3 NIL NIL 1-2 PUS NIL NIL N NIL NIL
39 4205 40/F 0.4 0.2 0.2 15 14 163 7.2 4.1 3.1 9.7 3.6 3.1 NIL NIL 1-2 PUS NIL NIL N NIL NIL
40 5184 37/M 0.7 0.4 0.3 31 25 169 7 3.9 3.1 10.3 4 4.1 NIL NIL 2.3 PUS NIL NIL N NIL NIL
OP/IP AFTER TREATMENT
S.NO OP/IP.NO AGE/ Sex BILIRUBIN SGOT SGPT PROTEIN CAL PHOS URIC 
ACID
URINE MOTION
Age/ 
Sex Hb TC TRBC Urea Creatine AFB X-RAY PERF
P L E 1/2 Hr 1 Hr F PP Total HDL LDL VLDL TGL
1 C80516 40/F 11.6 8600 60 35 5 2 8 3.9 60 70 25 0.7 161 39 93 29 164 Negative Normal 130
2 C80591 20/F 10.8 5900 61 37 6 4 10 3.5 83 95 19 0.6 166 36 96 34 172 Negative Normal 120
3 C79343 21/F 10.3 6000 57 40 7 4 12 3.3 81 96 16 0.6 154 34 94 24 120 Negative Normal 150
4 C80968 25/F 10.4 8600 66 30 7 4 10 3.4 78 94 17 0.6 205 48 133 24 123 Negative Normal 130
5 C83148 29/F 10 7000 74 20 5 6 16 3.3 75 97 15 0.6 160 26 115 19 95 Negative Normal 100
6 C83357 29/F 12.9 8700 62 35 5 10 24 4.3 80 101 22 0.6 158 50 88 20 102 Negative Normal 180
7 C83859 21/F 11.6 7300 57 39 14 4 8 4.6 85 105 19 0.6 206 36 147 23 113 Negative Normal 150
8 C84354 23/F 9.5 4600 53 40 4 8 6 3.5 85 95 18 0.7 143 25 90 28 140 Negative Normal 160
9 C85576 34/F 10.8 8000 61 38 10 8 18 3.6 78 90 17 0.6 134 30 82 22 110 Negative Normal 170
10 C85444 40/F 9.5 5700 64 30 8 6 8 3.9 80 98 22 0.7 165 30 114 21 109 Negative Normal 160
11 C85401 28/F 11 6200 65 32 4 4 12 4 86 102 20 0.6 183 36 110 37 138 Negative Normal 150
12 C87290 42/F 10.6 7800 65 30 5 2 6 4.1 78 90 15 0.6 158 27 114 17 85 Negative Normal 110
13 C87563 52/F 11.6 8600 60 35 4 8 26 3.9 60 70 25 0.7 161 39 93 29 164 Negative Normal 140
14 4077 33/F 10.8 5900 61 37 4 8 18 3.5 83 95 19 0.6 166 36 96 34 172 Negative Normal 130
15 C89542 42/F 10.3 6000 57 40 5 6 14 3.3 81 96 16 0.6 154 34 94 24 120 Negative Normal 180
16 C93882 44/F 10.4 8600 66 30 1 4 12 3.4 78 94 17 0.6 205 48 133 24 123 Negative Normal 110
17 C88940 33/F 10 7000 74 20 3 4 10 3.3 75 97 15 0.6 160 26 115 19 95 Negative Normal 160
18 C91895 18/F 12.9 8700 62 35 7 4 8 4.3 80 101 22 0.6 158 50 88 20 102 Negative Normal 180
19 4043 35/F 11.6 7300 57 39 3 8 10 4.6 92 103 19 0.6 206 36 147 23 113 Negative Normal 180
20 C87827 32/F 9.5 4600 53 40 4 4 12 3.5 85 95 18 0.7 143 25 90 28 140 Negative Normal 190
OP/IP Before Treatment
Slno Ip/OP
SugarDC CholesterolESR
Age/ 
Sex Hb TC TRBC Urea Creatine AFB X-RAY PERF
P L E 1/2 Hr 1 Hr F PP Total HDL LDL VLDL TGL
Slno Ip/OP
SugarDC CholesterolESR
21 4254 47/F 10.8 8000 61 38 4 4 10 3.6 83 98 17 0.6 134 30 82 22 110 Negative Normal 160
22 4147 46/F 9.5 5700 64 30 10 2 12 3.9 80 98 22 0.7 165 30 114 21 109 Negative Normal 190
23 D001578 32/F 11 6200 65 32 5 12 26 4 86 102 20 0.6 183 36 110 37 138 Negative Normal 130
24 4206 55/F 10.6 7800 65 30 7 8 12 4.1 78 90 15 0.6 158 27 114 17 85 Negative Normal 180
25 4202 31/F 11.6 8600 60 35 9 12 30 3.9 60 70 25 0.7 161 39 93 29 164 Negative Normal 160
26 4205 40/F 10 7000 74 20 5 8 16 3.3 75 97 15 0.6 160 26 115 19 95 Negative Normal 150
27 4983 29/M 11.1 6900 60 37 10 4 10 3.6 68 75 15 0.6 201 33 138 30 150 Negative Normal 180
28 C84952 46/M 10 5000 54 39 6 6 10 3.3 84 88 22 0.6 132 34 82 16 80 Negative Normal 210
29 C86528 38/M 15 7400 62 36 6 2 4 5 84 94 26 0.7 176 28 127 22 108 Negative Normal 230
30 C87412 40/M 11.2 6800 65 25 8 4 8 3.9 80 112 24 0.6 142 31 73 38 149 Negative Normal 210
31 C89103 55/M 11.8 8100 53 40 7 6 8 3.7 88 112 20 0.6 189 37 120 32 164 Negative Normal 180
32 C92628 32/M 11.6 8900 65 31 9 4 8 3.8 79 97 17 0.6 161 32 107 22 112 Negative Normal 160
33 C90031 25/M 10.8 8500 63 29 7 6 10 3.6 85 105 18 0.6 187 44 113 30 141 Negative Normal 250
34 C90298 30/M 14.2 9800 65 31 6 2 6 4.7 78 96 23 0.6 239 39 169 31 155 Negative Normal 210
35 C92056 26/M 11.1 6900 60 37 5 6 8 3.6 68 75 15 0.6 201 33 138 30 150 Negative Normal 190
36 C91493 28/M 10 5000 54 39 5 10 24 3.3 84 88 22 0.6 132 34 82 16 80 Negative Normal 210
37 C94291 21/M 15 7400 62 36 6 2 6 5 84 94 26 0.7 176 28 127 22 108 Negative Normal 170
38 B73595 43/M 11.2 6800 65 25 5 6 8 3.9 80 112 24 0.6 142 31 73 38 149 Negative Normal 210
39 5120 54/M 11.8 8100 53 40 6 8 30 3.7 88 112 20 0.6 189 37 120 32 164 Negative Normal 230
40 5184 37/M 11.6 8900 65 31 3 2 8 3.8 79 97 17 0.6 161 32 107 22 112 Negative Normal 220
TOTA DIR INDIR TOTA ALB GLOB ALB SUGA DEP BS BP URO OVA CYST
1 C80516 40/F 0.7 0.4 0.3 22 25 270 8 4.2 3.8 9 3.5 3.1 NIL NIL 2-
4PUS
NIL NIL N NIL NIL
2 4983 29/M 0.7 0.4 0.3 14 16 203 7.9 4.5 3.4 9.6 3 3.9 NIL NIL 2-4 
PUS
NIL NIL N NIL NIL
3 C80591 20/F 0.7 0.4 0.3 30 17 192 6.2 3.7 2.5 11.4 3.3 3.7 NIL NIL 1-
2PUS
NIL NIL N NIL NIL
4 C79343 21/F 0.7 0.4 0.3 20 17 201 6.8 3.8 3 10.7 3.5 4 NIL NIL 2-4 
PUS
NIL NIL N NIL NIL
5 C80968 25/F 0.7 0.4 0.3 9 18 195 7.7 4.2 3.5 9.3 3.4 4.9 NIL NIL 1-2 
PUS
NIL NIL N NIL NIL
6 C84952 46/M 0.6 0.3 0.3 29 32 141 7.8 4 3.5 8.7 4.2 6.7 NIL NIL 2-4 
PUS
NIL NIL N NIL NIL
7 C83148 29/F 0.6 0.4 0.2 20 29 214 7.3 4.3 3 8.6 3.9 4.8 NIL NIL 1.3 
PUS
NIL NIL N NIL NIL
8 C83357 29/F 0.6 0.3 0.3 20 22 144 7.5 4.6 3.5 9.9 4.3 4.8 NIL NIL 0-1 
PUS
NIL NIL N NIL NIL
9 C83859 21/F 0.9 0.5 0.4 24 21 295 7 3.4 3.6 9.9 3.5 3.9 NIL NIL 5-10 
PUS
NIL NIL N NIL NIL
10 C84354 23/F 0.7 0.4 0.3 29 24 204 6.6 3.8 3.2 10.3 4.4 3.7 NIL NIL 1-2 
PUS
NIL NIL N NIL NIL
11 C86528 38/M 0.6 0.3 0.3 27 26 343 8 4.2 3.8 8.7 4.5 3.8 NIL NIL 2-4 
PUS
NIL NIL N NIL NIL
12 C85576 34/F 0.7 0.4 0.3 23 17 116 6.8 3.8 3 10.1 3.6 3.4 NIL NIL 1-2 
PUS
NIL NIL N NIL NIL
13 C85444 40/F 0.7 0.4 0.3 48 50 286 8.3 4.3 4 10.9 3.4 4.6 NIL NIL 1-2 
PUS
NIL NIL N NIL NIL
14 C85401 28/F 0.6 0.3 0.3 18 20 237 8.5 4.3 4.2 9.8 4.2 4.3 NIL NIL 3-4 
PUS
NIL NIL N NIL NIL
15 C87290 42/F 0.6 0.3 0.3 21 19 193 7.1 4.1 3 9.9 3.6 3.8 NIL NIL 3-5 
PUS
NIL NIL N NIL NIL
16 C87563 52/F 0.5 0.3 0.2 16 17 217 7.5 3.6 3.9 9.3 3.5 6.2 NIL NIL 1-
3PUS
NIL NIL N NIL NIL
17 C87412 40/M 0.6 0.3 0.3 31 26 214 8 4.5 3.5 9.3 3.5 3.9 NIL NIL 4-6 
PUS
NIL NIL N NIL NIL
18 C89103 55/M 0.7 0.4 0.3 17 31 171 7.6 4.3 3.7 8.9 3.7 4.3 NIL NIL 4-5 
PUS
NIL NIL N NIL NIL
19 4077 33/F 0.5 0.3 0.2 26 28 171 7.8 4.3 3.5 8.7 3.9 4.7 NIL NIL 2-4 
PUS
NIL NIL N NIL NIL
20 C89542 42/F 0.7 0.4 0.3 14 22 270 7.8 4.7 3.1 9.5 3.6 4.1 NIL NIL 2-4 
PUS
NIL NIL N NIL NIL
21 C93882 44/F 0.5 0.3 0.2 27 26 184 7.2 3.8 3.4 8.8 4.1 4.2 NIL NIL 1-
2PUS
NIL NIL N NIL NIL
22 C88940 33/F 0.6 0.3 0.3 34 31 284 8.2 4.4 3.8 10.9 4 4.1 NIL NIL 1-2 
PUS
NIL NIL N NIL NIL
23 C91895 18/F 0.7 0.4 0.3 28 25 189 7.7 4 4 9.3 2.9 3.7 NIL NIL 1-
2PUS
NIL NIL N NIL NIL
24 C92628 32/M 0.7 0.4 0.3 21 18 201 7.9 4.6 3.3 10.5 4.4 5.9 NIL NIL 1-2 
PUS
NIL NIL N NIL NIL
25 4043 35/F 0.4 0.2 0.2 20 16 131 7.8 4.3 3.5 10.5 4.2 2.1 NIL NIL 2-4 
PUS
NIL NIL N NIL NIL
26 C87827 32/F 0.5 0.3 0.2 17 12 131 7.8 4.8 3 9.7 3.2 4.6 NIL NIL 2-4 
PUS
NIL NIL N NIL NIL
27 C90031 25/M 0.7 0.4 0.3 27 26 234 7.2 4.1 3.1 9.2 3.9 5.1 NIL NIL 2.4 
PUS
NIL NIL N NIL NIL
28 C90298 30/M 0.7 0.4 0.3 20 17 174 7.9 4.4 3.5 7.1 3.2 3.3 NIL NIL 2-4 
PUS
NIL NIL N NIL NIL
29 C92056 26/M 0.7 0.4 0.3 27 24 156 7.9 4.2 3.7 8.7 3.8 4.5 NIL NIL 2-4 
PUS
NIL NIL N NIL NIL
30 C91493 28/M 0.6 0.4 0.2 30 33 193 6.9 3.8 3.1 11.1 3.1 4.7 NIL NIL 3-6 
PUS
NIL NIL N NIL NIL
31 C94291 21/M 0.9 0.5 0.4 19 22 285 8.4 4.6 3.8 8.5 4.8 3.3 NIL NIL 2-4 
PUS
NIL NIL N NIL NIL
32 B73595 43/M 0.7 0.4 0.3 39 58 296 8.5 5.1 3.4 9.6 3.5 4.6 NIL NIL 2-3 
PUS
NIL NIL N NIL NIL
33 4254 47/F 0.8 0.5 0.3 15 21 109 7.4 3.8 3.2 8.8 3.7 4.6 NIL NIL 2-4 
PUS
NIL NIL N NIL NIL
34 5120 54/M 0.6 0.3 0.3 36 30 127 8.5 4.5 4 8.7 3.6 4.7 NIL NIL 1-2 
PUS
NIL NIL N NIL NIL
35 4147 46/F 0.4 0.2 0.2 21 17 139 8 3.1 4.9 8.7 3.8 4.6 NIL NIL 2-4 
PUS
NIL NIL N NIL NIL
36 D001578 32/F 0.5 0.3 0.2 20 19 178 7.1 3.7 3.4 9.3 4 3.9 NIL NIL 2-
4PUS
NIL NIL N NIL NIL
37 4206 55/F 0.8 0.5 0.4 23 13 181 7.9 4.8 3.1 9.1 3.3 4.3 NIL NIL 2-4 
PUS
NIL NIL N NIL NIL
38 4202 31/F 0.5 0.3 0.2 21 17 160 7.4 3.8 3.6 9.5 4.1 2.1 NIL NIL 2-4 
PUS
NIL NIL N NIL NIL
39 4205 40/F 0.5 0.3 0.2 26 28 171 7.8 4.3 3.5 8.7 3.9 4.7 NIL NIL 2-4 
PUS
NIL NIL N NIL NIL
40 5184 37/M 0.7 0.4 0.3 20 17 174 7.9 4.4 3.5 7.1 3.2 3.3 NIL NIL 2-4 
PUS
NIL NIL N NIL NIL
OP/IP Before Treatment
S.NO OP.NO
AGE/ 
Sex
BILIRUBIN
SGOT SGPT
ALKP
HOS
PROTEIN
CAL PHOS
URIC 
ACID
URINE MOTION
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